299. 嚢胞性線維症 Disease details / Clinical trials / Drug dev / DR info

0.12% saline
   Johns Hopkins University
      2007   Phase 2   NCT01293084   -
0.9% isotonic saline (IS), 4ML
   Heidelberg University
      2012   Phase 2   NCT01619657   Germany
0.9% W/V sodium chloride solution
   Merck Sharp & Dohme Corp.
      2010   Phase 2   NCT01181622   United States
      2006   Phase 3   NCT00357279   Canada;United States
1,5 (butylimino)-1,5-dideoxy-D-glucitol
   Actelion Pharmaceuticals Ltd
      2007   Phase 2   EUCTR2006-002049-35-ES   Spain
1-cyclopropyl-6-fluoro-1,4-dihydro-4-OXO-7-[1-piperazinyl]-3-quinoline carboxylic acid
   Bayer HealthCare AG
      2007   -   EUCTR2007-002912-24-DE   Germany
100 MG ELX (VX-445) / 50 MG TEZ / 75 MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
100 MG ELX /50 MG TEZ /75 MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
100 MG ELX/50 MG TEZ /75 MG IVA FDC
   VERTEX PHARMACEUTICALS INCORPORATED
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
100 MG ELX/50 MG TEZ/75 MG IVA fixed dose combination
   Vertex Pharmaceuticals Incorporated
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
100 MG TEZ/150 MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
100 MG VX-445 /50 MG TEZ/75 MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
100 MG VX-445/50 MG TEZ /75 MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
100 MG/M2 dose
   University of Washington
      2010   Phase 1   NCT01093521   United States
100-MG ELX (VX-445) / 50-MG TEZ / 75-MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
100-MG ELX (VX-455) / 50-MG TEZ / 75-MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
100-MG ELX / 50-MG TEZ / 75 -MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
100-MG VX-445 / 50-MG TEZ / 75- MG IVA FDC
   VERTEX PHARMACEUTICALS INCORPORATED
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
100-MG VX-445 / 50-MG TEZ / 75-MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
100-MG VX-445 /50-MG TEZ/75-MG
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
100-MG VX-445/50-MG TEZ/75-MG IVA FDC
   VERTEX PHARMACEUTICALS INCORPORATED
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
100G ELX / 50MG TEZ / 75MG IVA
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
100MG ELX/50MG TEZ /75MG IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
100MG VX-445/50MG TEZ /75MG IVA FDC
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
12-month questionnaire
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
129XE
   Children's Hospital Medical Center, Cincinnati
      2022   Phase 4   NCT05517655   United States
129XE small and large human lung coil
   Thunder Bay Regional Health Research Institute
      2020   Early Phase 1   NCT02748798   Canada
150-MG ivacaftor
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
150MG ivacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
2% chlorhexidine solution wipes
   University of North Carolina, Chapel Hill
      2011   Phase 2   NCT01349192   United States
2,3-dihydroxybutanedioic acid
   University of LIverpool
      2019   Phase 1;Phase 2   EUCTR2017-001259-29-GB   United Kingdom
2-aminoethanethiol
   University of LIverpool
      2019   Phase 1;Phase 2   EUCTR2017-001259-29-GB   United Kingdom
200 MG/M2 dose
   University of Washington
      2010   Phase 1   NCT01093521   United States
2622u90 duramycin
   AOP Orphan Pharmaceuticals AG
      2008   -   EUCTR2006-006693-24-CZ   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-006693-24-DE   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
      -   Phase 2   EUCTR2006-006693-24-PL   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
3 MG
   Verona Pharma plc
      2024   Phase 2   NCT06559150   Spain;United Kingdom;United States
3HE human lung coil
   Thunder Bay Regional Health Research Institute
      2020   Early Phase 1   NCT02748798   Canada
4% chlorhexidine gluconate liquid skin cleanser
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
4.2% nacl/inhalation solution
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
4D-710
   4D Molecular Therapeutics
      2022   Phase 1/Phase 2   NCT05248230   United States
5-methyltetrahydrofolate and vitamin B12
   Universita di Verona
      2004   -   NCT00730509   Italy
50 MG ELX/25 MG TEZ/37.5 MG IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
50 MG ELX/25 MG TEZ/37.5 MG IVA fixed dose combination
   Vertex Pharmaceuticals Incorporated
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
5000 IU OF cholecalciferol
   St. Michael's Hospital, Toronto
      2008   -   NCT00685971   Canada
552-02
   Parion Sciences
      2006   Phase 1/Phase 2   NCT00274313   United States
6% hypertonic saline (HS), 4ML
   Heidelberg University
      2012   Phase 2   NCT01619657   Germany
7% hypertonic saline VIA nebulization
   University of North Carolina, Chapel Hill
      2024   Phase 4   NCT06242795   United States
7% nacl
   University of North Carolina
      2001   Phase 2   NCT00274391   United States
7% saline
   Johns Hopkins University
      2007   Phase 2   NCT01293084   -
75-MG ivacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
80MG ELX / 40MG TEZ / 60MG IVA
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
A-step
   The Alfred
      2016   -   NCT02717650   Australia
AAC hexal
   Aarhus University Hospital
      2016   Phase 2   EUCTR2016-000354-35-DK   Denmark
ABBV-119
   AbbVie
      2021   Phase 2   NCT04853368   Australia;Belgium;Czechia;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005805-25-NL   Australia;Belgium;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom
      2021   Phase 2   EUCTR2020-005805-25-HU   Hungary
      2021   Phase 2   EUCTR2020-005805-25-BE   Belgium;Hungary;Netherlands
ABBV-2222
   AbbVie Deutschland
      2022   Phase 2   EUCTR2019-000750-63-RO   Belgium;Canada;Czechia;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-NL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-HU   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-GB   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-FR   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-BE   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005805-25-NL   Australia;Belgium;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom
      2021   Phase 2   EUCTR2020-005805-25-HU   Hungary
      2021   Phase 2   EUCTR2020-005805-25-BE   Belgium;Hungary;Netherlands
      2020   Phase 2   EUCTR2019-000750-63-PL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
ABBV-3067
   AbbVie Deutschland
      2022   Phase 2   EUCTR2019-000750-63-RO   Belgium;Canada;Czechia;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-NL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-HU   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-GB   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-FR   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-BE   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005805-25-NL   Australia;Belgium;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom
      2021   Phase 2   EUCTR2020-005805-25-HU   Hungary
      2021   Phase 2   EUCTR2020-005805-25-BE   Belgium;Hungary;Netherlands
      2020   Phase 2   EUCTR2019-000750-63-PL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
ABBV-576
   AbbVie
      2022   Phase 1   NCT05530278   United States
      2021   Phase 2   NCT04853368   Australia;Belgium;Czechia;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom;United States
Abelcet
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-019194-15-IT   Italy
Absorptive clearance scan
   Tim Corcoran
      2013   Phase 1   NCT01887197   United States
ACC
   Aarhus University Hospital
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
ACC600tabs
   Rigshospitalet
      2010   Phase 4   EUCTR2007-001401-15-DK   Denmark
Accelerometry TO assess physical activity
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Acebilustat
   Celtaxsys Inc.
      2016   Phase 2   EUCTR2015-002677-38-IT   Belgium;France;Germany;Italy;Netherlands;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-GB   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-DE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-BE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
Acetate
   University of Texas Southwestern Medical Center
      2014   Early Phase 1   NCT02036879   United States
Acetylcysteine
   Aarhus University Hospital
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
   Rigshospitalet
      2010   Phase 4   EUCTR2007-001401-15-DK   Denmark
   University Hospital, Ghent
      2010   Phase 4   NCT00996424   Belgium
   West China Hospital, Sichuan University
      2020   Phase 4   ChiCTR2000031817   China
Acetylcysteine sodium
   Aarhus University Hospital
      2016   Phase 2   EUCTR2016-000354-35-DK   Denmark
Acide tranexamique mylan 0,5 G/ 5 ML, solution injectable
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2021   Phase 3   EUCTR2020-005931-58-FR   France
Active treatment group 7% hypertonic saline
   University of Washington, the Collaborative Health Studies Coordinating Center
      2015   Phase 2/Phase 3   NCT02950883   Australia;Belgium;Canada;Denmark;France;Italy;Netherlands;Spain;United States
Actrapid 100 IU/ML, solution FOR injection IN A vial
   St George's, University of London
      2008   -   EUCTR2007-004956-35-GB   United Kingdom
Actrapid penfill 100UI/ML
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
Acute antioxidant
   Augusta University
      2015   -   NCT02690064   United States
AD26.COV2-S.02
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
AD5-CB-cftr
   National Center for Research Resources (NCRR)
      1993   Phase 1   NCT00004779   -
Additional health questionnaire
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Adempas
   Bayer
      2014   Phase 2   NCT02170025   Belgium;Canada;France;Germany;Greece;Italy;Netherlands;United Kingdom;United States
Adempas 0.125 MG
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
Adempas 0.5 MG
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
   Bayer HealthCare AG
      2015   Phase 2   EUCTR2013-004595-35-NL   Belgium;Canada;France;Germany;Netherlands;United Kingdom;United States
Adempas 1.0 MG
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
   Bayer HealthCare AG
      2015   Phase 2   EUCTR2013-004595-35-NL   Belgium;Canada;France;Germany;Netherlands;United Kingdom;United States
Adempas 2.0 MG
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
   Bayer HealthCare AG
      2015   Phase 2   EUCTR2013-004595-35-NL   Belgium;Canada;France;Germany;Netherlands;United Kingdom;United States
Adeno-associated virus-cftr vector
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      1999   Phase 1   NCT00004533   -
Adrenalina
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
Adrulipase
   Entero Therapeutics
      2023   Phase 2   NCT05719311   United States
Advagraf prolonged-release hard capsules
   Hopital Erasme - Chest service
      2009   Phase 4   EUCTR2009-014050-15-BE   Belgium
AER002
   Aerovance Inc
      2005   Phase 1;Phase 2   EUCTR2005-000313-35-GB   United Kingdom
Aerobic exercise
   University of Alabama at Birmingham
      2008   -   NCT01759342   United States
Aeroquin
   Amgen
      2010   Phase 3   NCT01180634   Australia;Canada;Israel;New Zealand;United States
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-IE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019634-26-GB   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   -   EUCTR2010-019634-26-DE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      -   Phase 3   EUCTR2010-019634-26-FR   France;Germany;Ireland;United Kingdom
Aerosolized, human, plasma-derived alpha-1 antitrypsin
   Kamada, Ltd.
      2007   Phase 2   NCT00499837   Israel
Aerosoltherapy
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2018   -   NCT03655249   Belgium
Aerovanc
   Savara Inc.
      2011   Phase 1   NCT01537666   Australia
AIR - oxygen
   Assistance Publique - Hôpitaux de Paris
      2012   -   NCT01586728   France
AIR dnase
   Protalix
      2016   Phase 2   NCT02722122   Israel
      2015   Phase 1   NCT02605590   Israel
Airway clearance technique
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2012   -   NCT02201082   Belgium
Albuterol
   National Center for Research Resources (NCRR)
      2000   -   NCT00005110   United States
   University of Arizona
      2009   -   NCT01880723   United States
   University of Florida
      2007   -   NCT01851642   United States
Alendronate
   Istituto Auxologico Italiano
      2002   Phase 3   NCT01812551   Holy See (Vatican City State);Italy
   McMaster University
      2003   Phase 4   NCT00157690   Canada
Alendronate sodium
   University of North Carolina
      1998   -   NCT00004489   United States
Alginate oligosaccharide
   AlgiPharma AS
      2015   Phase 2   NCT02453789   Germany
      2014   Phase 2   NCT02157922   Denmark;Germany;Norway;Sweden;United Kingdom
ALLO-hmscs
   Joshua M Hare
      2020   Phase 1   NCT03058068   United States
Alpha-1 HC 100 MG
   Grifols Therapeutics Inc.
      2012   Phase 2   NCT01684410   United States
Alpha-1 HC 200 MG
   Grifols Therapeutics Inc.
      2012   Phase 2   NCT01684410   United States
Alpha1-proteinase inhibitor
   Grifols Therapeutics Inc.
      2003   Phase 2   NCT00486837   -
ALTU-135
   ALTUS PHARMACEUTICALS INC
      2007   -   EUCTR2007-000178-21-IT   Italy
      2007   -   EUCTR2007-000171-41-IT   Italy
   Altus Pharmaceuticals Inc
      2007   Phase 3   EUCTR2007-000171-41-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000171-41-PL   Italy;Poland;Slovakia
   Altus Pharmaceuticals Inc.
      2007   Phase 3   EUCTR2007-000178-21-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000178-21-PL   Italy;Poland;Slovakia
Altus-135
   ALTUS PHARMACEUTICALS INC
      2007   -   EUCTR2007-000171-41-IT   Italy
ALX-009
   Alaxia SAS
      2015   Phase 1   NCT02598999   France
Amikacin
   Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine
      2015   -   ChiCTR-IPC-15005915   -
   Qilu Hospital of Shandong University
      2014   Phase 4   NCT02081963   China
   The Leeds Teaching Hospitals NHS Trust
      2015   -   NCT02489955   United Kingdom
   University Hospital St Luc, Brussels
      2014   -   NCT02084043   Belgium;Switzerland
Amikacin nebulization
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2012   -   NCT02201082   Belgium
Amikacin sulfate
   INSMED INCORPORATED
      2012   -   EUCTR2011-000443-24-IT   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000441-20-IT   Austria;Bulgaria;Canada;Denmark;Greece;Hungary;Ireland;Italy;Netherlands;Spain;United Kingdom
   Insmed Incorporated
      2013   Phase 3   EUCTR2011-000443-24-NL   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2011-000443-24-SE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2011-000443-24-PL   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2011-000443-24-DK   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2011-000443-24-BE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-NL   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-IE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-DK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-BG   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2012   Phase 3   EUCTR2011-000441-20-BE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   Phase 3   EUCTR2011-000443-24-SK   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-IE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-HU   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-GR   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000443-24-GB   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000443-24-FR   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-DE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000443-24-BG   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000443-24-AT   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000442-38-ES   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-000442-38-BG   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-000441-20-SK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-HU   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-GR   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000441-20-GB   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-DE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-AT   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      -   Phase 3   EUCTR2011-000442-38-PL   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
   Transave, Inc.
      2007   -   EUCTR2006-006980-22-BE   Belgium;Hungary
      -   Phase 2   EUCTR2006-006980-22-PL   Belgium;Hungary;Poland;Slovakia
Amikacine nebulization
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2015   -   NCT02535130   Belgium
Amikin, amiklin, amicacin, BB-K8, biklin, fabianol, kaminax, mikavir, novamin, pierami
   Transave, Inc
      2005   Phase 2   EUCTR2005-004389-17-HU   Hungary
Amikin®, amiklin, amicacin, BB-K8, biklin®, fabianol®, kaminax, mikavir, novamin®, pierami
   Transave, Inc.
      2005   -   EUCTR2005-004899-21-BE   Belgium
Amilasa
   ANTHERA Pharmaceuticals, Inc.
      2016   Phase 3   EUCTR2016-002851-92-ES   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
Amiloride
   FDA Office of Orphan Products Development
      1996   -   NCT00004705   -
Amiloride HCL
   University of North Carolina
      2001   Phase 2   NCT00274391   United States
Amiloride solution FOR inhalation
   Children's Hospital Boston
      2006   Phase 1   NCT00547053   United States
Aminoglycoside
   Chris Goss
      2023   Phase 4   NCT05548283   Canada;United States
Amitriptylin-CT
   PSKS
      -   Phase 2   EUCTR2008-002673-13-DE   Germany
Amitriptylin-CT tabletten
   Paediatrisches Sekretariat fuer Klinische Studien
      2006   Phase 2   EUCTR2006-002259-33-DE   Germany
Amitriptyline
   PSKS
      -   Phase 2   EUCTR2008-002673-13-DE   Germany
   Paediatrisches Sekretariat fuer Klinische Studien
      2006   Phase 2   EUCTR2006-002259-33-DE   Germany
   University Children’s Hospital Tuebingen
      2009   Phase 2   NCT01309178   Germany
   University Hospital Tuebingen
      2006   Phase 2   NCT00515229   Germany
Amoxicillin
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Amoxicillin and clavulanic acid
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Amphotericin B
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-019194-15-IT   Italy
   Poitiers University Hospital
      2014   Phase 2   NCT02273661   France
Amylase
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2016-002851-92-HU   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 4   EUCTR2016-002851-92-CZ   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-002851-92-PL   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
   Altus Pharmaceuticals Inc
      2007   Phase 3   EUCTR2007-000171-41-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000171-41-PL   Italy;Poland;Slovakia
   Altus Pharmaceuticals Inc.
      2007   Phase 3   EUCTR2007-000178-21-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000178-21-PL   Italy;Poland;Slovakia
Anakinra
   Heidelberg University
      2022   Phase 2   NCT03925194   Germany
   Ruprecht-Karls-University Heidelberg, Medical Faculty
      2019   Phase 2   EUCTR2016-004786-80-DE   Germany
Andecaliximab
   Gilead Sciences
      2016   Phase 2   NCT02759562   Australia;Belgium;Canada;France;Germany;Ireland;Spain;United Kingdom;United States
ANG003
   Anagram Therapeutics, Inc.
      2023   Phase 1   NCT06052293   United States
Anthropometric measurements
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
ANTI-pseudomonas IGY gargle
   Immunsystem AB
      2003   Phase 1/Phase 2   NCT00633191   Sweden
ANTI-reflux pharmacotherapy
   Bayside Health
      2001   -   NCT00164021   Australia
Antibiotic
   Aradigm Corporation
      2010   -   NCT01090908   -
   Chris Goss
      2016   Phase 4   NCT02781610   Canada;United States
Antioxidant cocktail
   Augusta University
      2011   Phase 2   NCT01772758   United States
Antioxidant supplement
   Ain Shams University
      2024   -   NCT06875050   Egypt
Antistaminici H1 - H2
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
AP-PA02
   Armata Pharmaceuticals, Inc.
      2023   Phase 2   NCT05616221   United States
      2020   Phase 1/Phase 2   NCT04596319   United States
Aquadek
   University of Colorado, Denver
      2007   Phase 1/Phase 2   NCT01018303   United States
Aquadeks-2
   University of Colorado, Denver
      2013   Phase 2   NCT01859390   United States
ARCT-032
   Arcturus Therapeutics, Inc.
      2024   Phase 2   NCT06747858   United States
      2023   Phase 1   NCT05712538   New Zealand
ARD-3150
   Aradigm Corporation
      2015   Phase 3   EUCTR2013-005366-19-PL   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005366-19-FR   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005348-28-PL   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-RO   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-IT   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-HU   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-GB   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-ES   Australia;Canada;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-RO   Australia;Canada;Georgia;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-LV   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IT   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IE   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-HU   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-GB   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-ES   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
Aridol or osmohale
   Pharmaxis Pharmaceuticals Limited
      -   Phase 3   EUCTR2007-001412-23-DE   Germany;Ireland;United Kingdom
Arikayce™ 140 MG
   Insmed Incorporated
      2008   Phase 1/Phase 2   NCT00558844   United States
Arikayce™ 560 MG
   Insmed Incorporated
      2008   Phase 1/Phase 2   NCT00558844   United States
Arikayce™ 70 MG
   Insmed Incorporated
      2008   Phase 1/Phase 2   NCT00558844   United States
Arina-1
   Renovion, Inc.
      2022   Phase 2   NCT05495243   United States
ARO-enac
   Arrowhead Pharmaceuticals
      2020   Phase 1   NCT04375514   Australia;New Zealand
Assessment OF arterial stiffness using THE vasera VS-1500N
   I.M. Sechenov First Moscow State Medical University
      2023   -   NCT05727852   Russian Federation
Asthma patients
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2015   -   NCT02558127   Spain
Ataluren
   PTC THERAPEUTICS, INC.
      2010   -   EUCTR2010-019692-30-IT   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
   PTC Therapeutics
      2015   Phase 3   NCT02456103   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   NCT02139306   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   NCT02107859   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2010   Phase 3   NCT01140451   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2009   Phase 3   NCT00803205   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2007   Phase 2   NCT00458341   Belgium;France;Israel
      2005   Phase 2   NCT00237380   Israel
   PTC Therapeutics, Inc
      2011   Phase 3   EUCTR2010-019692-30-GB   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019692-30-ES   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-019692-30-DE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   -   EUCTR2010-019692-30-SE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   -   EUCTR2010-019692-30-NL   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2010   -   EUCTR2010-019692-30-BE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-BE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   PTC Therapeutics, Inc.
      2016   Phase 3   EUCTR2014-005355-83-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-GR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005449-35-FR   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2015   Phase 3   EUCTR2013-004581-34-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-GR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005449-35-SE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-IT   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-ES   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-DE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-BE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-004581-34-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Germany;Greece;Israel;Italy;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Germany;Greece;Israel;Italy;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
   University of Alabama at Birmingham
      2017   Phase 4   NCT03256968   United States
Atorvastatin
   NHS Lothian
      2010   Phase 4   EUCTR2010-022042-24-GB   United Kingdom
      2010   Phase 4   EUCTR2010-022040-20-GB   United Kingdom
   University of Edinburgh
      2010   Phase 4   NCT01299194   United Kingdom
      2010   Phase 4   NCT01299181   United Kingdom
Atropina
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
Augmentin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Autogenic drainage
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2018   -   NCT03655249   Belgium
Avian polyclonal IGY antibody against PA
   MUKOVISZIDOSE E.V.
      2012   Phase 3   EUCTR2011-000801-39-IT   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
   Mukoviszidose Institute gGmbH
      2014   Phase 3   EUCTR2011-000801-39-HU   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2014   Phase 3   EUCTR2011-000801-39-ES   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2014   Phase 3   EUCTR2011-000801-39-AT   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2013   Phase 3   EUCTR2011-000801-39-IE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2012   Phase 3   EUCTR2011-000801-39-SE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2012   Phase 3   EUCTR2011-000801-39-BE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2011   Phase 3   EUCTR2011-000801-39-DE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
AZD1236
   AstraZeneca
      2009   Phase 2   NCT00812045   Canada;Netherlands;Poland;Spain
   AstraZeneca AB
      2008   -   EUCTR2008-004699-34-NL   Netherlands;Spain
      2008   -   EUCTR2008-004699-34-ES   Netherlands;Spain
AZD5634
   AstraZeneca
      2017   Phase 1   NCT02950805   United States
AZD5634 FOR infusion
   AstraZeneca
      2016   Phase 1   NCT02679729   United States
AZD5634 FOR inhalation
   AstraZeneca
      2016   Phase 1   NCT02679729   United States
AZD7986
   Insmed Incorporated
      2021   Phase 3   EUCTR2020-003688-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-IE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2019   Phase 2   EUCTR2017-002533-32-BE   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-SE   Australia;Belgium;Bulgaria;Denmark;France;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-PL   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-NL   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-GB   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-ES   Australia;Belgium;Bulgaria;Canada;Denmark;France;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-DK   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-DE   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-BG   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2020-003688-25-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
AZD9668
   AstraZeneca
      2008   Phase 2   NCT00757848   Denmark;Germany;Poland;Russian Federation;Sweden;United Kingdom
   AstraZeneca AB
      2009   -   EUCTR2008-001530-27-GB   Denmark;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-001530-27-DK   Denmark;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-001530-27-SE   Denmark;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-001530-27-DE   Denmark;Germany;Sweden;United Kingdom
Azithromycin
   Assistance Publique Hopitaux De Marseille
      2015   Phase 3   NCT02531984   -
   Bonnie Ramsey
      2014   Phase 3   NCT02054156   United States
   Copenhagen CF-centre
      2009   Phase 4   EUCTR2006-003275-12-NO   Denmark;Norway;Sweden
      2007   Phase 4   EUCTR2006-003275-12-DK   Denmark
      -   Phase 4   EUCTR2006-003275-12-SE   Denmark;Norway;Sweden
   Hospices Civils de Lyon
      2023   -   NCT05663255   -
      2014   -   NCT02803944   France
   Instituto de Investigacion Sanitaria La Fe
      2006   -   NCT01463371   Spain
   Seattle Children's Hospital
      2016   Phase 4   NCT02677701   United States
   St. Michael's Hospital, Toronto
      2006   Phase 2   NCT00298922   Canada
   The First People' Hospital of Jiashan
      2022   Phase 4   ChiCTR2100052906   China
   The University of Queensland
      2012   Phase 3   NCT01270074   Australia;New Zealand
   University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn)
      2012   Phase 4   NCT03045198   -
   University of Colorado, Denver
      2014   -   NCT02372383   United States
Azithromycin 250 MG tablets
   CF Therapeutics Development Network Coordinating Center
      2007   Phase 4   NCT00431964   Canada;United States
Azithromycin 500 MG FILM-coated tablet
   university medical center utrecht
      2018   Phase 4   EUCTR2016-001440-18-NL   Netherlands
Azithromycin dihydrate
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      -   Phase 3   EUCTR2014-003023-22-FR   France
Azli
   GILEAD SCIENCES INC.
      2012   -   EUCTR2011-001255-36-IT   Austria;Germany;Ireland;Italy;Netherlands;Spain;United States
   Gilead Sciences, Inc.
      2012   Phase 3   EUCTR2011-001362-18-ES   France;Germany;Italy;Poland;Spain;United States
   Gilead Sciences
      2017   Phase 3   NCT03219164   Austria;Belgium;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2012   Phase 3   NCT01641822   United States
      2011   Phase 3   NCT01404234   France;Germany;Italy;Poland;Spain;United States
      2011   Phase 2   NCT01375049   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2011   Phase 3   NCT01314716   Australia;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
      2011   Phase 3   NCT01313624   Australia;Canada;United States
      2010   Phase 3   NCT01059565   Canada;United States
      2008   Phase 3   NCT00757237   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2008   Phase 3   NCT00712166   Australia;Canada;United States
      2005   Phase 3   NCT00128492   Australia;Canada;New Zealand;United States
      2005   Phase 3   NCT00112359   Australia;Canada;New Zealand;United States
      2005   Phase 3   NCT00104520   United States
   Gilead Sciences Inc
      2010   -   EUCTR2007-004277-26-AT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2007-004277-26-GB   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-PT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-NL   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-FR   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-ES   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DK   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-BE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      -   -   EUCTR2007-004277-26-Outside-EU/EEA   United States
   Gilead Sciences, Inc.
      2018   Phase 3   EUCTR2016-002749-42-NL   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002749-42-GR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-IT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-GB   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-FR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-ES   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DK   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-BE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-AT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2012   -   EUCTR2011-001362-18-DE   France;Germany;Italy;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-NL   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-IE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-DE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   Phase 2   EUCTR2011-001255-36-BE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-AT   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2011   Phase 2   EUCTR2011-001255-36-ES   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      -   Phase 3   EUCTR2016-002749-42-IE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      -   -   EUCTR2015-000398-11-Outside-EU/EEA   United States
      -   -   EUCTR2015-000397-36-Outside-EU/EEA   Canada
      -   -   EUCTR2015-000396-26-Outside-EU/EEA   United States
      -   -   EUCTR2015-000395-97-Outside-EU/EEA   Australia;Canada;United States
      -   -   EUCTR2011-001362-18-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2011-001362-18-FR   France;Germany;Italy;Poland;Spain;United States
      -   -   EUCTR2011-001255-36-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2011-001255-36-FR   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      -   -   EUCTR2009-011740-19-Outside-EU/EEA   Canada;United States
Aztreonam
   Gilead Sciences
      2003   Phase 2   NCT01055847   United States
   Gilead Sciences Inc
      2008   -   EUCTR2007-004277-26-IT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      -   -   EUCTR2007-004277-26-Outside-EU/EEA   United States
   Gilead Sciences, Inc.
      2018   Phase 3   EUCTR2016-002749-42-NL   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002749-42-GR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-IT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-GB   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-FR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-ES   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DK   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-BE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-AT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-002749-42-IE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      -   -   EUCTR2015-000398-11-Outside-EU/EEA   United States
      -   -   EUCTR2015-000397-36-Outside-EU/EEA   Canada
      -   -   EUCTR2015-000396-26-Outside-EU/EEA   United States
      -   -   EUCTR2015-000395-97-Outside-EU/EEA   Australia;Canada;United States
      -   -   EUCTR2009-011740-19-Outside-EU/EEA   Canada;United States
   Liverpool Heart & Chest Hospital
      2016   Phase 4   EUCTR2016-002832-34-GB   United Kingdom
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2017   Phase 4   NCT02894684   United Kingdom
Aztreonam FOR inhalation solution
   Gilead Sciences
      2011   Phase 2   NCT01375049   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2008   Phase 3   NCT00757237   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
   Gilead Sciences, Inc.
      2012   -   EUCTR2011-001362-18-DE   France;Germany;Italy;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-NL   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-IE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-DE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   Phase 2   EUCTR2011-001255-36-BE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-AT   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2011   Phase 2   EUCTR2011-001255-36-ES   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      -   -   EUCTR2011-001362-18-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2011-001362-18-FR   France;Germany;Italy;Poland;Spain;United States
      -   -   EUCTR2011-001255-36-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2011-001255-36-FR   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
Aztreonam lysine
   Gilead Sciences
      2009   -   NCT00989807   Canada
   Gilead Sciences Inc
      2010   -   EUCTR2007-004277-26-AT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2007-004277-26-GB   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-PT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-NL   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-FR   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-ES   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DK   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-BE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
Aztreonam lysine FOR inhalation
   Gilead Sciences
      2003   -   NCT00499720   Puerto Rico;United States
   Novartis Pharmaceuticals
      2010   -   NCT01460836   -
Aztreonam solucióN para inhalacióN
   Gilead Sciences, Inc.
      2012   Phase 3   EUCTR2011-001362-18-ES   France;Germany;Italy;Poland;Spain;United States
Aztreonan lysine
   Gilead Sciences Inc
      2008   -   EUCTR2007-004277-26-IT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
Bactrim
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Balance exercise
   University of Alabama at Birmingham
      2008   -   NCT01759342   United States
BAY 85-8501
   Bayer HealthCare AG
      2013   Phase 2   EUCTR2012-004491-18-IT   Italy;United Kingdom
      2013   Phase 2   EUCTR2012-004491-18-GB   Italy;Spain;United Kingdom
      2013   -   EUCTR2012-004491-18-ES   Spain;United Kingdom
BAY Q 3939
   Bayer HealthCare AG
      2007   -   EUCTR2007-002912-24-DE   Germany
BAY63-2521
   Bayer
      2014   Phase 2   NCT02170025   Belgium;Canada;France;Germany;Greece;Italy;Netherlands;United Kingdom;United States
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
   Bayer HealthCare AG
      2015   Phase 2   EUCTR2013-004595-35-NL   Belgium;Canada;France;Germany;Netherlands;United Kingdom;United States
BAY85-8501
   Bayer
      2013   Phase 2   NCT01818544   France;Germany;Italy;Spain;United Kingdom
BAYQ3939
   BAYER HEALTHCARE AG
      2013   Phase 3   EUCTR2011-004208-39-IT   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
   Bayer
      2016   -   NCT02661438   United States
      2016   -   NCT02555059   Japan
      2013   Phase 3   NCT01764841   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
      2009   Phase 2   NCT00930982   Australia;Germany;Spain;Sweden;United Kingdom;United States
      2009   Phase 1   NCT00910351   United States
      2008   Phase 2   NCT00645788   Australia;Canada;Denmark;Germany;Israel;Norway;Sweden;United Kingdom;United States
   Bayer AG
      2014   Phase 3   EUCTR2013-004659-19-BG   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
   Bayer AG
      2014   Phase 3   EUCTR2013-004659-19-NL   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-LT   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-DE   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-CZ   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-AT   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
   Bayer HealthCare AG
      2014   Phase 3   EUCTR2011-004208-39-SK   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2014   -   EUCTR2011-004208-39-LV   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-GB   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-FR   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-ES   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
      2013   -   EUCTR2011-004208-39-DK   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-DE   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2009   -   EUCTR2009-009869-34-SE   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-GB   Germany;Spain;Sweden;United Kingdom
      2009   Phase 2   EUCTR2009-009869-34-ES   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-DE   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008314-40-SE   Denmark;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-008314-40-DK   Denmark;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-008314-40-DE   Denmark;Germany;Sweden;United Kingdom
   Bayer Healthcare AG
      2009   -   EUCTR2008-008314-40-GB   Denmark;Germany;Sweden;United Kingdom
   Bayer Healthcare AG, D-51368 Leverkusen, Germany
      2014   Phase 3   EUCTR2013-004659-19-SK   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-PT   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-LV   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
BCG tice vaccine
   Johns Hopkins University
      2021   Phase 2   NCT04884308   United States
Benralizumab
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
   AstraZeneca
      2021   Phase 3   NCT05006573   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
   AstraZeneca AB
      2021   Phase 3   EUCTR2020-004068-24-PL   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DK   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DE   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
BETA-lactam antibiotic
   Chris Goss
      2023   Phase 4   NCT05548283   Canada;United States
Bethkis
   Mylan Inc.
      2015   -   NCT02449031   United States
BH4 20MG
   Augusta University
      2011   Phase 2   NCT01772758   United States
BH4 5MG
   Augusta University
      2011   Phase 2   NCT01772758   United States
BI 1265162
   Boehringer Ingelheim
      2019   Phase 2   NCT04059094   Belgium;Canada;France;Germany;Spain;Sweden;United Kingdom;United States
BI 1265162 10 µG
   Boehringer Ingelheim
      2019   Phase 2   EUCTR2019-000261-21-SE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim France
      2019   Phase 2   EUCTR2019-000261-21-FR   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Limited
      2019   Phase 2   EUCTR2019-000261-21-IE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000261-21-GB   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2019   Phase 2   EUCTR2019-000261-21-DE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim, S.A.
      2019   Phase 2   EUCTR2019-000261-21-ES   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2019   Phase 2   EUCTR2019-000261-21-BE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
BI 1265162 100 µG
   Boehringer Ingelheim
      2019   Phase 2   EUCTR2019-000261-21-SE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim France
      2019   Phase 2   EUCTR2019-000261-21-FR   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Limited
      2019   Phase 2   EUCTR2019-000261-21-IE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000261-21-GB   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2019   Phase 2   EUCTR2019-000261-21-DE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim, S.A.
      2019   Phase 2   EUCTR2019-000261-21-ES   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2019   Phase 2   EUCTR2019-000261-21-BE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
BI 1265162 25 µG
   Boehringer Ingelheim
      2019   Phase 2   EUCTR2019-000261-21-SE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim France
      2019   Phase 2   EUCTR2019-000261-21-FR   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Limited
      2019   Phase 2   EUCTR2019-000261-21-IE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000261-21-GB   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2019   Phase 2   EUCTR2019-000261-21-DE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim, S.A.
      2019   Phase 2   EUCTR2019-000261-21-ES   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2019   Phase 2   EUCTR2019-000261-21-BE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
BI 1265162 50 µG
   Boehringer Ingelheim
      2019   Phase 2   EUCTR2019-000261-21-SE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim France
      2019   Phase 2   EUCTR2019-000261-21-FR   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Limited
      2019   Phase 2   EUCTR2019-000261-21-IE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000261-21-GB   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2019   Phase 2   EUCTR2019-000261-21-DE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   Boehringer Ingelheim, S.A.
      2019   Phase 2   EUCTR2019-000261-21-ES   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2019   Phase 2   EUCTR2019-000261-21-BE   Belgium;Canada;France;Germany;Ireland;Spain;Sweden;United Kingdom;United States
BI 1291583
   Boehringer Ingelheim
      2024   Phase 2   NCT05865886   Belgium;France;Germany;Italy;Netherlands;Spain;United States
BI 1323495
   Boehringer Ingelheim
      2021   Phase 1   NCT04656275   Germany;United Kingdom
BI 3720931
   Boehringer Ingelheim
      2025   Phase 1/Phase 2   NCT06962852   France;Italy;Netherlands;Spain;United Kingdom
      2024   Phase 1/Phase 2   NCT06515002   France;Italy;Netherlands;Spain;United Kingdom
BI 443651
   Boehringer Ingelheim
      2017   Phase 1   NCT02976519   Germany;United Kingdom
BIA SUB-study
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Biil 284 BS, high dose
   Boehringer Ingelheim
      2002   Phase 1   NCT02269189   -
Biil 284 BS, high dose, adult patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
Biil 284 BS, high dose, pediatric patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
Biil 284 BS, LOW dose
   Boehringer Ingelheim
      2002   Phase 1   NCT02269189   -
Biil 284 BS, LOW dose, adult patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
Biil 284 BS, LOW dose, pediatric patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
Biil 284 BS, medium dose, adult patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
Biil 284 BS, medium dose, pediatric patients
   Boehringer Ingelheim
      2001   Phase 1   NCT02265679   -
BIO-25 probiotic
   Sheba Medical Center
      2010   -   NCT01201434   -
Bisphosphonate treatment
   Gilles Boire
      2001   Phase 4   NCT01882400   Canada
BLF
   Alaxia SAS
      2015   Phase 1   NCT02598999   France
Blood draw
   Emory University
      2015   -   NCT02589444   United States
   University of Florida
      2007   -   NCT01851642   United States
Blood glucose results
   Royal Brompton & Harefield NHS Foundation Trust
      2013   -   NCT01883037   United Kingdom
Blood or saliva sample collection
   Children's Hospital of Philadelphia
      2013   -   NCT01852448   United States
Blood sample
   Assistance Publique - Hôpitaux de Paris
      2024   -   NCT06147414   France
      2019   -   NCT03894657   France
   Hopital Foch
      2016   -   NCT02850692   France
   Hospices Civils de Lyon
      2022   -   NCT05614336   France
BMI and lean mass index from DXA
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Boost VHC
   Virginia Commonwealth University
      2022   -   NCT03931252   United States
Boots high strength garlic odour controlled
   University of Nottingham
      2005   Phase 2   EUCTR2005-000311-98-GB   United Kingdom
Bramicil - 100 MG/ 2 ML soluzione iniettabile 10 fiale DA 2 ML
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
Bramitob
   ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
      -   Phase 4   EUCTR2014-001401-41-IT   Italy;Netherlands
   Erasmus University Medical Centre
      2012   -   EUCTR2012-002503-17-NL   Netherlands
   Haga Hospital
      2014   -   EUCTR2013-004488-30-NL   Netherlands
Bramitob 300MG/4ML nebuliser solution
      2014   -   EUCTR2014-001401-41-NL   Netherlands
Bramitob*nebul 28F 300MG/4ML
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
      2011   -   EUCTR2011-001821-26-IT   Italy
Bramitob*nebul 56F 300MG/4ML
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
Bramitob® administered BY pari eflow® rapid electronic nebulizer
   Chiesi Farmaceutici S.p.A.
      2010   Phase 1   NCT01116089   Czech Republic;Czechia;Moldova, Republic of;Russian Federation;Slovakia
Bramitob® administered BY pari LC® plus nebulizer
   Chiesi Farmaceutici S.p.A.
      2010   Phase 1   NCT01116089   Czech Republic;Czechia;Moldova, Republic of;Russian Federation;Slovakia
Breath test using THE compact PTR-TOF-MS
   I.M. Sechenov First Moscow State Medical University
      2023   -   NCT05727852   Russian Federation
Brensocatib
   INSMED INCORPORATED
      2021   Phase 3   EUCTR2020-003688-25-IT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Insmed Incorporated
      2021   -   NCT05344508   -
      2021   Phase 2   NCT05090904   United States
      2021   Phase 3   EUCTR2020-003688-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-IE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      -   Phase 3   EUCTR2020-003688-25-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Brensocatib 10 MG
   Fernandez C
      2020   Phase 3   JPRN-jRCT2031210048   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Peru;Portugal;Slovakia;Spain;Taiwan;Thailand;Turkey;UK;USA
   Insmed Incorporated
      2020   Phase 3   NCT04594369   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03218917   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
Brensocatib 25 MG
   Fernandez C
      2020   Phase 3   JPRN-jRCT2031210048   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Peru;Portugal;Slovakia;Spain;Taiwan;Thailand;Turkey;UK;USA
   Insmed Incorporated
      2020   Phase 3   NCT04594369   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03218917   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
Broccoli sprouts
   University Hospitals Cleveland Medical Center
      2011   -   NCT01315665   United States
Bronchial mucus collection
   University Hospital, Grenoble
      2021   -   NCT04687319   -
Bronchitol
   PHARMAXIS LTD
      2014   Phase 3   EUCTR2013-005357-79-SK   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
   Pharmaxis Limited
      2016   Phase 3   EUCTR2013-005357-79-SE   Argentina;Australia;Belgium;Bulgaria;Canada;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2013-005357-79-GR   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2013-005357-79-BG   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-IT   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-HU   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-CZ   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-BE   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   Pharmaxis Ltd.
      2014   -   EUCTR2012-002699-14-NL   Argentina;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom
      2014   -   EUCTR2012-002699-14-IT   Argentina;Belgium;Canada;Italy;Netherlands;United Kingdom
      2013   Phase 2   EUCTR2012-002699-14-GB   Argentina;Belgium;Canada;France;Italy;Netherlands;United Kingdom
      2013   -   EUCTR2012-002699-14-BE   Belgium;Canada;France;Germany;Italy;Netherlands;Switzerland;United Kingdom
      -   Phase 2   EUCTR2012-002699-14-FR   Argentina;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom
Bucelipase alfa
   Biovitrum AB
      2008   -   EUCTR2007-004063-21-NL   Netherlands
Budesonide-formoterol single inhaler
   Hospital General de Requena
      2004   -   NCT00728715   Spain
Burlulipase
   Nordmark Arzneimittel GmbH & Co. KG
      2013   Phase 1/Phase 2   NCT01710644   United States
BX004-A
   BiomX Ltd.
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-NL   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-CZ   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
   BiomX, Inc.
      2022   Phase 1/Phase 2   NCT05010577   Czechia;Israel;Netherlands;Spain;United States
C01ca04 - dopamina
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
Calcium carbonate
   University of North Carolina
      1998   -   NCT00004489   United States
Calfactant
   University of Pittsburgh
      2008   -   NCT00628134   United States
Candy glucose tolerance test
   Mayo Clinic
      2021   -   NCT04579939   United States
Cavosonstat
   Nivalis Therapeutics, Inc.
      2016   Phase 1   NCT02934139   United States
      2016   Phase 2   NCT02724527   United States
      2015   Phase 2   NCT02589236   United States
Cayston
   Gilead Sciences, Inc.
      2012   Phase 3   EUCTR2011-001362-18-ES   France;Germany;Italy;Poland;Spain;United States
   Gilead Sciences Inc
      2010   -   EUCTR2007-004277-26-AT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2007-004277-26-GB   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      -   -   EUCTR2007-004277-26-Outside-EU/EEA   United States
   Gilead Sciences, Inc.
      2018   Phase 3   EUCTR2016-002749-42-NL   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002749-42-GR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-IT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-GB   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-FR   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-ES   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DK   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-DE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-BE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002749-42-AT   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2012   -   EUCTR2011-001362-18-DE   France;Germany;Italy;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-NL   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-IE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-DE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   Phase 2   EUCTR2011-001255-36-BE   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2012   -   EUCTR2011-001255-36-AT   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      2011   Phase 2   EUCTR2011-001255-36-ES   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      -   Phase 3   EUCTR2016-002749-42-IE   Austria;Belgium;Denmark;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      -   -   EUCTR2015-000398-11-Outside-EU/EEA   United States
      -   -   EUCTR2015-000397-36-Outside-EU/EEA   Canada
      -   -   EUCTR2015-000396-26-Outside-EU/EEA   United States
      -   -   EUCTR2015-000395-97-Outside-EU/EEA   Australia;Canada;United States
      -   -   EUCTR2011-001362-18-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2011-001362-18-FR   France;Germany;Italy;Poland;Spain;United States
      -   -   EUCTR2011-001255-36-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2011-001255-36-FR   Austria;Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Spain;United States
      -   -   EUCTR2009-011740-19-Outside-EU/EEA   Canada;United States
   Liverpool Heart & Chest Hospital
      2016   Phase 4   EUCTR2016-002832-34-GB   United Kingdom
   Mylan Inc.
      2015   -   NCT02449031   United States
Cayston 75 MG pulver UND Lösungsmittel ZUR herstellung einer Lösung FüR einen vernebler
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
Cayston aztreonam 75 MG powder and solvent FOR nebuliser solution
   GILEAD SCIENCES INC.
      2012   Phase 3   EUCTR2011-001362-18-IT   France;Germany;Italy;Spain;United States
      2012   -   EUCTR2011-001255-36-IT   Austria;Germany;Ireland;Italy;Netherlands;Spain;United States
CB-280
   Calithera Biosciences, Inc
      2020   Phase 1   NCT04279769   Canada;United States
Cefalexin
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Cefiderocol
   Hartford Hospital
      2022   Phase 4   NCT05314764   United States
Ceftaroline
   Children's Hospital Medical Center, Cincinnati
      2017   Phase 4   NCT03771313   United States
Ceftazidim fresenius kabi 2000 MG poeder voor oplossing voor injectie OF infusie
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Ceftazidima pentaidrato
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
Ceftazidime
   Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire
      2001   Phase 4   NCT00333385   France
   Imperial College London
      2010   Phase 4   NCT01044719   United Kingdom
   Imperial College, London
      2009   -   EUCTR2009-014042-28-GB   United Kingdom
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
   University College Cork
      2013   -   NCT02526004   Ireland
   University Ghent
      2016   -   NCT02840136   Belgium
   University Hospitals Bristol NHS Foundation Trust
      2016   Phase 4   EUCTR2009-012575-10-SE   Sweden;United Kingdom
      2009   Phase 4   EUCTR2009-012575-10-GB   Sweden;United Kingdom
Ceftazidime and tobramycin
   University of North Carolina, Chapel Hill
      2004   Phase 1   NCT00823238   United States
Ceftazidime pentahydrate
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Ceftazidime/avibactam
   University of Southern California
      2015   Phase 4   NCT02504827   United States
Ceftolozane/tazobactam
   Joseph L. Kuti, PharmD
      2015   Phase 4   NCT02421120   United States
   Sunshine Coast Hospital and Health Service
      2023   Phase 4   NCT06035055   -
Cefuroxim
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Cefuroxime
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Cephalexin
   University of British Columbia
      2020   Phase 3   NCT04553419   Canada
CF fatalism scale
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
CF patients with A G551D mutation and treated with ivacaftor
   Assistance Publique - Hôpitaux de Paris
      2014   -   NCT02194881   France
Cftr modulators
   Children's Hospital Medical Center, Cincinnati
      2021   -   NCT04580368   United States
   Hospices Civils de Lyon
      2023   -   NCT05581056   France
   Indiana University
      2019   -   NCT04206436   United States
   Societe Francaise de la Mucoviscidose
      2020   -   NCT04301856   France
   Universidad Europea de Madrid
      2020   -   NCT04415268   Spain
Cftr potentiator
   Novartis Pharma AG
      2021   Phase 2   EUCTR2019-002840-26-DE   China;Germany;Spain;United Kingdom
      2020   Phase 2   EUCTR2019-002840-26-GB   China;Germany;Spain;United Kingdom
Chadox1 NCOV-19
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
CHF 6333
   Chiesi Farmaceutici S.p.A.
      2019   Phase 1   NCT04010799   Germany
CHF6333
   Chiesi Farmaceutici S.p.A.
      2016   Phase 1   NCT03056326   Belgium
Chlorhexidine gluconate
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
Chlorhexidine gluconate oral rinse
   University of North Carolina, Chapel Hill
      2011   Phase 2   NCT01349192   United States
Cholecalciferol
   Children's Hospital of Philadelphia
      2008   Phase 3   NCT00762918   United States
   Emory University
      2011   Phase 3   NCT01426256   United States
   Heba Omara
      2018   Phase 2/Phase 3   NCT04411901   Egypt
   Shanghai Pulmonary Hospital, Shanghai, China
      2015   Phase 4   NCT02507843   China
   University of North Carolina
      1998   -   NCT00004489   United States
   University of Pittsburgh
      2010   -   NCT01222273   United States
Cholecalciferol pill
   Hospital Infantil de Mexico Federico Gomez
      2022   Phase 4   NCT05276960   Mexico
Choline chloride
   University Hospital Tuebingen
      2014   -   NCT03312140   -
Choline supplementation
   University of British Columbia
      2007   -   NCT00686361   Canada
Chronic antioxidant
   Augusta University
      2015   -   NCT02690064   United States
Cipro inhale
   Bayer
      2008   Phase 2   NCT00645788   Australia;Canada;Denmark;Germany;Israel;Norway;Sweden;United Kingdom;United States
   Bayer HealthCare AG
      2009   -   EUCTR2009-009869-34-SE   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-GB   Germany;Spain;Sweden;United Kingdom
      2009   Phase 2   EUCTR2009-009869-34-ES   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-DE   Germany;Spain;Sweden;United Kingdom
Ciprofloxacin
   AZIENDA OSPEDALIERA MEYER
      2008   -   EUCTR2008-006502-42-IT   Italy
   Bayer
      2016   -   NCT02555059   Japan
      2009   Phase 2   NCT00930982   Australia;Germany;Spain;Sweden;United Kingdom;United States
      2009   Phase 1   NCT00910351   United States
      2008   Phase 2   NCT00645788   Australia;Canada;Denmark;Germany;Israel;Norway;Sweden;United Kingdom;United States
   Bayer HealthCare AG
      2009   -   EUCTR2009-009869-34-SE   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-GB   Germany;Spain;Sweden;United Kingdom
      2009   Phase 2   EUCTR2009-009869-34-ES   Germany;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-009869-34-DE   Germany;Spain;Sweden;United Kingdom
      2007   -   EUCTR2007-002912-24-DE   Germany
   Belfast City Hospital Trust
      2005   Phase 4   EUCTR2005-003837-42-GB   United Kingdom
   Chronic Obstructive Pulmonary Disease Trial Network, Denmark
      2018   Phase 4   NCT03262142   Denmark
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
   University Hospitals Bristol NHS Foundation Trust
      2016   Phase 4   EUCTR2009-012575-10-SE   Sweden;United Kingdom
      2009   Phase 4   EUCTR2009-012575-10-GB   Sweden;United Kingdom
   Vertex Pharmaceuticals Incorporated
      2014   Phase 1   NCT02015507   -
      2013   Phase 1   NCT01768663   United States
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Ciprofloxacin (BAYQ3939) DRY powder FOR inhalation
   Bayer
      2014   Phase 3   NCT02106832   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Czechia;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
Ciprofloxacin dispersion FOR inhalation
   Aradigm Corporation
      2014   Phase 3   NCT02104245   Australia;Canada;Former Serbia and Montenegro;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;New Zealand;Peru;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   NCT01515007   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;New Zealand;Poland;Romania;South Africa;Spain;Taiwan;United Kingdom;United States
Ciprofloxacin DPI
   BAYER HEALTHCARE AG
      2013   Phase 3   EUCTR2011-004208-39-IT   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
   Bayer
      2016   -   NCT02661438   United States
      2013   Phase 3   NCT01764841   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
   Bayer AG
      2014   Phase 3   EUCTR2013-004659-19-BG   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
   Bayer AG
      2014   Phase 3   EUCTR2013-004659-19-NL   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-LT   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-DE   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-CZ   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-AT   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
   Bayer HealthCare AG
      2014   Phase 3   EUCTR2011-004208-39-SK   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2014   -   EUCTR2011-004208-39-LV   Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-GB   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-FR   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-ES   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom;United States
      2013   -   EUCTR2011-004208-39-DK   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004208-39-DE   Argentina;Australia;Brazil;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Serbia;Slovakia;Spain;United Kingdom;United States
   Bayer Healthcare AG, D-51368 Leverkusen, Germany
      2014   Phase 3   EUCTR2013-004659-19-SK   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-PT   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Germany;Hong Kong;Hungary;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
      2014   Phase 3   EUCTR2013-004659-19-LV   Argentina;Australia;Austria;Brazil;Bulgaria;China;Czech Republic;Germany;Hong Kong;Korea, Republic of;Latvia;Lithuania;Netherlands;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Thailand;Turkey;United States
Ciprofloxacin FOR inhalation
   Aradigm Corporation
      2015   Phase 3   EUCTR2013-005366-19-PL   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005366-19-FR   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005348-28-PL   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-RO   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-IT   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-HU   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-GB   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-ES   Australia;Canada;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-RO   Australia;Canada;Georgia;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-LV   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IT   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IE   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-HU   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-GB   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-ES   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2010   Phase 2   NCT00889967   Canada;Germany;United Kingdom;United States
      2010   -   EUCTR2009-014412-35-GB   Germany;United Kingdom
      2010   Phase 2   EUCTR2009-014412-35-DE   Germany;United Kingdom
Ciprofloxacin hydrochloride
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
   Aradigm Corporation
      2015   Phase 3   EUCTR2013-005366-19-PL   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005366-19-FR   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005348-28-PL   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-RO   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-IT   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-HU   Australia;Canada;France;Georgia;Germany;Hungary;Israel;Italy;New Zealand;Poland;Romania;Serbia;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-GB   Australia;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005366-19-ES   Australia;Canada;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-RO   Australia;Canada;Georgia;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-LV   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;New Zealand;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IT   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-IE   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-HU   Australia;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-GB   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Poland;Romania;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005348-28-ES   Australia;Canada;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2010   -   EUCTR2009-014412-35-GB   Germany;United Kingdom
      2010   Phase 2   EUCTR2009-014412-35-DE   Germany;United Kingdom
Ciprofloxacin hydrochloride monohydrate
   COP:TRIN Region Hovedstaden (Gentofte hospital)
      2017   Phase 4   EUCTR2015-003399-58-DK   Denmark
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
Ciprofloxacin inhale
   Bayer HealthCare AG
      2009   -   EUCTR2008-008314-40-SE   Denmark;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-008314-40-DK   Denmark;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-008314-40-DE   Denmark;Germany;Sweden;United Kingdom
   Bayer Healthcare AG
      2009   -   EUCTR2008-008314-40-GB   Denmark;Germany;Sweden;United Kingdom
Ciprofloxacina cloridrato
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
Ciproxin
   Belfast City Hospital Trust
      2005   Phase 4   EUCTR2005-003837-42-GB   United Kingdom
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Ciproxin suspension
   Southampton University Hospital Trust
      2008   -   EUCTR2008-001769-27-GB   United Kingdom
Ciproxin*6CPR RIV 500MG
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
Clarithromycin
   Chinese University of Hong Kong
      2020   -   NCT04658277   Hong Kong
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
   Wake Forest University
      2000   Phase 2   NCT00205634   United States
Claritromycin 500MG film coated tablets
   university medical center utrecht
      2018   Phase 4   EUCTR2016-001440-18-NL   Netherlands
Clavulanic acid
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Clindamycin
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
CMS
   EnBiotix, Inc.
      2022   Phase 3   EUCTR2022-000476-18-SK   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
      2022   Phase 3   EUCTR2022-000476-18-HU   Australia;Bulgaria;Greece;Hungary;Poland;Slovakia;United Kingdom
      -   Phase 3   EUCTR2022-000476-18-PL   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
   Zambon SpA
      2018   Phase 3   NCT03460704   Argentina;Australia;Canada;France;Germany;Greece;Israel;Italy;New Zealand;Poland;Portugal;United States
      2017   Phase 3   NCT03093974   Australia;Belgium;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
CMTX-101
   Clarametyx Biosciences, Inc.
      2024   Phase 1/Phase 2   NCT06159725   United States
Cobamamide
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-020516-11-IT   Italy
Colfinair 2 MIU powder FOR nebuliser solution
   EnBiotix, Inc.
      2022   Phase 3   EUCTR2022-000476-18-SK   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
      2022   Phase 3   EUCTR2022-000476-18-HU   Australia;Bulgaria;Greece;Hungary;Poland;Slovakia;United Kingdom
      -   Phase 3   EUCTR2022-000476-18-PL   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
Colimicina - 1000000 U/4 ML polvere E solvente PER soluzione iniettabile PER USO intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ML
   AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER
      2016   Phase 3   EUCTR2015-003881-96-IT   Italy
Colimycine inhalation
   Poitiers University Hospital
      2011   Phase 1   NCT01537614   France
Colimycine injectable
   Poitiers University Hospital
      2011   Phase 1   NCT01537614   France
Colistimetato sodico
   AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER
      2016   Phase 3   EUCTR2015-003881-96-IT   Italy
Colistimethat-natrium
   University of Jena
      2009   -   EUCTR2008-007877-19-DE   Germany
Colistimethate
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharma Services AG
      2015   -   EUCTR2012-001565-33-IE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   Phase 4   EUCTR2012-001565-33-GB   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-001565-33-DE   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharmaceuticals
      2013   Phase 4   NCT01844778   Germany;Ireland;Spain;Switzerland;United Kingdom
Colistimethate 75 MG inhaled TWO times daily
   Dartmouth-Hitchcock Medical Center
      2014   -   NCT02113397   United States
Colistimethate sodium
   Aarhus University Hospital, Department of Respiratory Medicine
      2015   Phase 2   EUCTR2015-003662-87-DK   Denmark
   CUB - Hôpital Erasme
      2014   Phase 4   EUCTR2013-004987-80-BE   Belgium
   EnBiotix, Inc.
      2022   Phase 3   EUCTR2022-000476-18-SK   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
      2022   Phase 3   EUCTR2022-000476-18-HU   Australia;Bulgaria;Greece;Hungary;Poland;Slovakia;United Kingdom
      -   Phase 3   EUCTR2022-000476-18-PL   Greece;Hungary;Poland;Serbia;Slovakia;Ukraine
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-DK   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-BE   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-AT   Austria;Belgium;Denmark
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
   Profile Pharma Ltd
      2010   -   EUCTR2008-005045-34-IE   Ireland;United Kingdom
      2008   Phase 3   EUCTR2008-005045-34-GB   Ireland;Russian Federation;Ukraine;United Kingdom
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   University of Colorado, Denver
      2013   -   NCT02288429   United States
   ZAMBON SPA
      2020   Phase 3   EUCTR2016-004558-13-IT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2017   Phase 3   EUCTR2015-002743-33-IT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
   Zambon S.p.A.
      2020   Phase 3   EUCTR2016-004558-13-PT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2020   Phase 3   EUCTR2016-004558-13-GR   Argentina;Australia;Canada;France;Germany;Greece;Israel;Italy;New Zealand;Poland;Portugal;United States
      2020   Phase 3   EUCTR2016-004558-13-DE   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2018   Phase 3   EUCTR2015-002743-33-NL   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2015-002743-33-GR   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2016-004558-13-PL   Argentina;Australia;Canada;France;Germany;Greece;Israel;Italy;New Zealand;Poland;Portugal;United States
      2017   Phase 3   EUCTR2016-004558-13-FR   Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2017   Phase 3   EUCTR2015-002743-33-PT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-GB   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-ES   Belgium;Germany;Italy;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-DE   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
Colistimethate sodium (BAN, usan), colistimethatum natricum, colistin sodium methanesulfonate
   Forest Laboratories UK Ltd.
      2011   -   EUCTR2011-000192-13-PL   Germany;Poland;Ukraine;United Kingdom
      2011   -   EUCTR2011-000192-13-GB   Germany;Poland;United Kingdom
      2011   -   EUCTR2011-000192-13-DE   Germany;Poland;Ukraine;United Kingdom
Colistin
   AZIENDA OSPEDALIERA MEYER
      2008   -   EUCTR2008-006502-42-IT   Italy
   AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER
      2016   Phase 3   EUCTR2015-003881-96-IT   Italy
   National Jewish Health
      2016   Phase 4   NCT02918409   United States
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   Universitaire Ziekenhuizen Leuven
      2001   Phase 4   NCT01400750   Belgium
   University Hospital Tuebingen
      2014   Phase 3   NCT03341741   -
   University of Jena
      2009   Phase 2   NCT01035853   Germany
Colistin CF
   University of Jena
      2009   -   EUCTR2008-007877-19-DE   Germany
Colistin forest - trockenstechampullen MIT Lösungsmittel
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
Colistin mesilate sodium
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
Colistineb 2MUI
   CUB - Hôpital Erasme
      2014   Phase 4   EUCTR2013-004987-80-BE   Belgium
Collection OF arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after katrio initiation
   Hospices Civils de Lyon
      2022   -   NCT06197490   France
Colobreathe
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-DK   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-BE   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-AT   Austria;Belgium;Denmark
   Forest Laboratories UK Ltd.
      2011   -   EUCTR2011-000192-13-PL   Germany;Poland;Ukraine;United Kingdom
      2011   -   EUCTR2011-000192-13-GB   Germany;Poland;United Kingdom
      2011   -   EUCTR2011-000192-13-DE   Germany;Poland;Ukraine;United Kingdom
Colomycin
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-DK   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-BE   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-AT   Austria;Belgium;Denmark
   The Leeds Teaching Hospitals NHS Trust
      2015   -   NCT02489955   United Kingdom
Comirnaty concentrate FOR dispersion FOR injection
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
Compound 1A
   PTC Therapeutics, Inc
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
Continuous glucose monitoring
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
   Katie Larson Ode
      2019   -   NCT03650712   United States
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2013   -   NCT01975259   United Kingdom
   University Hospital, Strasbourg, France
      2008   -   NCT00476281   France
Continuous infusion cefepime
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Continuous infusion ceftazidime
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Continuous infusion meropenem
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Continuous infusion piperacillin tazobactam
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Continuous infusion ticarcillin-clavulanate
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Control group 0.9% isotonic saline
   University of Washington, the Collaborative Health Studies Coordinating Center
      2015   Phase 2/Phase 3   NCT02950883   Australia;Belgium;Canada;Denmark;France;Italy;Netherlands;Spain;United States
Control multivitamin
   University of Colorado, Denver
      2013   Phase 2   NCT01859390   United States
Covid-19 vaccine janssen suspension FOR injection
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
Covid-19 vaccine moderna dispersion FOR injection
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
CPX
   FDA Office of Orphan Products Development
      1997   Phase 1   NCT00004428   -
CR002 liquid API
   CSL Behring
      2011   Phase 1   NCT01347190   Bulgaria;Hungary;Poland;United Kingdom
CRC3357, ZK-355322, leukoton
   Celtaxsys Inc.
      2016   Phase 2   EUCTR2015-002677-38-IT   Belgium;France;Germany;Italy;Netherlands;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-GB   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-DE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-BE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
Creon
   AbbVie
      2021   Phase 4   NCT05069597   United States
      2020   Phase 4   NCT04315311   United States
      2012   -   NCT01652157   United States
Creon 10.000, HåRDE enterokapsler
   Terese Katzenstein
      2020   Phase 4   EUCTR2019-004940-31-DK   Denmark
Creon 10000
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Creon 10000 capsules
   EURAND SPA
      2010   -   EUCTR2009-012842-21-IT   Bulgaria;Germany;Hungary;Italy;United Kingdom
Creon 25.000, HåRDE enterokapsler
   Terese Katzenstein
      2020   Phase 4   EUCTR2019-004940-31-DK   Denmark
Creon 25000
   Abbott Laboratories GmbH
      2013   -   EUCTR2013-002819-10-HU   Hungary;Russian Federation;Spain
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Creon 40.000, HåRDE enterokapsler
   Terese Katzenstein
      2020   Phase 4   EUCTR2019-004940-31-DK   Denmark
Creon IR
   Abbott
      2015   Phase 2   NCT02415959   Czech Republic;Hungary;Poland;Spain
   Abbott Laboratories GmbH
      2015   -   EUCTR2014-004519-35-HU   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-GB   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-CZ   Czech Republic;Hungary;Spain;United Kingdom
Creon N
   Abbott
      2014   Phase 3   NCT02137382   Hungary;Russian Federation;Spain
Creon N 25000
   Abbott Laboratories GmbH
      2013   -   EUCTR2013-002819-10-HU   Hungary;Russian Federation;Spain
Creon® 25,000
   Abbott Laboratories GmbH
      2015   -   EUCTR2014-004519-35-HU   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-GB   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-CZ   Czech Republic;Hungary;Spain;United Kingdom
Crestor
   University of Liverpool
      2014   Phase 2   EUCTR2014-002387-32-GB   United Kingdom
CSL787
   CSL Behring
      2020   Phase 1   NCT04643587   Germany;United Kingdom
CTX-4430
   Celtaxsys Inc.
      2016   Phase 2   EUCTR2015-002677-38-IT   Belgium;France;Germany;Italy;Netherlands;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-GB   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-DE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002677-38-BE   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
   Celtaxsys, Inc.
      2015   Phase 2   NCT02443688   Belgium;Canada;France;Germany;Italy;United Kingdom;United States
      2013   Phase 1   NCT01944735   United Kingdom
Curcuma longa extract CPL formaat 00 23,2 X 8,5 MM 723 MG
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000817-30-NL   Netherlands
Curcumin
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000817-30-NL   Netherlands
Curie artificial intelligence (AI) cough monitor
   University of Colorado, Denver
      2024   -   NCT06587126   United States
CYC202
   CHRU de Brest
      2015   Phase 2   EUCTR2015-002911-13-FR   France
Cystagon
   European Institute for Cystic Fibrosis Research (IERFC)
      2013   -   EUCTR2013-001258-82-IT   Italy
   University of LIverpool
      2019   Phase 1;Phase 2   EUCTR2017-001259-29-GB   United Kingdom
Cystagon (cysteamine bitartrate) immediate-release capsules
   University of Aberdeen
      2014   Phase 1;Phase 2   EUCTR2014-000284-40-GB   United Kingdom
Cysteamine
   NovaBiotics Ltd.
      2016   Phase 2   NCT03000348   Italy;United Kingdom;United States
   University of Aberdeen
      2014   Phase 1/Phase 2   NCT02212431   United Kingdom
Cysteamine bitartrate
   European Institute for Cystic Fibrosis Research (IERFC)
      2013   -   EUCTR2013-001258-82-IT   Italy
   NovaBiotics, Ltd
      2017   Phase 2   EUCTR2015-004986-99-IT   Italy;Netherlands;United Kingdom;United States
      2016   Phase 2   EUCTR2015-004986-99-GB   Italy;Netherlands;United Kingdom;United States
   University of LIverpool
      2019   Phase 1;Phase 2   EUCTR2017-001259-29-GB   United Kingdom
Cystic fibrosis ready TO USE supplemental food
   Washington University School of Medicine
      2018   Phase 1/Phase 2   NCT03462056   United States
Cystic fibrosis transmembrane conductance regulator
   University of Alabama at Birmingham
      1995   Phase 1   NCT00004806   -
D-A-tocopheryl PEG 1000 succinate
   ORPHAN
      2007   -   EUCTR2007-001007-38-FR   France
D6-25-hydroxyvitamin D3
   University of Washington
      2017   Phase 1   NCT03104855   United States
Data collection
   Assistance Publique - Hôpitaux de Paris
      2023   -   NCT05726994   France
DCI 1020
   Digestive Care, Inc.
      2009   -   NCT00663975   United States
DE-activated smart device
   Vertex Pharmaceuticals Incorporated
      2016   Phase 4   NCT02823470   Canada;United States
Decolonization
   State University of New York - Upstate Medical University
      2011   -   NCT01229553   United States
Denosumab
   University of Texas Southwestern Medical Center
      2021   Phase 4   NCT03921060   United States
Denufosol
   Merck Sharp & Dohme Corp.
      2005   Phase 2   NCT00130182   United States
      2005   Phase 2   NCT00103714   United States
      2003   Phase 2   NCT00056147   United States
Denufosol tetrasodium (INS37217) inhalation solution
   Merck Sharp & Dohme Corp.
      2008   Phase 3   NCT00625612   Australia;Canada;New Zealand;United States
      2007   Phase 2   NCT00425165   United States
      2006   Phase 3   NCT00357279   Canada;United States
      2001   Phase 1/Phase 2   NCT00034515   United States
Denufosol tetrasodium inhalation solution
   Merck Sharp & Dohme Corp.
      2010   Phase 2   NCT01181622   United States
      2009   Phase 3   NCT00846781   Australia;Canada;New Zealand;United States
Depelestat
   DEBIOPHARM S.A.
      2005   -   EUCTR2004-002341-12-IT   Belgium;Germany;Italy;United Kingdom
   Debiopharm SA
      2005   Phase 2   EUCTR2004-002341-12-GB   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-DE   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-BE   Belgium;Germany;Italy;United Kingdom
Desoxyribonuclease
   University of Jena
      -   Phase 3   EUCTR2007-001548-36-DE   Germany
Detoxifying agents FOR antineoplastic treatment
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-020516-11-IT   Italy
Deuterated ivacaftor
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
Deutivacaftor
   Vertex Pharmaceuticals Incorporated
      2019   Phase 2   EUCTR2018-003970-28-NL   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-GB   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-DE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-BE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
Dexa scan
   Katie Larson Ode
      2019   -   NCT03650712   United States
Dexamethasone
   ISTITUTO GIANNINA GASLINI
      2008   -   EUCTR2007-001782-15-IT   Italy
Dexamethasone sodium phosphate 250 MG/10 ML solution
   AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
      2011   -   EUCTR2011-000130-11-IT   Italy
DHA
   University of Massachusetts, Worcester
      2003   -   NCT00530244   United States
Dicloxacillin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Digitoxin
   National Jewish Health
      2010   Phase 2   NCT00782288   United States
Diponecaftor
   Kors van der Ent
      2024   Phase 2   NCT06468527   Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
Docosahexaenoic acid
   Hospices Civils de Lyon
      2010   Phase 2   NCT02690857   -
   University of Massachusetts, Worcester
      2003   -   NCT00530244   United States
Docosahexaenoic acid administration: 50 MG/KG/DAY during 12 months
   Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
      2011   -   NCT01783613   Spain
Docosahexanoic acid supplement
   Vanderbilt University
      2013   Phase 2   NCT00924547   United States
Doribax
   Johnson & Johnson Pharmaceutical Research & Development L.L.C
      -   -   EUCTR2015-001225-16-Outside-EU/EEA   United States
Doripenem hydrate
   Johnson & Johnson Pharmaceutical Research & Development L.L.C
      -   -   EUCTR2015-001225-16-Outside-EU/EEA   United States
Dornase alfa
   F. Hoffmann-La Roche AG
      -   Phase 4   EUCTR2015-003537-99-Outside-EU/EEA   United States
   Genentech, Inc.
      2012   Phase 4   NCT01712334   United States
      2008   Phase 4   NCT00680316   United States
      2007   Phase 4   NCT00434278   United States
   Nicole Hamblett
      2020   -   NCT06350474   United States
      2020   -   NCT04378153   United States
   Pharmaxis Ltd
      2004   Phase 2   EUCTR2004-001888-21-GB   United Kingdom
   University of Jena
      2007   Phase 3   NCT00534079   Germany
      -   Phase 3   EUCTR2007-001548-36-DE   Germany
   University of Vermont
      2006   Phase 2   NCT00416182   United States
Dornase alpha
   ErasmusMC - Sophia Children's Hospital
      -   -   EUCTR2007-000935-25-NL   Netherlands
   Pharmaxis
      2005   Phase 2   NCT00117208   United Kingdom
   University of Oklahoma
      2006   -   NCT00671723   United States
Doxycyclin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Doxycycline
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
   University of Alabama at Birmingham
      2008   -   NCT01112059   United States
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
DP mannitol
   Pharmaxis Ltd
      2004   Phase 2   EUCTR2004-001888-21-GB   United Kingdom
DRY powder tobramycin
   University Medical Center Groningen
      2013   -   EUCTR2012-004437-16-NL   Netherlands
      -   Phase 2   EUCTR2016-005014-21-NL   Netherlands
Dulaglutide 0.75MG/0.5ML INJ PEN
   University of Pennsylvania
      2021   Phase 2   NCT04731272   United States
Duramycin
   AOP ORPHAN PHARMACEUTICALS
      2008   -   EUCTR2006-006693-24-IT   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
   AOP Orphan Pharmaceuticals AG
      2008   Phase 2;Phase 3   EUCTR2006-006693-24-ES   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
      2007   -   EUCTR2006-006693-24-SE   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   -   EUCTR2006-006693-24-HU   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-006693-24-FR   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
      2007   -   EUCTR2006-006693-24-AT   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
Duramycin, 2622u90
   AOP Orphan Pharmaceuticals AG
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-SK   Czech Republic;Hungary;Slovakia
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-HU   Czech Republic;Hungary;Slovakia
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-CZ   Czech Republic;Hungary;Slovakia
      2006   -   EUCTR2005-004344-30-HU   Hungary
      2005   -   EUCTR2005-004344-30-AT   Austria;Hungary
DX-890
   DEBIOPHARM S.A.
      2005   -   EUCTR2004-002341-12-IT   Belgium;Germany;Italy;United Kingdom
Ecgc
   Hadassah Medical Organization
      2011   -   NCT00889434   Israel
Egcg + tocotrienol
   Hadassah Medical Organization
      2011   -   NCT00889434   Israel
Elasomeran
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
Elexacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
Elexacaftor / ivacaftor / tezacaftor
   Nottingham University Hospitals NHS Trust
      2022   -   NCT05699148   United Kingdom
   University of Erlangen-Nürnberg Medical School
      2020   -   NCT05576324   Germany
Elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG, 2 tablets each morning + ivacaftor 150 MG ONE tablet each evening
   CHC Montlegia
      2022   -   NCT05599230   Belgium
Elexacaftor-tezacaftor-ivacaftor exposure
   Jennifer Taylor-Cousar
      2019   -   NCT04056702   United States
Elexacaftor-tezacaftor-ivacaftor treatment
   University Hospital, Strasbourg, France
      2024   -   NCT06331000   France
Elexacaftor/tezacaftor/ivacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
ELX
   VERTEX PHARMACEUTICALS INCORPORATED
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005320-38-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
ELX-02
   Eloxx Pharmaceuticals Inc
      2019   Phase 2   EUCTR2018-000966-12-DE   Australia;Germany;Israel
   Eloxx Pharmaceuticals, Inc.
      2019   Phase 2   NCT04135495   Canada;United States
      2019   Phase 2   NCT04126473   Australia;Germany;Israel
ELX/TEZ/IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2024   Phase 3   NCT06460506   Australia;Canada;Denmark;Germany;Netherlands;Switzerland;United Kingdom
      2023   Phase 3   NCT05882357   Australia;Canada;Denmark;Germany;Netherlands;Switzerland;United Kingdom
      2022   Phase 3   NCT05331183   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   NCT05274269   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   NCT05153317   Australia;Canada;Germany;United Kingdom;United States
      2022   Phase 3   NCT05111145   Australia;Belgium;Canada;Czechia;Spain
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   NCT05076149   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   NCT05033080   Australia;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   -   NCT04702360   -
      2021   Phase 3   NCT04545515   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2020   Phase 3   NCT04362761   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   NCT04183790   Australia;Canada;Ireland;United Kingdom;United States
      2020   -   NCT04058210   -
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   NCT04105972   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   NCT04058366   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   NCT04058353   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   NCT04043806   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
Emea/H/C/000125
   European Institute for Cystic Fibrosis Research (IERFC)
      2013   -   EUCTR2013-001258-82-IT   Italy
Empagliflozin
   Amir Moheet
      2023   Phase 2/Phase 3   NCT06149793   United States
END-OF-life nursing education consortium-pediatric palliative care AS WEB based-training plus usual care
   Altoosi University College
      2020   -   NCT04461561   Iraq
Engineerd protein inhibitor OF human neutrophil elastase
   Debiopharm SA
      2005   Phase 2   EUCTR2004-002341-12-GB   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-DE   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-BE   Belgium;Germany;Italy;United Kingdom
Engineered protein inhibitor OF human neutrophil elastase
   Debiopharm SA
      2005   Phase 2   EUCTR2004-002341-12-GB   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-DE   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-BE   Belgium;Germany;Italy;United Kingdom
Ensure high protein
   Virginia Commonwealth University
      2022   -   NCT03931252   United States
Ensure plus
   Texas A&M University
      2011   -   NCT01494909   United States
Environmental decontamination
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
      2011   Phase 2   NCT01349192   United States
EPI-HNE4 DX-890
   Debiopharm SA
      2005   Phase 2   EUCTR2004-002341-12-GB   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-DE   Belgium;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-002341-12-BE   Belgium;Germany;Italy;United Kingdom
Ergocalciferol
   Atlanta VA Medical Center
      2006   -   NCT00450073   United States
Esomeprazole
   Biovitrum AB
      2008   -   EUCTR2007-004063-21-NL   Netherlands
   Columbia University
      2008   Phase 2   NCT01983774   United States
Essential amino acid intake + leucine VS total AA supplement
   Texas A&M University
      2008   -   NCT01172301   United States
Estradiol 2 MG
   Emory University
      2019   Phase 4   NCT03724955   United States
ETD001
   Enterprise Therapeutics Ltd
      2024   Phase 2   NCT06478706   France;Germany;Italy;United Kingdom
ETD001 multiple once daily doses
   Enterprise Therapeutics Ltd
      2021   Phase 1   NCT04926701   United Kingdom
ETD001 multiple twice daily doses
   Enterprise Therapeutics Ltd
      2021   Phase 1   NCT04926701   United Kingdom
ETD001 single dose
   Enterprise Therapeutics Ltd
      2021   Phase 1   NCT04926701   United Kingdom
Ethambutol
   University of Colorado, Denver
      2014   -   NCT02372383   United States
Ethinyl estradiol
   University of Texas Southwestern Medical Center
      2014   Early Phase 1   NCT02036879   United States
EU orphan designation number EU/3/02/120
   AOP Orphan Pharmaceuticals AG
      2006   -   EUCTR2005-004344-30-HU   Hungary
      2005   -   EUCTR2005-004344-30-AT   Austria;Hungary
EUR-1008
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-DE   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
   Forest Laboratories
      2010   Phase 4   NCT01131507   United States
      2010   Phase 4   NCT01100606   United States
      2006   Phase 3   NCT00981214   United States
      2006   Phase 3   NCT00297167   United States
EUR-1008 25,000 units
   Aptalis Pharma
      2012   Phase 3   NCT01641393   Belgium;Bulgaria;France;Germany;Italy;Poland;United Kingdom
Evaluation OF THE parameters OF THE lithiasis assessment before and after kaftrio initiation
   Hospices Civils de Lyon
      2022   -   NCT06197490   France
EX-vivo approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Exercise
   Institut de Recherches Cliniques de Montreal
      2019   -   NCT03710538   Canada
Exercise capacity
   Hacettepe University
      2019   -   NCT03902236   Turkey
Exhaled breath collection
   Assistance Publique - Hôpitaux de Paris
      2023   -   NCT05726994   France
Exhaled nitric oxide
   The Hospital for Sick Children
      2010   -   NCT01155115   Canada
EZ-2053 5MG/KG
   Neovii Biotech
      2005   Phase 3   NCT00105183   Australia;Austria;Canada;United States
Fasenra
   AstraZeneca AB
      2021   Phase 3   EUCTR2020-004068-24-PL   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DK   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DE   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
FAT soluble vitamins supplementation
   Ain Shams University
      2024   -   NCT06875050   Egypt
FDL169
   Flatley Discovery Lab LLC
      2018   Phase 1/Phase 2   NCT03756922   United Kingdom
      2018   Phase 1   NCT03527095   United Kingdom
      2017   Phase 1   NCT03424252   United Kingdom
      2017   Phase 1   NCT03093714   Australia;Czechia;Germany;United Kingdom
      2016   Phase 1/Phase 2   NCT02767297   United Kingdom
      2015   Phase 1   NCT02680418   United Kingdom
      2015   Phase 1   NCT02359357   United Kingdom
FDL176
   Flatley Discovery Lab LLC
      2018   Phase 1/Phase 2   NCT03756922   United Kingdom
      2017   Phase 1   NCT03173573   Australia
FDL176 & FDL169 coadministration
   Flatley Discovery Lab LLC
      2018   Phase 1   NCT03516331   United Kingdom
Fenretinide
   Elias Matouk
      2014   Phase 1   NCT02141958   Canada
Ferinject
   University of Oxford / Clinical Trials and Research Governance
      2018   Phase 4   EUCTR2018-002366-39-GB   United Kingdom
Ferric carboxymaltose
   University of Oxford
      2019   Phase 4   NCT03632525   United Kingdom
   University of Oxford / Clinical Trials and Research Governance
      2018   Phase 4   EUCTR2018-002366-39-GB   United Kingdom
Ferrous sulfate 325MG
   Dartmouth-Hitchcock Medical Center
      2011   -   NCT01755455   United States
Finely ground flaxseed powder
   University of Pennsylvania
      2012   Phase 1   NCT02014181   United States
Fish OIL
   Nestlé
      2016   -   NCT02646995   Switzerland
Flexibility and postural exercise
   University of Alabama at Birmingham
      2008   -   NCT01759342   United States
Flucloxacillin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Flucloxacillin 250MG/5ML sugar-free powder FOR oral solution
   Alder Hey Children's NHS Foundation Trust
      2016   Phase 4   EUCTR2016-002578-11-GB   United Kingdom
Flucloxacillin sodium
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
Flucloxicillin
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
Fluticasone
   Royal Brompton & Harefield NHS Foundation Trust
      2001   -   NCT00220259   United Kingdom
Forlax 4 G, poudre pour solution buvable EN sachet
   CHU de Bordeaux
      2020   Phase 2   EUCTR2019-004958-29-FR   France
Fortum
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
Fruit juice
   Emory University
      2014   -   NCT02202876   United States
FTI, azli
   Gilead Sciences
      2008   Phase 2   NCT00794586   United States
Fucidin tablets
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Fusidic acid
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Fusidin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
G1117337
   Galapagos NV
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002181-42-DE   Germany
G914167
   Galapagos NV
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
G957389
   Galapagos NV
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-NL   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-GB   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-ES   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-BE   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002837-31-CZ   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-IE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-GB   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-DE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-BE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
GAD-7
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Galicaftor
   AbbVie
      2022   Phase 1   NCT05530278   United States
      2021   Phase 2   NCT04853368   Australia;Belgium;Czechia;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom;United States
   AbbVie Deutschland
      2022   Phase 2   EUCTR2019-000750-63-RO   Belgium;Canada;Czechia;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-NL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-HU   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-GB   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-FR   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000750-63-BE   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005805-25-NL   Australia;Belgium;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom
      2021   Phase 2   EUCTR2020-005805-25-HU   Hungary
      2021   Phase 2   EUCTR2020-005805-25-BE   Belgium;Hungary;Netherlands
      2020   Phase 2   EUCTR2019-000750-63-PL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
Gallium nitrate
   Chris Goss
      2021   Phase 1   NCT04294043   United States
   University of Washington
      2016   Phase 2   NCT02354859   United States
GDC-6988
   Genentech, Inc.
      2024   Phase 1/Phase 2   NCT06603246   United States
Genistein
   Children's Hospital of Philadelphia
      2003   Phase 1/Phase 2   NCT00590538   United States
      2001   Phase 1/Phase 2   NCT00016744   United States
   UMC Utrecht
      2017   Phase 2   EUCTR2016-001619-19-NL   Netherlands
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000817-30-NL   Netherlands
Genisteine plus 150 MG CPL formaat 1 18,7 X 6,4 MM 438 MG
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000817-30-NL   Netherlands
Gentamicin
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 2   NCT00376428   France
Gernebcin 80 MG
   University of Jena
      2008   -   EUCTR2008-000164-17-DE   Germany
Ghrelin
   Papworth Hospital
      2010   -   NCT00763477   United Kingdom
GIP
   University of Pennsylvania
      2013   -   NCT01851694   United States
Giving DHA-rich supplement
   University Hospital, Ghent
      2007   Phase 2   NCT00221546   Belgium
Glargine
   Federico II University
      2006   Phase 4   NCT00483769   Italy
Glargine insulin
   University of Minnesota - Clinical and Translational Science Institute
      2003   Phase 3   NCT00222521   United States
GLP-1
   University of Pennsylvania
      2013   -   NCT01851694   United States
GLPG1837
   Galapagos NV
      2016   Phase 2   EUCTR2015-003292-30-NL   Belgium;Netherlands
      2016   Phase 2   EUCTR2015-003292-30-BE   Belgium;Netherlands
      2016   Phase 2   EUCTR2015-003291-77-IE   Australia;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2015-003291-77-GB   Australia;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2015-003291-77-DE   Australia;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2015-003291-77-CZ   Australia;Czech Republic;Germany;Ireland;United Kingdom
GLPG1837 dose 1
   Galapagos NV
      2016   Phase 2   NCT02707562   Australia;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   NCT02690519   Belgium;Netherlands
GLPG1837 dose 2
   Galapagos NV
      2016   Phase 2   NCT02707562   Australia;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   NCT02690519   Belgium;Netherlands
GLPG1837 dose 3
   Galapagos NV
      2016   Phase 2   NCT02707562   Australia;Czech Republic;Germany;Ireland;United Kingdom
GLPG2222
   Galapagos NV
      2018   Phase 1   NCT03540524   Belgium;Bulgaria;Germany;Greece;Netherlands;Serbia;Sweden;United Kingdom
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
      2017   Phase 2   NCT03045523   Australia;Belgium;Czechia;Germany;Ireland;United Kingdom
      2017   Phase 2   EUCTR2016-004477-40-NL   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-GB   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-ES   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-004477-40-BE   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002837-31-CZ   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-IE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-GB   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-DE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
      2016   Phase 2   EUCTR2016-002837-31-BE   Australia;Belgium;Czech Republic;Germany;Ireland;United Kingdom
GLPG2222 100 MG
   Galapagos NV
      2017   Phase 2   NCT03119649   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
GLPG2222 200 MG
   Galapagos NV
      2017   Phase 2   NCT03119649   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
GLPG2222 400 MG
   Galapagos NV
      2017   Phase 2   NCT03119649   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
GLPG2222 50 MG
   Galapagos NV
      2017   Phase 2   NCT03119649   Belgium;Netherlands;Serbia;Spain;United Kingdom;United States
GLPG2451 dose regimen A
   Galapagos NV
      2018   Phase 1   NCT03540524   Belgium;Bulgaria;Germany;Greece;Netherlands;Serbia;Sweden;United Kingdom
GLPG2451 dose regimen B
   Galapagos NV
      2018   Phase 1   NCT03540524   Belgium;Bulgaria;Germany;Greece;Netherlands;Serbia;Sweden;United Kingdom
GLPG2737
   Galapagos NV
      2018   Phase 1   NCT03540524   Belgium;Bulgaria;Germany;Greece;Netherlands;Serbia;Sweden;United Kingdom
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
      2017   Phase 2   NCT03474042   Germany
      2017   Phase 2   EUCTR2017-002181-42-DE   Germany
GLPG2737 single dose
   Galapagos NV
      2017   Phase 1   NCT03450720   Belgium
GLPG3067
   Galapagos NV
      2018   Phase 2   EUCTR2018-000098-61-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Netherlands;New Zealand;Serbia;United Kingdom;United States
GLPG3067 single dose
   Galapagos NV
      2018   Phase 1   NCT03589313   Belgium
Glucose
   Christoph Saner
      2015   -   NCT02569229   Switzerland
   Jagdeesh Ullal
      2020   Phase 4   NCT04533646   United States
   National Center for Research Resources (NCRR)
      2001   -   NCT00014768   United States
Glucose profile FOR 2 weeks
   Imperial College London
      2009   -   NCT01091025   United Kingdom
Glucose solution AT A dose OF 1.75 G/KG (UP TO A maximum OF 75 G) FOR THE ogtt and glucose solution AT A dose OF 0.5 G/KG (UP TO A maximum OF 35 G) WAS injected IN 2.5-3 MIN FOR THE igtt
   Hospices Civils de Lyon
      2009   -   NCT02723968   -
Glutamine
   Emory University
      2010   Phase 2   NCT01051999   United States
Glutathione
   AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI
      2009   -   EUCTR2008-005080-33-IT   Italy
Glutathione sodium
   Aarhus University Hospital
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
Glycine
   Instituto Nacional de Enfermedades Respiratorias
      2012   Phase 2   NCT01417481   Mexico
Glycine buffer
   Case Western Reserve University
      2018   Phase 1/Phase 2   NCT03617718   United States
Glycosbio nutritional supplement
   GlycosBio, Inc.
      2018   -   NCT04966897   United States
Growth hormone
   University of Texas Southwestern Medical Center
      2006   -   NCT00287430   -
   University of Utah
      2001   Phase 2   NCT00016445   United States
Growth hormone stimulation test
   University of Texas Southwestern Medical Center
      2006   -   NCT00287443   United States
GS-5737
   Gilead Sciences
      2013   Phase 1   NCT01840735   United States
      2012   Phase 1   NCT01793649   United States
GS-5745
   Gilead Sciences, Inc.
      2016   Phase 2   EUCTR2015-002192-23-ES   Australia;Belgium;Canada;France;Germany;Ireland;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002192-23-DE   Australia;Belgium;Canada;France;Germany;Ireland;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002192-23-BE   Australia;Belgium;Canada;France;Germany;Ireland;Spain;United Kingdom;United States
GS-9411
   Gilead Sciences
      2009   Phase 1   NCT01025713   Australia
      2009   Phase 1   NCT00999531   Australia
      2009   Phase 1   NCT00951522   Australia
      2008   Phase 1   NCT00800579   Australia
GSH
   Mukoviszidose Institut gGmbH i. G.
      2006   -   EUCTR2005-003870-88-DE   Germany
H02 - corticosteroidi sistemici
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
H5.001cbcftr
   National Center for Research Resources (NCRR)
      1995   Phase 1   NCT00004287   -
HAND-grip strength
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Heparin 25MG inhalation powder, hard capsule
   VECTURA LIMITED
      2010   -   EUCTR2007-006276-11-IT   Ireland;Italy
   Vectura Limited
      2008   -   EUCTR2007-006276-11-IE   Ireland;Italy
      2008   -   EUCTR2007-006276-11-GB   Ireland;Italy;United Kingdom
      -   Phase 2   EUCTR2007-006276-11-PL   Ireland;Italy;Poland;United Kingdom
Heparin sodium
   Vectura Limited
      2008   -   EUCTR2007-006276-11-IE   Ireland;Italy
      2008   -   EUCTR2007-006276-11-GB   Ireland;Italy;United Kingdom
      -   Phase 2   EUCTR2007-006276-11-PL   Ireland;Italy;Poland;United Kingdom
Hepatic elastography
   Hopital Foch
      2016   -   NCT02850692   France
Heracillin
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Hfnt during exercise
   The Leeds Teaching Hospitals NHS Trust
      2019   -   NCT03965832   United Kingdom
Hgpiv diagnosis test
   Hospices Civils de Lyon
      2009   -   NCT02723968   -
High dose OF budesonide
   Hospital General de Requena
      2004   -   NCT00728715   Spain
High glycemic index meal
   Emory University
      2014   -   NCT02202876   United States
HIGH-dose vitamin D3
   Emory University
      2015   -   NCT02589444   United States
History and physical
   University of Florida
      2007   -   NCT01851642   United States
Hmscs
   Marilyn Glassberg
      2016   Phase 1   NCT02625246   United States
Homar-IR diagnosis test
   Hospices Civils de Lyon
      2009   -   NCT02723968   -
Home oral glucose tolerance test KIT
   Great Ormond Street Hospital for Children NHS Foundation Trust
      2015   -   NCT02703155   United Kingdom
HP 129XE
   Thunder Bay Regional Health Research Institute
      2020   Early Phase 1   NCT02748798   Canada
HP 3HE
   Thunder Bay Regional Health Research Institute
      2020   Early Phase 1   NCT02748798   Canada
HSK31858
   Haisco Pharmaceutical Group Co., Ltd.
      2022   Phase 2   NCT05601778   China
HSK31858, tablet
   Haisco Pharmaceutical Group Co., Ltd.
      2024   Phase 3   NCT06660992   China
Human recombinant growth hormone
   National Center for Research Resources (NCRR)
      2000   Phase 3   NCT00005112   United States
Hunger vital sign questionnaire
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Hyaluronan
   Ospedale Civile Ca' Foncello
      2009   -   NCT01658449   Italy
Hydrocortisone
   Birmingham Children's Hospital NHS Foundation Trust
      2012   -   EUCTR2011-005790-23-GB   United Kingdom
Hydroxychloroquine
   Vanderbilt University
      2006   Phase 1   NCT00311883   United States
Hyperglycemic clamp with concurrent GIP infusion
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2013   -   NCT01975259   United Kingdom
Hyperglycemic clamp with concurrent GLP-1 infusion
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2013   -   NCT01975259   United Kingdom
Hyperpolarized helium-3
   University of Massachusetts, Worcester
      2008   -   NCT00846573   United States
Hyperpolarized helium-3 MRI OF THE chest
   University of Virginia
      2011   -   NCT02163681   United States
Hyperpolarized XE129
   Children's Hospital Medical Center, Cincinnati
      2024   -   NCT06339593   United States
   Mario Castro, MD, MPH
      2020   Phase 1   NCT04624490   United States
Hyperpolarized xenon
   Children's Hospital Medical Center, Cincinnati
      2016   -   NCT02848560   United States
Hyperpolarized xenon 129
   Children's Hospital Medical Center, Cincinnati
      2020   Phase 4   NCT04467957   United States
Hyperpolarized xenon GAS
   Children's Hospital Medical Center, Cincinnati
      2018   -   NCT03593434   United States
   University of North Carolina, Chapel Hill
      2018   Early Phase 1   NCT03482960   United States
Hyperpolarized xenon MRI
   Papworth Hospital NHS Foundation Trust
      2016   -   NCT02912637   United Kingdom
Hyperpolarized xenon-129
   The University of Nottingham
      -   Phase 2   EUCTR2019-003052-36-GB   United Kingdom
Hypertonic bicarbonate
   Joseph Pilewski
      2014   Phase 1   NCT03391414   United States
Hypertonic saline
   Adelaida Lamas Ferreiro
      2009   Phase 4   NCT01377792   Spain
   CF Therapeutics Development Network Coordinating Center
      2009   -   NCT00709280   Canada;United States
      2007   -   NCT00546663   Canada;United States
   Erasmus MC
      2018   Phase 3   EUCTR2015-004143-39-IT   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2017   Phase 3   EUCTR2015-004143-39-ES   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2017   Phase 3   EUCTR2015-004143-39-DK   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-NL   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-BE   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      -   Phase 3   EUCTR2015-004143-39-FR   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
   Joseph Zabner
      2011   Phase 1/Phase 2   NCT01355796   United States
   Nicole Hamblett
      2020   -   NCT04378153   United States
   Ospedale Civile Ca' Foncello
      2009   -   NCT01658449   Italy
   Parion Sciences
      2015   Phase 2   NCT02343445   United States
   Royal Prince Alfred Hospital, Sydney, Australia
      2000   Phase 3   NCT00271310   -
   The Alfred
      2007   Phase 3   NCT00484263   Australia
   The Hospital for Sick Children
      2011   Phase 2   NCT02276898   Canada
      2008   -   NCT00700050   Canada
      2008   Phase 3   NCT00635141   Canada
      2006   Phase 1   NCT00753987   Canada
      2006   Phase 2   NCT00721071   Canada
   Tim Corcoran
      2017   Phase 1   NCT02947126   United States
      2013   Phase 1   NCT01887197   United States
   University of North Carolina, Chapel Hill
      2009   -   NCT01031706   United States
   University of Oklahoma
      2006   -   NCT00671723   United States
   University of Pittsburgh
      2014   Phase 1   NCT02141191   United States
      2010   Phase 1   NCT01223183   United States
   University of Washington, the Collaborative Health Studies Coordinating Center
      2015   -   NCT02378467   Canada;United States
Hypertonic saline solution
   China-Japan Friendship Hospital
      2024   Phase 0   ChiCTR2400093811   China
   University Hospital Ghent
      2007   -   EUCTR2007-002707-40-BE   Belgium
Hypoglycemic clamp
   Yale University
      2015   Early Phase 1   NCT02398383   United States
Ibuprofen
   FDA Office of Orphan Products Development
      1996   -   NCT00004440   -
   Ramsey, Bonnie, MD
      2004   -   NCT00219895   United States
   University Hospitals Cleveland Medical Center
      2007   -   NCT00531882   United States
Icenticaftor
   Novartis Pharma AG
      2021   Phase 2   EUCTR2019-002840-26-DE   China;Germany;Spain;United Kingdom
      2020   Phase 2   EUCTR2019-002840-26-GB   China;Germany;Spain;United Kingdom
ICS+laba
   Shanghai Pulmonary Hospital, Shanghai, China
      2011   Phase 4   NCT02782312   China
Idpm
   Pharmaxis Pharmaceuticals Limited
      2009   -   EUCTR2008-002740-42-NL   Belgium;France;Germany;Netherlands
      2009   Phase 3   EUCTR2008-002740-42-FR   Belgium;France;Germany;Netherlands
      2009   -   EUCTR2008-002740-42-BE   Belgium;France;Germany;Netherlands
      2008   -   EUCTR2008-002740-42-DE   Belgium;France;Germany;Netherlands
      2007   -   EUCTR2007-001412-23-IE   Ireland;United Kingdom
      -   Phase 3   EUCTR2007-001412-23-DE   Germany;Ireland;United Kingdom
Idpm: inhaled DRY powder mannitol
   Pharmaxis Ltd
      2009   -   EUCTR2008-008228-34-GB   United Kingdom
   Pharmaxis Pharmaceuticals Limited
      2009   -   EUCTR2007-001412-23-GB   Ireland;United Kingdom
   Pharmaxis UK Limited
      2007   Phase 3   EUCTR2006-004078-28-GB   United Kingdom
IGE025
   Novartis Pharma Services AG
      2009   -   EUCTR2007-006648-23-NL   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2009   -   EUCTR2007-006648-23-GB   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-006648-23-DE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-006648-23-BE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
IGY
   Mukoviszidose Institut gGmbH
      2011   Phase 3   NCT01455675   Austria;Belgium;Germany;Hungary;Ireland;Italy;Poland;Spain;Sweden
IHMA-2121771-1
   BiomX Ltd.
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-NL   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-CZ   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
IHMA-2121771-2
   BiomX Ltd.
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-NL   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-CZ   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
IHMA-2121908-1
   BiomX Ltd.
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-NL   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
      2023   Phase 1;Phase 2   EUCTR2022-003810-35-CZ   Czech Republic;Czechia;Israel;Netherlands;Spain;United States
Imipenem/cilastatin/relebactam
   Hartford Hospital
      2023   Phase 4   NCT05561764   United States
Impact-nutridrink
   University Hospital, Motol
      2013   Phase 4   NCT02048592   Czech Republic
IN-vitro approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Increlex*SC 1FL 4ML 10MG/ML
   AZIENDA OSPEDALIERA DI PARMA
      2011   -   EUCTR2011-002719-27-IT   Italy
Indirect calorimetry
   University of Texas Southwestern Medical Center
      2006   -   NCT00287443   United States
Indium-dtpa
   Tim Corcoran
      2017   Phase 1   NCT02947126   United States
Indusil*OS GTT FL 30MG+FL 15ML
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-020516-11-IT   Italy
Influenza vaccination
   Assistance Publique - Hôpitaux de Paris
      2009   Phase 4   NCT01499914   France
Inhaled AR-501
   Aridis Pharmaceuticals, Inc.
      2018   Phase 1/Phase 2   NCT03669614   United States
Inhaled DRY powder mannitol
   Pharmaxis Pharmaceuticals Limited
      2009   -   EUCTR2008-002740-42-NL   Belgium;France;Germany;Netherlands
      2009   Phase 3   EUCTR2008-002740-42-FR   Belgium;France;Germany;Netherlands
      2009   -   EUCTR2008-002740-42-BE   Belgium;France;Germany;Netherlands
      2008   -   EUCTR2008-002740-42-DE   Belgium;France;Germany;Netherlands
      2007   -   EUCTR2007-001412-23-IE   Ireland;United Kingdom
      -   Phase 3   EUCTR2007-001412-23-DE   Germany;Ireland;United Kingdom
Inhaled mannitol
   Pharmaxis
      2014   Phase 3   NCT02134353   Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Israel;Italy;Mexico;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States
      2013   Phase 2   NCT01883531   United Kingdom
      2008   Phase 3   NCT00630812   Argentina;Belgium;Canada;France;Germany;Netherlands;United States
      2004   Phase 2   NCT00455130   Australia;New Zealand
Inhaled reduced glutathione
   Serafino A. Marsico
      2010   Phase 3   NCT01450267   Italy
Inhaled SNSP113
   Synspira, Inc.
      2017   Phase 1   NCT03309358   United Kingdom
Inhaled sodium pyruvate
   University of Minnesota - Clinical and Translational Science Institute
      2006   Phase 1   NCT00332215   United States
Inhaled tobramycin
   Seattle Children's Hospital
      2016   Phase 4   NCT02677701   United States
   University of North Carolina, Chapel Hill
      2004   Phase 1   NCT00823238   United States
Inhaled vancomycin
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
Inhaler
   Boehringer Ingelheim
      2024   Phase 1/Phase 2   NCT06515002   France;Italy;Netherlands;Spain;United Kingdom
   CHIRON CORPORATION LIMITED
      2006   -   EUCTR2005-003772-37-IT   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   University of Florida
      2007   -   NCT01851642   United States
Initiation OF cftr modulator
   Children's Hospital Medical Center, Cincinnati
      2020   Phase 4   NCT04467957   United States
      2020   Phase 4   NCT04259970   Canada;United States
Injected abdominal CT
   Hopital Foch
      2016   -   NCT02850692   France
Inomax 400PPM MOL/MOL inhalation GAS
   Southampton University Hopsitals NHS Trust
      2011   -   EUCTR2010-023529-39-GB   United Kingdom
INS1007
   INSMED INCORPORATED
      2021   Phase 3   EUCTR2020-003688-25-IT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-IT   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
   Insmed Incorporated
      2021   Phase 3   EUCTR2020-003688-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-IE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-003688-25-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003688-25-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Türkiye;United Kingdom;United States
      2019   Phase 2   EUCTR2017-002533-32-BE   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-SE   Australia;Belgium;Bulgaria;Denmark;France;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-PL   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-NL   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-GB   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-ES   Australia;Belgium;Bulgaria;Canada;Denmark;France;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-DK   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-DE   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002533-32-BG   Australia;Belgium;Bulgaria;Denmark;Germany;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Singapore;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2020-003688-25-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Serbia;Slovakia;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Insulin
   Fondazione per la ricerca sulla Fibrosi Cistica
      2005   Phase 3   NCT00687466   Italy
   Jagdeesh Ullal
      2020   Phase 4   NCT04533646   United States
   Mukoviszidose Institut gGmbH
      2001   Phase 3   NCT00662714   Austria;France;Germany;Italy
   National Center for Research Resources (NCRR)
      2001   -   NCT00014768   United States
Insulin asparte
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2001   Phase 3   NCT00072904   Canada;United States
Insulin detemir [rdna origin] injection
   Nationwide Children's Hospital
      2008   Phase 2/Phase 3   NCT00639626   United States
Insulin glargine
   ISTITUTO GIANNINA GASLINI
      2005   -   EUCTR2005-002135-27-IT   Italy
Insulin pump
   University of Texas Southwestern Medical Center
      2006   -   NCT00287456   United States
Insuline humaine recombinante
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
Interferon gamma-1B
   InterMune
      2002   Phase 1/Phase 2   NCT00043342   United States
      2001   Phase 1/Phase 2   NCT00043316   United States
Intermittent, short infusion cefepime
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Intermittent, short infusion ceftazidime
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Intermittent, short infusion meropenem
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Intermittent, short infusion piperacillin tazobactam
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Intermittent, short infusion ticarcillin-clavulanate
   The Alfred
      2012   Phase 4   NCT01667094   Australia
Inulin
   Emory University
      2020   Phase 4   NCT04118010   United States
Ionis-enacrx
   Ionis Pharmaceuticals, Inc.
      2018   Phase 1   NCT03647228   Germany;United Kingdom
Iontophoresis sessions IN forearm OF subjects with pilocarpine
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2017   -   NCT03584841   Belgium
Isotonic saline
   CF Therapeutics Development Network Coordinating Center
      2009   -   NCT00709280   Canada;United States
   China-Japan Friendship Hospital
      2024   Phase 0   ChiCTR2400093811   China
   Erasmus MC
      2018   Phase 3   EUCTR2015-004143-39-IT   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2017   Phase 3   EUCTR2015-004143-39-ES   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2017   Phase 3   EUCTR2015-004143-39-DK   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-NL   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-BE   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      -   Phase 3   EUCTR2015-004143-39-FR   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
   The Hospital for Sick Children
      2011   Phase 2   NCT02276898   Canada
      2008   Phase 3   NCT00635141   Canada
   Tim Corcoran
      2017   Phase 1   NCT02947126   United States
   University of Jena
      2007   Phase 3   NCT00534079   Germany
   University of Pittsburgh
      2010   Phase 1   NCT01223183   United States
      2008   -   NCT00628134   United States
   University of Washington, the Collaborative Health Studies Coordinating Center
      2015   -   NCT02378467   Canada;United States
Itepekimab
   Sanofi
      2024   Phase 2   NCT06280391   Argentina;Brazil;Canada;Chile;China;Czechia;Denmark;France;Germany;Greece;Israel;Italy;Japan;Netherlands;Poland;Spain;Taiwan;Turkey;United Kingdom;United States
Itraconazole
   CHU de Rennes (Rennes University Hospital Centre)
      2012   -   EUCTR2011-005799-41-GB   United Kingdom
   Novartis Pharmaceuticals
      2008   Phase 4   NCT00787917   Belgium;Germany;Italy;Netherlands;United Kingdom
   Ottawa Hospital Research Institute
      2007   Phase 4   NCT00528190   Canada
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1   NCT06154447   United States
      2013   Phase 1   NCT01768663   United States
Itraconazole 65 MG
   Postgraduate Institute of Medical Education and Research
      2023   Phase 3   NCT06160713   India
Itraconazole/voriconazole
   Rennes University Hospital
      2014   Phase 2   NCT01576315   France;United Kingdom
IV amikacin
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV ceftazidime
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV glucose tolerance test
   University of Texas Southwestern Medical Center
      2006   -   NCT00287443   United States
IV meropenem
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV piperacillin-tazobactam
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV ticarcillin-clavulanate
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV tobramycin
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
IV vancomycin hydrochloride
   Savara Inc.
      2011   Phase 1   NCT01537666   Australia
IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1/Phase 2   NCT05668741   Australia;Belgium;Canada;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 2   NCT03911713   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 3   NCT03691779   Australia;Ireland;United Kingdom;United States
      2018   Phase 2   NCT03625466   Germany
      2018   Phase 3   NCT03601637   Canada;United States
      2018   Phase 3   NCT03525574   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   NCT03447262   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2016   Phase 1   NCT03486236   United Kingdom
      2016   Phase 2   NCT02971839   United States
      2016   Phase 2   NCT02951182   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
Ivacaftor
   Antwerp University Hospital
      2018   Phase 4   EUCTR2018-001573-24-BE   Belgium
   Children's Hospital of Philadelphia
      2019   -   NCT03783286   United States
   Eloxx Pharmaceuticals Inc
      2019   Phase 2   EUCTR2018-000966-12-DE   Australia;Germany;Israel
   Eloxx Pharmaceuticals, Inc.
      2019   Phase 2   NCT04135495   Canada;United States
      2019   Phase 2   NCT04126473   Australia;Germany;Israel
   Medical University of South Carolina
      2016   Phase 3   NCT02934698   -
   Richard Barry Moss
      2015   -   NCT02310789   United States
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   The Alfred
      2014   Phase 4   NCT01937325   Australia
   University of California, San Francisco
      2013   -   NCT01784419   United States
   VERTEX PHARMACEUTICALS INCORPORATED
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-NL   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-GB   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-DE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-BE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2017   Phase 3   NCT03277196   Australia;Canada;Germany;Ireland;United Kingdom;United States
      2017   Phase 3   NCT03068312   Israel
      2017   Phase 3   EUCTR2017-001379-21-GB   Canada;Germany;Ireland;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001997-16-IE   Canada;Germany;Ireland;United Kingdom;United States
      2016   Phase 1   NCT03029455   United Kingdom
      2016   Phase 2   NCT02951195   United States
      2016   Phase 3   NCT02742519   Australia;Canada;United Kingdom
      2016   Phase 3   NCT02725567   Australia;Canada;Ireland;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
      2016   Phase 3   EUCTR2015-001267-39-GB   Australia;Canada;France;United Kingdom
      2015   -   NCT02445053   Italy;Netherlands;United Kingdom
      2015   Phase 3   NCT02390219   United States
      2014   Phase 2   NCT02070744   United States
      2014   Phase 1   NCT02015507   -
      2013   Phase 3   NCT01946412   Canada;United Kingdom;United States
      2013   Phase 1   NCT01910415   Netherlands
      2013   Phase 1   NCT01899105   United States
      2013   Phase 3   NCT01897233   Canada;United States
      2013   Phase 1   NCT01768663   United States
      2013   Phase 3   NCT01707290   Belgium;France;Ireland;United Kingdom;United States
      2013   Phase 3   NCT01705145   Canada;United Kingdom;United States
      2013   Phase 3   EUCTR2012-000386-20-GB   Canada;United Kingdom;United States
      2013   Phase 3   EUCTR2012-000204-15-GB   Canada;United Kingdom;United States
      2013   Phase 2   EUCTR2011-003821-93-DE   Canada;Germany;United Kingdom;United States
      2012   Phase 2   NCT01685801   United States
      2012   Phase 3   NCT01614470   Belgium;France;United States
      2012   Phase 3   NCT01614457   Ireland;United Kingdom;United States
      2012   Phase 2   NCT01531673   Canada;Germany;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-GB   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-BE   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000388-26-BE   Belgium;France;United States
      2012   -   EUCTR2012-000387-19-GB   United Kingdom;United States
      2012   Phase 2   EUCTR2011-003821-93-GB   Canada;Germany;United Kingdom;United States
      2011   Phase 2   NCT01262352   Canada;Ireland;United Kingdom;United States
      2010   Phase 2   NCT01225211   Australia;Belgium;France;Germany;Ireland;New Zealand;United Kingdom;United States
      2010   Phase 3   NCT01117012   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2010-020546-96-GB   Canada;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   Phase 3   EUCTR2009-012997-11-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 2   NCT00953706   United States
      2009   Phase 3   NCT00909727   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   NCT00909532   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   -   EUCTR2008-007479-26-IE   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007479-26-GB   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   -   EUCTR2008-007479-26-DE   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   -   EUCTR2008-007416-15-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007416-15-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-IE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2017-000673-37-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2017-000672-28-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2015-001997-16-GB   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001997-16-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001267-39-FR   Australia;Canada;France;United Kingdom
      -   -   EUCTR2009-010261-23-Outside-EU/EEA   United States
      -   -   EUCTR2008-007416-15-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
   university medical center utrecht
      2018   Phase 4   EUCTR2016-001440-18-NL   Netherlands
Ivacaftor 125MG tablet
   Vertex Pharmaceuticals Incorporated
      2014   Phase 3   EUCTR2013-000604-41-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   -   EUCTR2013-000604-41-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-SE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-NL   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IT   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
Ivacaftor 150 MG
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
Ivacaftor 150 MG or 250 MG
   Vertex Pharmaceuticals Incorporated
      2007   Phase 2   NCT00457821   Canada;Germany;United States
Ivacaftor 25 MG/75 MG
   Vertex Pharmaceuticals Incorporated
      2007   Phase 2   NCT00457821   Canada;Germany;United States
Ivacaftor 59,5MG
   Vertex Pharmaceuticals Incorporated
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
Ivacaftor 59.5MG
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
Ivacaftor 75 MG
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
Ivacaftor 75 MG/150 MG
   Vertex Pharmaceuticals Incorporated
      2007   Phase 2   NCT00457821   Canada;Germany;United States
Ivacaftor 75MG
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
Ivacaftor and symdeko
   University of Alabama at Birmingham
      2018   Phase 4   NCT03624101   United States
Ivacaftor exposed
   Vertex Pharmaceuticals Incorporated
      2013   -   NCT01863238   United States
Ivacaftor or elexacaftor/tezacaftor/ivacaftor
   Sonya Heltshe
      2020   -   NCT04509050   United States
   University of California, Los Angeles
      2023   -   NCT06191640   United States
Ivacaftor+lumacaftor
   Assistance Publique - Hôpitaux de Paris
      2016   -   NCT03475381   France
Ivacaftor/ataluren
   University of Alabama at Birmingham
      2017   Phase 4   NCT03256799   United States
Ivacaftor/kalydeco
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000817-30-NL   Netherlands
J01gb01
   University Medical Center Groningen
      2013   -   EUCTR2012-004437-16-NL   Netherlands
      -   Phase 2   EUCTR2016-005014-21-NL   Netherlands
JBT-101
   CORBUS PHARMACEUTICALS, INC
      2018   Phase 2   EUCTR2017-003723-29-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
   Corbus Pharmaceuticals Inc.
      2015   Phase 2   NCT02465450   Belgium;France;Germany;Italy;Poland;United Kingdom;United States
   Corbus Pharmaceuticals, Inc.
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-RO   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-NL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SK   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-PT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002581-23-DE   Belgium;France;Germany;Israel;Italy;Poland;United Kingdom;United States
      2015   Phase 2   EUCTR2015-002581-23-GB   Belgium;France;Germany;Israel;Italy;Poland;United Kingdom;United States
      2015   Phase 2   EUCTR2015-002581-23-FR   Belgium;France;Germany;Israel;Italy;Poland;United Kingdom;United States
      2015   Phase 2   EUCTR2015-002581-23-BE   Belgium;France;Germany;Israel;Italy;Poland;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2   EUCTR2017-003723-29-FR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
JBT101
   CORBUS PHARMACEUTICALS, INC
      2016   Phase 2   EUCTR2015-002581-23-IT   Belgium;France;Germany;Italy;United Kingdom
Kaftrio
   Haga Teaching Hospital
      2021   Phase 4   EUCTR2020-005224-12-NL   Netherlands
   Royal College of Surgeons, Ireland
      2020   Phase 4   NCT04602468   Ireland;United Kingdom
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
Kalydeco
      2019   Phase 4   EUCTR2019-001314-41-NL   Netherlands
   Eloxx Pharmaceuticals Inc
      2019   Phase 2   EUCTR2018-000966-12-DE   Australia;Germany;Israel
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-001379-21-GB   Canada;Germany;Ireland;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001997-16-IE   Canada;Germany;Ireland;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001267-39-GB   Australia;Canada;France;United Kingdom
      2016   Phase 3   EUCTR2014-004838-25-DE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-AT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004788-18-BE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-BE   Austria;Belgium;Canada;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-SE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-NL   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IT   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-GB   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-ES   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DK   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   -   EUCTR2014-004827-29-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-IT   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004787-37-ES   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-DE   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-AT   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2014   -   EUCTR2010-020413-90-IE   Australia;Belgium;France;Germany;Ireland;United Kingdom;United States
      2014   Phase 2   EUCTR2010-020413-90-GB   Australia;Belgium;Germany;Ireland;United Kingdom;United States
      2013   Phase 3   EUCTR2012-000386-20-GB   Canada;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-GB   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-BE   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000388-26-BE   Belgium;France;United States
      2012   -   EUCTR2012-000387-19-GB   United Kingdom;United States
      2011   -   EUCTR2010-020413-90-DE   Australia;Belgium;Germany;New Zealand;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-BE   Australia;Belgium;Germany;Ireland;New Zealand;United Kingdom;United States
      2010   Phase 3   EUCTR2009-012997-11-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-IE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2017-000673-37-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2017-000672-28-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2015-001997-16-GB   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001997-16-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001267-39-FR   Australia;Canada;France;United Kingdom
Kalydeco 150 MG FILM-C
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
Kalydeco 150 MG FILM-coated tablets
   VERTEX PHARMACEUTICALS INCORPORATED
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-IT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-NL   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-GB   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-DE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-BE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004134-29-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2018-000126-55-NL   Netherlands
      2018   Phase 3   EUCTR2017-004134-29-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-IE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-GB   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-ES   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000797-11-NL   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 3   EUCTR2017-000540-18-DE   France;Germany;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-NL   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-GB   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-ES   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-DE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-BE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-AT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000454-36-DK   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-004133-82-DE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2017-004132-11-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-000540-18-FR   France;Germany;United States
Kalydeco 150MG
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
KB001
   KaloBios Pharmaceuticals
      2008   Phase 1/Phase 2   NCT00638365   United States
KB001-A
   KaloBios Pharmaceuticals
      2012   Phase 2   NCT01695343   Australia;Israel;New Zealand;United States
KB407
   Krystal Biotech, Inc.
      2023   Phase 1   NCT05504837   United States
      2022   Phase 1   NCT05095246   Australia
Ketone monoester
   University of Alabama at Birmingham
      2021   -   NCT04938726   United States
Kineret
   Ruprecht-Karls-University Heidelberg, Medical Faculty
      2019   Phase 2   EUCTR2016-004786-80-DE   Germany
KIT2014
   Kither Biotech Srl
      2024   Phase 1   NCT06659757   Australia
Klacid
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Kreon 25 000
   Abbott Laboratories GmbH
      2015   -   EUCTR2014-004519-35-HU   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-GB   Czech Republic;Hungary;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-004519-35-ES   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-CZ   Czech Republic;Hungary;Spain;United Kingdom
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-DE   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
Kreon 25,000 units
   Aptalis Pharma
      2012   Phase 3   NCT01641393   Belgium;Bulgaria;France;Germany;Italy;Poland;United Kingdom
Kreon 25000
   Abbott Laboratories GmbH
      2013   -   EUCTR2013-002819-10-ES   Hungary;Russian Federation;Spain
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-DE   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
   Axcan Pharma Inc.
      -   -   EUCTR2010-019267-11-DE   Germany
Kreon DE liberacióN inmediata
   Abbott Laboratories GmbH
      2015   Phase 2   EUCTR2014-004519-35-ES   Czech Republic;Hungary;Spain;United Kingdom
Kreon N 25000
   Abbott Laboratories GmbH
      2013   -   EUCTR2013-002819-10-ES   Hungary;Russian Federation;Spain
Kreon® 25,000
   Abbott Laboratories GmbH
      2015   Phase 2   EUCTR2014-004519-35-ES   Czech Republic;Hungary;Spain;United Kingdom
   Forest Laboratories
      2011   Phase 4   NCT01327703   Germany;Poland
L-alanine
   Emory University
      2010   Phase 2   NCT01051999   United States
L-arginine
   The Hospital for Sick Children
      2006   Phase 2   NCT00405665   Canada
L-glutamine
   University of Nottingham
      2008   Phase 4   EUCTR2007-006204-37-GB   United Kingdom
L-lysine N acetylcysteinate
   LABORATOIRES SMB S.A.
      2010   -   EUCTR2010-018454-13-IT   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
L-lysine N-acetylcysteinate
   LABORATOIRES SMB S.A.
      2010   -   EUCTR2010-018454-13-IT   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
L-lysine- N-acetylcysteinate
   Laboratoires SMB S.A.
      2010   Phase 3   EUCTR2010-018454-13-ES   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
L-lysine-N-acetyl-L-cysteinate
   Laboratoires SMB S.A.
      -   Phase 3   EUCTR2010-018454-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
L-lysine-N-acetylcysteinate
   Laboratoires SMB S.A.
      2010   -   EUCTR2010-018454-13-HU   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-GB   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-DE   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-CZ   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
Laba/lama
   Shanghai Pulmonary Hospital, Shanghai, China
      2020   Phase 4   NCT04509661   -
Lactic acid producing organisms
   UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
      2009   -   EUCTR2009-015875-28-IT   Italy
      2009   -   EUCTR2009-011289-27-IT   Italy
Lactizole nebulization
   Medical Universtity of Lodz
      2019   -   NCT04058340   Poland
Lactobacillus reuteri
   Azienda Policlinico Umberto I
      2009   Phase 4   NCT01737983   Italy
Lactobacillus rhamnosus
   Cantonal Hospital of St. Gallen
      2013   -   NCT01837355   Switzerland
Lactobacillus rhamnosus GG
   Federico II University
      2010   Phase 3   NCT01956916   Italy
      2009   Phase 3   NCT01961661   Italy
Lansoprazole
   Arkansas Children's Hospital Research Institute
      2006   Phase 1   NCT00458614   United States
Lantus 100 units/ML solution FOR injection IN A cartridge
   HagaZiekenhuis, pulmonary department
      2012   -   EUCTR2011-001916-69-NL   Netherlands
Lantus® 100 units/ML solution FOR injection IN A vial. lantus® 100 units/ML solution FOR injection IN A cartridge. lantus® 100 units/ML solution FOR injection IN A PRE-filled PEN
   St George's, University of London
      2008   -   EUCTR2007-004956-35-GB   United Kingdom
LAU-7B
   Laurent Pharmaceuticals Inc.
      2018   Phase 2   NCT03265288   Australia;Canada;United States
Lefamulin
   Nabriva Therapeutics AG
      2022   Phase 1   NCT05225805   United States
Lenabasum
   CORBUS PHARMACEUTICALS, INC
      2018   Phase 2   EUCTR2017-003723-29-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
   Corbus Pharmaceuticals Inc.
      2015   Phase 2   NCT02465450   Belgium;France;Germany;Italy;Poland;United Kingdom;United States
   Corbus Pharmaceuticals, Inc.
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-RO   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-NL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SK   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-PT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2   EUCTR2017-003723-29-FR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
Lenabasum 20 MG
   Corbus Pharmaceuticals Inc.
      2017   Phase 2   NCT03451045   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
Lenabasum 5 MG
   Corbus Pharmaceuticals Inc.
      2017   Phase 2   NCT03451045   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
Leucine
   National Center for Research Resources (NCRR)
      2001   -   NCT00014768   United States
Levemir 100 U/ML solution FOR injection IN A cartridge, levemir 100 U/ML solution FOR injection IN A PRE-filled PEN
   St George's, University of London
      2008   -   EUCTR2007-004956-35-GB   United Kingdom
Levemir flexpen
   Liverpool Heart and Chest Hospital NHS Trust
      2013   -   EUCTR2012-002880-86-GB   United Kingdom
Levemir penfill
   Sheffield Children's NHS Trust
      2006   Phase 4   EUCTR2005-002997-31-GB   United Kingdom
Levofloxacin
   Amgen
      2009   Phase 1   NCT00840333   United States
      2007   Phase 1   NCT00503490   United States
   Horizon Pharma USA, Inc.
      2011   Phase 3   NCT01270347   France;Germany;Ireland;Israel;United Kingdom;United States
   Mpex Pharmaceuticals, Inc.
      2008   -   EUCTR2008-001728-30-NL   Germany;Netherlands
      2008   -   EUCTR2008-001728-30-DE   Germany;Netherlands
Levofloxacin hemihydrate
   Medical University of Vienna
      2020   Phase 4   EUCTR2019-000955-16-AT   Austria
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-IE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019634-26-GB   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   -   EUCTR2010-019634-26-DE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      -   Phase 3   EUCTR2010-019634-26-FR   France;Germany;Ireland;United Kingdom
Levofloxacin kabi
   Medical University of Vienna
      2020   Phase 4   EUCTR2019-000955-16-AT   Austria
Linez
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Linezolid
   University of Texas Southwestern Medical Center
      2010   Phase 2   NCT00625703   United States
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Linoleic acid supplementation
   Karolinska Institutet
      2021   -   NCT04531410   Italy;Norway;Poland;Sweden
Lipasa
   ANTHERA Pharmaceuticals, Inc.
      2016   Phase 3   EUCTR2016-002851-92-ES   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
Lipase
   ALTUS PHARMACEUTICALS INC
      2007   -   EUCTR2007-000178-21-IT   Italy
      2007   -   EUCTR2007-000171-41-IT   Italy
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2016-002851-92-HU   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 4   EUCTR2016-002851-92-CZ   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-002851-92-PL   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
   EURAND SPA
      2010   -   EUCTR2009-012842-21-IT   Bulgaria;Germany;Hungary;Italy;United Kingdom
Lipase clec
   Altus Pharmaceuticals Inc
      2007   Phase 3   EUCTR2007-000171-41-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000171-41-PL   Italy;Poland;Slovakia
   Altus Pharmaceuticals Inc.
      2007   Phase 3   EUCTR2007-000178-21-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000178-21-PL   Italy;Poland;Slovakia
Lipase LIP2 from yarrowia lipolytica
   AzurRx
      2020   Phase 2   EUCTR2018-003831-31-ES   Hungary;Poland;Spain
   AzurRx SAS
      -   Phase 2   EUCTR2018-003831-31-PL   Hungary;Poland;Spain;Turkey
Lipitor
   NHS Lothian
      2010   Phase 4   EUCTR2010-022042-24-GB   United Kingdom
      2010   Phase 4   EUCTR2010-022040-20-GB   United Kingdom
Liposomal amikacin
   INSMED INCORPORATED
      2012   -   EUCTR2011-000443-24-IT   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000441-20-IT   Austria;Bulgaria;Canada;Denmark;Greece;Hungary;Ireland;Italy;Netherlands;Spain;United Kingdom
   Insmed Incorporated
      2013   Phase 3   EUCTR2011-000443-24-NL   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2011-000443-24-SE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2011-000443-24-PL   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2011-000443-24-DK   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2011-000443-24-BE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-NL   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-IE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-DK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-BG   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2012   Phase 3   EUCTR2011-000441-20-BE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   Phase 3   EUCTR2011-000443-24-SK   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-IE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-HU   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-GR   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000443-24-GB   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000443-24-FR   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000443-24-ES   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   -   EUCTR2011-000443-24-DE   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000443-24-BG   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-000443-24-AT   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2011-000442-38-ES   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-000442-38-BG   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-000441-20-SK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-HU   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-GR   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000441-20-GB   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-DE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-AT   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      -   Phase 3   EUCTR2011-000442-38-PL   Australia;Bulgaria;France;Macedonia, the former Yugoslav Republic of;New Zealand;Poland;Serbia;Spain;Sweden;Ukraine;United States
   Transave, Inc.
      2007   Phase 2   EUCTR2006-006980-22-SK   Belgium;Hungary;Poland;Slovakia
      2007   -   EUCTR2006-006980-22-HU   Belgium;Hungary
      2007   -   EUCTR2006-006980-22-BE   Belgium;Hungary
      -   Phase 2   EUCTR2006-006980-22-PL   Belgium;Hungary;Poland;Slovakia
Liposomal amikacin FOR inhalation
   Insmed Incorporated
      2012   Phase 3   NCT01316276   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2012   Phase 3   NCT01315691   -
      2012   Phase 3   NCT01315678   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom
Liprotamasa
   ANTHERA Pharmaceuticals, Inc.
      2016   Phase 3   EUCTR2016-002851-92-ES   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
Liprotamase
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2016-002851-92-HU   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 4   EUCTR2016-002851-92-CZ   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-002851-92-PL   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
   Anthera Pharmaceuticals
      2017   Phase 3   NCT03051490   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2016   Phase 4   NCT02823964   Czech Republic;Czechia;Hungary;Israel;Poland;Spain;United States
      2015   Phase 3   NCT02279498   Canada;Czech Republic;Czechia;Hungary;Israel;Poland;Spain;United States
      2007   Phase 3   NCT00449904   United States
      2007   Phase 3   NCT00449878   United States
      2004   Phase 2   NCT00095732   United States
Liprotamase powder FOR oral solution
   Anthera Pharmaceuticals
      2016   Phase 3   NCT02734810   United States
Lonodelestat
   Santhera Pharmaceuticals (Switzerland) Ltd
      2018   Phase 1;Phase 2   EUCTR2018-002550-71-DE   Germany
Losartan
   University of Kansas Medical Center
      2024   Phase 2   NCT06364176   United States
      2022   Early Phase 1   NCT03435939   United States
   University of Miami
      2017   Phase 2   NCT03206788   United States
LOW glycemic index meal
   Emory University
      2014   -   NCT02202876   United States
LU 70274
   Nordmark Arzneimittel GmbH
      2006   -   EUCTR2006-005180-25-DE   Germany
Lubiprostone
   University of Arkansas
      2008   -   NCT00706004   United States
Lucinactant first
   University of North Carolina, Chapel Hill
      2008   Phase 2   NCT00934362   United States
LUM
   Vertex Pharmaceuticals Incorporated
      2018   Phase 2   NCT03625466   Germany
      2018   Phase 3   NCT03601637   Canada;United States
LUM/IVA
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   NCT04235140   Canada;United States
      2017   Phase 3   NCT03125395   Canada;United States
      2017   Phase 2   NCT03061331   Netherlands
      2016   Phase 4   NCT02875366   Australia;United Kingdom
      2016   Phase 4   NCT02823470   Canada;United States
      2016   Phase 3   NCT02797132   Canada;United States
      2015   Phase 3   NCT02544451   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
LUM/IVA fixed-dose combination
   Vertex Pharmaceuticals Incorporated
      2018   Phase 2   EUCTR2017-003761-99-DE   Germany
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
Lumacaftor
   Antwerp University Hospital
      2018   Phase 4   EUCTR2018-001573-24-BE   Belgium
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
      2015   Phase 3   NCT02390219   United States
      2013   Phase 1   NCT01910415   Netherlands
      2013   Phase 1   NCT01899105   United States
      2013   Phase 3   NCT01897233   Canada;United States
      2013   Phase 1   NCT01768663   United States
      2010   Phase 2   NCT01225211   Australia;Belgium;France;Germany;Ireland;New Zealand;United Kingdom;United States
Lumacaftor / ivacaftor
   Vertex Pharmaceuticals Incorporated
      2018   Phase 2   EUCTR2017-003761-99-DE   Germany
Lumacaftor plus ivacaftor
   Hannover Medical School
      2016   -   NCT02807415   Germany
Lumacaftor plus ivacaftor combination
   Vertex Pharmaceuticals Incorporated
      2013   Phase 3   NCT01931839   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   NCT01807949   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   NCT01807923   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
Lumacaftor, ivacaftor drug combination
   Carmel Medical Center
      2016   -   NCT04623879   -
Lumacaftor-ivacaftor
   Massachusetts General Hospital
      2018   -   NCT02653027   -
      2016   -   NCT02858843   -
Lumacaftor-ivacaftor treatment
   University Hospital, Strasbourg, France
      2016   -   NCT03512119   France
Lumacaftor/ivacaftor
   Vertex Pharmaceuticals Incorporated
      2016   Phase 4   EUCTR2016-000066-34-GB   Australia;United Kingdom
      2014   -   EUCTR2010-020413-90-IE   Australia;Belgium;France;Germany;Ireland;United Kingdom;United States
      2014   Phase 2   EUCTR2010-020413-90-GB   Australia;Belgium;Germany;Ireland;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-DE   Australia;Belgium;Germany;New Zealand;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-BE   Australia;Belgium;Germany;Ireland;New Zealand;United Kingdom;United States
      -   Phase 3   EUCTR2023-000946-41-Outside-EU/EEA   Canada;United States
      -   Phase 3   EUCTR2017-001309-34-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2017-001078-41-Outside-EU/EEA   Canada;United States
Lumacaftor/ivacaftor 100MG/125MG tablets
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2015-001644-11-GB   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-FR   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DK   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-BE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-SE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-GB   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-DK   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-DE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-BE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001644-11-SE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-000543-16-FR   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
Lumacaftor/ivacaftor 200MG/125MG
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
Lumacaftor/ivacaftor 200MG/125MG tablets
   Vertex Pharmaceuticals Inc.
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2015-001644-11-GB   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-FR   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DK   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-BE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   -   EUCTR2013-000604-41-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-SE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-NL   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IT   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001644-11-SE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
Lumacaftor/ivacaftor 200MG/83MG tablet
   Vertex Pharmaceuticals Incorporated
      2014   Phase 3   EUCTR2013-000604-41-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   -   EUCTR2013-000604-41-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-SE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-NL   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IT   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
Lung clearance index
   The Hospital for Sick Children
      2015   Phase 2   NCT02740868   Canada
   University of North Carolina, Chapel Hill
      2015   Early Phase 1   NCT03497117   United States
LYM-X-sorb powder
   Avanti Polar Lipids, Inc.
      2007   Phase 2   NCT00406536   United States
Macroduct sweat stimulator
   Richard Barry Moss
      2015   -   NCT02310789   United States
Macrogol
   University Hospital, Bordeaux
      2020   Phase 2   NCT04458129   -
MAG-DHA
   SCF Pharma
      2015   Phase 2   NCT02518672   Canada
Magnetic resonance imaging
   The Hospital for Sick Children
      2015   Phase 2   NCT02740868   Canada
Mannite
   University Children’s Hospital Tuebingen
      2009   Phase 2   NCT01309178   Germany
Mannitol
   PHARMAXIS LTD
      2014   Phase 3   EUCTR2013-005357-79-SK   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
   Pharmaxis
      2008   Phase 1   NCT00792714   Australia;United Kingdom
      2007   Phase 3   NCT00446680   Australia;Ireland;United Kingdom
      2005   Phase 2   NCT00251056   Argentina;Canada
   Pharmaxis Limited
      2016   Phase 3   EUCTR2013-005357-79-SE   Argentina;Australia;Belgium;Bulgaria;Canada;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2013-005357-79-GR   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2013-005357-79-BG   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-IT   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-HU   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-CZ   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005357-79-BE   Argentina;Belgium;Bulgaria;Canada;Czech Republic;France;Greece;Hungary;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   Pharmaxis Ltd.
      2014   -   EUCTR2012-002699-14-NL   Argentina;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom
      2014   -   EUCTR2012-002699-14-IT   Argentina;Belgium;Canada;Italy;Netherlands;United Kingdom
      2013   Phase 2   EUCTR2012-002699-14-GB   Argentina;Belgium;Canada;France;Italy;Netherlands;United Kingdom
      2013   -   EUCTR2012-002699-14-BE   Belgium;Canada;France;Germany;Italy;Netherlands;Switzerland;United Kingdom
      -   Phase 2   EUCTR2012-002699-14-FR   Argentina;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom
Mannitol + pulmozyme
   Pharmaxis
      2005   Phase 2   NCT00117208   United Kingdom
Mannitol inhalant product
   University of North Carolina, Chapel Hill
      2023   Phase 4   NCT05740618   United States
Mannitol inhalation powder
   Tim Corcoran
      2013   Phase 1   NCT01887197   United States
Maralixibat
   Children's Hospital Los Angeles
      2024   Phase 2/Phase 3   NCT06413368   United States
Matched isoglycemic clamp
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2013   -   NCT01975259   United Kingdom
Measure OF endothelial function
   Hopital Foch
      2016   -   NCT02850692   France
Mecasermin
   AZIENDA OSPEDALIERA DI PARMA
      2011   -   EUCTR2011-002719-27-IT   Italy
MEDI-563
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
   AstraZeneca AB
      2021   Phase 3   EUCTR2020-004068-24-PL   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DK   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
      2021   Phase 3   EUCTR2020-004068-24-DE   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Japan;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Viet Nam
Medical grade oxygen
   Hal C Charles
      2012   Phase 1   NCT01731015   United States
Mediterranean diet
   Ain Shams University
      2024   -   NCT06875050   Egypt
Melphalan
   Federal State Budgetary Institution, Pulmonology Scientific Research Institute
      2018   Phase 2   NCT04278040   Russian Federation
Menadiol diphosphate
   Barts and the London NHS Trust
      2006   Phase 3   EUCTR2006-000945-20-GB   United Kingdom
Menadiol sodium diphosphate
   Barts and the London NHS Trust
      2006   Phase 3   EUCTR2006-000945-20-GB   United Kingdom
Meropenem
   Imperial College London
      2010   Phase 4   NCT01044719   United Kingdom
   Imperial College, London
      2009   -   EUCTR2009-014042-28-GB   United Kingdom
   Joseph Kuti
      2012   Phase 4   NCT01429259   United States
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
   University Ghent
      2016   -   NCT02840136   Belgium
Meropenem fresenius kabi 1 G poeder voor oplossing voor injectie OF infusie
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Meropenem infusion
   St. Michael's Hospital, Toronto
      2010   -   NCT01158937   Canada
Meropenem trihydrate
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Mesenchymal stem cells
   University Hospitals Cleveland Medical Center
      2016   Phase 1   NCT02866721   United States
Metformin hydrochloride
   University of Kansas Medical Center
      2022   Phase 2   NCT04530383   United States
Metformine HCL 500 PCH
   Staf Longziekten
      2009   -   EUCTR2009-009875-37-NL   Netherlands
Midazolam
   AbbVie
      2022   Phase 1   NCT05530278   United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1   NCT06154447   United States
Miglustat
   Actelion
      2008   Phase 2   NCT00742092   Belgium
      2007   Phase 2   NCT00537602   Spain
   Actelion Pharmaceuticals Ltd
      2008   -   EUCTR2008-002352-20-BE   Belgium
      2007   Phase 2   EUCTR2006-002049-35-ES   Spain
   Assistance Publique - Hôpitaux de Paris
      2015   Phase 2/Phase 3   NCT02325362   France
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2009   Phase 2   NCT00945347   Belgium
Minocycline
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
      2011   Phase 2   NCT01349192   United States
Minocycline hydrochloride
   AOU Meyer
      2013   Phase 3   EUCTR2013-000219-25-IT   Italy
Mixed meal test evaluation test ARM
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2011   -   NCT03644199   United Kingdom
Mixed meal tolerance test
   Yale University
      2015   Early Phase 1   NCT02398383   United States
Modified lipid formulation
   Nestlé
      2016   -   NCT02646995   Switzerland
Molgramostim
   Savara Inc.
      2015   Phase 1   NCT02468908   United Kingdom
Molgramostim nebulizer solution
   Savara Inc.
      2019   Phase 2   NCT03597347   United States
Moli 1901
   AOP ORPHAN PHARMACEUTICALS
      2008   -   EUCTR2006-006693-24-IT   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
   AOP Orphan Pharmaceuticals AG
      2007   Phase 2;Phase 3   EUCTR2006-006693-24-FR   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
MOLI1901
   AOP Orphan Pharmaceuticals AG
      2008   Phase 2;Phase 3   EUCTR2006-006693-24-ES   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
      2008   -   EUCTR2006-006693-24-CZ   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   Phase 2   NCT00671736   Austria
      2007   -   EUCTR2006-006693-24-SE   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   -   EUCTR2006-006693-24-HU   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2007   Phase 2;Phase 3   EUCTR2006-006693-24-DE   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
      2007   -   EUCTR2006-006693-24-AT   Austria;Czech Republic;France;Germany;Hungary;Italy;Spain;Sweden
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-SK   Czech Republic;Hungary;Slovakia
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-HU   Czech Republic;Hungary;Slovakia
      2006   Phase 2;Phase 3   EUCTR2005-005594-29-CZ   Czech Republic;Hungary;Slovakia
      2006   -   EUCTR2005-004344-30-HU   Hungary
      2005   -   EUCTR2005-004344-30-AT   Austria;Hungary
      -   Phase 2   EUCTR2006-006693-24-PL   Austria;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Sweden
Monitor
   Jagdeesh Ullal
      2020   Phase 4   NCT04533646   United States
Moxifloxacin
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1   NCT05867147   United States
Moxifloxacin hydrochloride
   Vertex Pharmaceuticals Incorporated
      2013   Phase 1   NCT01910415   Netherlands
MP-376
   Amgen
      2009   Phase 1   NCT00840333   United States
      2008   Phase 2   NCT00677365   Germany;Netherlands;United States
      2007   Phase 1   NCT00503490   United States
   Horizon Pharma USA, Inc.
      2011   Phase 3   NCT01270347   France;Germany;Ireland;Israel;United Kingdom;United States
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-IE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019634-26-GB   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   -   EUCTR2010-019634-26-DE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2008   -   EUCTR2008-001728-30-NL   Germany;Netherlands
      2008   -   EUCTR2008-001728-30-DE   Germany;Netherlands
      -   Phase 3   EUCTR2010-019634-26-FR   France;Germany;Ireland;United Kingdom
MRI with PFP
   University of North Carolina, Chapel Hill
      2015   Early Phase 1   NCT03497117   United States
MRT5005
   Translate Bio, Inc.
      2018   Phase 1/Phase 2   NCT03375047   United States
MS1819
   AzurRx BioPharma, Inc.
      2020   Phase 2   NCT04375878   Poland;United States
MS1819-SD
   AzurRx
      2020   Phase 2   EUCTR2018-003831-31-ES   Hungary;Poland;Spain
      2019   Phase 2   EUCTR2018-003831-31-HU   Hungary;Poland;Spain
   AzurRx BioPharma, Inc.
      2019   Phase 2   NCT03746483   Poland;United States
   AzurRx SAS
      2019   Phase 2   NCT04302662   Hungary;Turkey
      -   Phase 2   EUCTR2018-003831-31-PL   Hungary;Poland;Spain;Turkey
MSI-1995
   Genaera Corporation
      2005   Phase 2   EUCTR2004-004334-13-IE   Ireland
MTT
   Pharmaxis Pharmaceuticals Limited
      2009   -   EUCTR2008-002740-42-NL   Belgium;France;Germany;Netherlands
      2009   Phase 3   EUCTR2008-002740-42-FR   Belgium;France;Germany;Netherlands
      2009   -   EUCTR2008-002740-42-BE   Belgium;France;Germany;Netherlands
      2008   -   EUCTR2008-002740-42-DE   Belgium;France;Germany;Netherlands
Mucoid exopolysaccharide P. aeruginosa immune globulin IV
   National Center for Research Resources (NCRR)
      1995   Phase 2   NCT00004747   -
Mucolysin
   Aarhus University Hospital
      2016   Phase 2   EUCTR2016-000354-35-DK   Denmark
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
Mucomyst
   Aarhus University Hospital
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
Multistrain probiotic
   Oslo University Hospital
      2024   -   NCT06284577   Norway
Mupirocin
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
      2011   Phase 2   NCT01349192   United States
Mupirocin intranasal creme
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
Muscle oxygenation
   Hacettepe University
      2019   -   NCT03902236   Turkey
Mycobacteriophage
   National Jewish Health
      2024   -   NCT06262282   United States
N-(5-hydroxy-2,4- BIS(trimethylsilyl)phenyl)-4-OXO- 1,4-dihydroquinoline-3-carboxamide
   Proteostasis Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
N-(5-hydroxy-2,4-BIS(trimethylsilyl)phenyl)-4-OXO-1,4-dihydroquinoline-3-carboxamide
   Proteostasis Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-YL)cyclobutyl)-3-phenylisoxazole-5-carboxamide
   Proteostasis Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
N-acetylcystein
   Rigshospitalet
      2010   Phase 4   EUCTR2007-001401-15-DK   Denmark
N-acetylcysteine
   Qilu Hospital of Shandong University
      2014   -   NCT02088216   China
   Stanford University
      2008   Phase 2   NCT00809094   United States
   University Hospital Ghent
      2009   -   EUCTR2008-008317-20-BE   Belgium
N6022
   Nivalis Therapeutics, Inc.
      2014   Phase 1   NCT01746784   United States
N91115
   Nivalis Therapeutics, Inc.
      2015   Phase 1   NCT02275936   United States
      2014   Phase 1   NCT02227888   United States
NAC
   Stanford University
      2008   Phase 2   NCT00809094   United States
Nacystelyn
   LABORATOIRES SMB S.A.
      2010   -   EUCTR2010-018454-13-IT   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
   Laboratoires SMB S.A.
      2010   -   EUCTR2010-018454-13-HU   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-GB   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-ES   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-DE   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-CZ   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      -   Phase 3   EUCTR2010-018454-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
NAL
   LABORATOIRES SMB S.A.
      2010   -   EUCTR2010-018454-13-IT   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
   Laboratoires SMB S.A.
      2010   -   EUCTR2010-018454-13-HU   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-GB   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-ES   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018454-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-DE   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      2010   -   EUCTR2010-018454-13-CZ   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom
      -   Phase 3   EUCTR2010-018454-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Spain;United Kingdom
Nasal aztreonam
   Virginia Commonwealth University
      2017   Phase 2   NCT02730793   United States
Nasal brushing
   Assistance Publique - Hôpitaux de Paris
      2019   -   NCT03894657   France
Nasal rinsing with xylitol
   Universitaire Ziekenhuizen KU Leuven
      2022   -   NCT05531630   Belgium
Navocaftor
   AbbVie
      2022   Phase 1   NCT05530278   United States
      2021   Phase 2   NCT04853368   Australia;Belgium;Czechia;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom;United States
   AbbVie Deutschland
      2022   Phase 2   EUCTR2019-000750-63-RO   Belgium;Canada;Czechia;France;Hungary;Netherlands;Poland;Puerto Rico;Romania;Serbia;Slovakia;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005805-25-NL   Australia;Belgium;Germany;Hungary;Netherlands;New Zealand;Slovakia;United Kingdom
      2021   Phase 2   EUCTR2020-005805-25-HU   Hungary
      2021   Phase 2   EUCTR2020-005805-25-BE   Belgium;Hungary;Netherlands
NEB/01-07
   Laboratoire Erempharma
      2008   -   EUCTR2007-003868-22-FR   France
Nebcin
   The Univeristy of Nottingham
      2010   Phase 4   EUCTR2010-023030-23-GB   United Kingdom
   University Hospital, Lille
      2017   Phase 3   NCT03066453   France
Nebcinal
   EREMPHARMA SAS
      -   Phase 1   EUCTR2010-023533-34-FR   France
   Erempharma SAS
      2009   -   EUCTR2009-013660-39-FR   France
Nebcinal tobi
   Erempharma
      2010   -   NCT01288170   France
Nebcine
   CHRU de Lille
      -   Phase 2   EUCTR2014-003882-10-FR   France
Nebulization tobramycin
   University Medical Center Groningen
      -   Phase 2   EUCTR2016-005014-21-NL   Netherlands
Nebulized ensifentrine suspension
   Verona Pharma plc
      2024   Phase 2   NCT06559150   Spain;United Kingdom;United States
Nexium 20
   Biovitrum AB
      2008   -   EUCTR2007-004063-21-NL   Netherlands
Nitrate
   Richard Barry Moss
      2015   -   NCT02310789   United States
Nitric oxide
   Advanced Inhalation Therapies Ltd
      2013   Phase 1/Phase 2   NCT01958944   Israel
   Southampton University Hopsitals NHS Trust
      2011   -   EUCTR2010-023529-39-GB   United Kingdom
   University Hospital Southampton NHS Foundation Trust
      2011   Phase 2   NCT02295566   United Kingdom
Nitric oxide 160 PPM
   Novoteris, LLC
      2017   Phase 2   NCT02498535   Canada;United States
Nitric oxide FOR inhalation
   Mallinckrodt
      2004   Phase 1/Phase 2   NCT00570349   United States
Nitrogen
   Mallinckrodt
      2004   Phase 1/Phase 2   NCT00570349   United States
   Universitair Ziekenhuis Brussel
      2017   -   NCT02950116   Belgium
NO doxycycline
   University of Southern California
      2008   Phase 4   NCT01323101   United States
NO pancreatic enzyme replacement therapy
   AbbVie
      2012   -   NCT01652157   United States
Nocturnal oxygen , nocturnal BI-level positive pressure ventilation
   Bayside Health
      2003   Phase 1/Phase 2   NCT00157183   Australia
NON invasive ventilation
   Karolinska University Hospital
      2016   -   NCT02684552   Sweden
NON-hormonal period
   University of Pennsylvania
      2014   Phase 1   NCT02144246   United States
None assigned
   Aradigm Corporation
      2010   -   EUCTR2009-014412-35-GB   Germany;United Kingdom
      2010   Phase 2   EUCTR2009-014412-35-DE   Germany;United Kingdom
Norethindrone
   University of Texas Southwestern Medical Center
      2014   Early Phase 1   NCT02036879   United States
Normal saline
   Mukoviszidose Institut gGmbH
      2007   Phase 2   NCT00506688   Germany
   Nivalis Therapeutics, Inc.
      2014   Phase 1   NCT01746784   United States
   Qilu Hospital of Shandong University
      2014   Phase 4   NCT02081963   China
   Translate Bio, Inc.
      2018   Phase 1/Phase 2   NCT03375047   United States
   University Hospital, Ghent
      2010   Phase 4   NCT00996424   Belgium
   University of Oklahoma
      2006   -   NCT00671723   United States
   University of Washington
      2016   Phase 2   NCT02354859   United States
Normal saline IV, salt tablets
   Bayside Health
      2004   Phase 2/Phase 3   NCT00163852   Australia
Normal saline solution
   University Hospital Ghent
      2007   -   EUCTR2007-002707-40-BE   Belgium
Norvir 100 MG FILM-coated tablets
   university medical center utrecht
      2018   Phase 4   EUCTR2016-001440-18-NL   Netherlands
Novo rapid
   Hadassah Medical Organization
      2010   -   NCT01149005   Israel
   Papworth Hospital NHS Foundation Trust
      2005   Phase 4   EUCTR2004-005019-28-GB   United Kingdom
Novonorm 0.5 MG
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
Novonorm 1 MG
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
Novonorm 2 MG
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
Novorapid / humalog short acting insulin
   Hadassah Medical Organization
      2010   -   NCT01149005   Israel
Novorapid aspartate
   Papworth Hospital NHS Foundation Trust
      2005   Phase 4   EUCTR2004-005019-28-GB   United Kingdom
Noxafil
   Bambino Gesù Hospital and Research Institute
      2021   Phase 2/Phase 3   NCT04966234   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom
   Karolinska University Hospital, Stockholm CF center
      2018   Phase 2   EUCTR2018-002579-16-SE   Sweden
   MSD
      2012   -   EUCTR2012-003140-68-GB   United Kingdom
Noxafil - 40 MG/ML sospensione orale USO orale flacone (vetro) 105 ML 1 flacone
   IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
      2020   Phase 2;Phase 3   EUCTR2019-004511-31-IT   Czech Republic;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
Noxafil - oral suspension 40 MG/ML
   Bambino Gesù Children's Hospital
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-NL   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-DE   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-PT   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-GR   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-FR   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 2;Phase 3   EUCTR2019-004511-31-GB   Czech Republic;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Bambino Gesù Children´s Hospital
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-ES   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
Noxafil 100 MG
   Bambino Gesù Children's Hospital
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-NL   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-DE   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-PT   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-GR   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      2021   Phase 2;Phase 3   EUCTR2019-004511-31-FR   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 2;Phase 3   EUCTR2019-004511-31-GB   Czech Republic;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Bambino Gesù Children´s Hospital
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-ES   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
Noxafil 100 MG tablets gastro-resistant
   Bambino Gesù Children's Hospital
      -   Phase 2;Phase 3   EUCTR2019-004511-31-IE   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
Nutridrink-impact
   University Hospital, Motol
      2013   Phase 4   NCT02048592   Czech Republic
Nutropin AQ
   Genentech, Inc.
      2003   Phase 2   NCT00079742   United States
   University of Massachusetts, Worcester
      2008   Phase 1   NCT00803179   United States
   University of Texas Southwestern Medical Center
      2000   Phase 2/Phase 3   NCT00256555   -
OGT 918
   Actelion Pharmaceuticals Ltd
      2007   Phase 2   EUCTR2006-002049-35-ES   Spain
Ogtt
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
   Massachusetts General Hospital
      2018   -   NCT02653027   -
Oleic acid supplementation
   Karolinska Institutet
      2021   -   NCT04531410   Italy;Norway;Poland;Sweden
Oligog
   AlgiPharma AS
      2011   -   EUCTR2010-023090-19-IE   Ireland;United Kingdom
Oligog CF-5/20
   AlgiPharma AS
      2019   Phase 2   EUCTR2018-000378-30-AT   Austria;Germany;Ireland;Poland;United Kingdom
      2011   Phase 1/Phase 2   NCT01465529   Ireland;United Kingdom
      2009   Phase 1   NCT00970346   United Kingdom
      -   Phase 2   EUCTR2018-000378-30-PL   Austria;Germany;Ireland;Poland;United Kingdom
   Algipharma AS
      2014   Phase 2   EUCTR2014-002125-35-DE   Germany
      2014   Phase 2   EUCTR2014-000844-13-SE   Denmark;Germany;Sweden
      2014   Phase 2   EUCTR2014-000844-13-DK   Denmark;Germany;Sweden
Oligog CF-5/20 - 17.5 MG
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-GB   Austria;Germany;Ireland;Poland;United Kingdom
      -   Phase 2   EUCTR2018-000378-30-IE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog CF-5/20, 17,5 MG, hartkapsel MIT pulver ZUR inhalation
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-DE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog CF/20 - 27.5 MG
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-GB   Austria;Germany;Ireland;Poland;United Kingdom
      -   Phase 2   EUCTR2018-000378-30-IE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog CF/20 - 37.5 MG
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-GB   Austria;Germany;Ireland;Poland;United Kingdom
      -   Phase 2   EUCTR2018-000378-30-IE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog CF/20, 27,5 MG, hartkapsel MIT pulver ZUR inhalation
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-DE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog CF/20, 37,5 MG, hartkapsel MIT pulver ZUR inhalation
   AlgiPharma AS
      2020   Phase 2   EUCTR2018-000378-30-DE   Austria;Germany;Ireland;Poland;United Kingdom
Oligog DPI
   AlgiPharma AS
      2019   Phase 2   NCT03822455   Australia
Oligog-CF5/20, alginate oligosaccharide (G-block) fragment
   AlgiPharma AS
      2011   Phase 2   EUCTR2010-023090-19-GB   Ireland;United Kingdom
Oligomer OF sodium alginate
   Algipharma AS
      2014   Phase 2   EUCTR2014-002125-35-DE   Germany
      2014   Phase 2   EUCTR2014-000844-13-SE   Denmark;Germany;Sweden
      2014   Phase 2   EUCTR2014-000844-13-DK   Denmark;Germany;Sweden
Omadacycline
   Paul Beringer
      2021   Phase 4   NCT04460586   United States
Omalizumab
   NOVARTIS FARMA
      2009   -   EUCTR2007-006648-23-IT   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
   Novartis Pharma Services AG
      2009   -   EUCTR2007-006648-23-GB   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-006648-23-DE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-006648-23-BE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
   Novartis Pharmaceuticals
      2008   Phase 4   NCT00787917   Belgium;Germany;Italy;Netherlands;United Kingdom
Omega 3 premium
   Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.)
      2008   Phase 3   EUCTR2006-004155-38-BE   Belgium
Omega-3 triglycerides
   Queen Fabiola Children's University Hospital
      2008   Phase 3   NCT00959010   Belgium
Omega-3-acid triglycerides
   Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.)
      2008   Phase 3   EUCTR2006-004155-38-BE   Belgium
Omeprazole 20MG capsule
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03551691   United States
ON-demand treatment
   Qilu Hospital of Shandong University
      2014   -   NCT02088216   China
ONCE-daily insulin detemir
   Sydney Children's Hospitals Network
      2010   Phase 3   NCT01100892   Australia;United States
Ophthalmologic examinations
   Vertex Pharmaceuticals Incorporated
      2013   -   NCT01863238   United States
Oral aztreonam
   Virginia Commonwealth University
      2017   Phase 2   NCT02730793   United States
Oral ciprofloxacin
   Seattle Children's Hospital
      2004   Phase 2   NCT00097773   United States
   Universitaire Ziekenhuizen Leuven
      2001   Phase 4   NCT01400750   Belgium
Oral glucose tolerance test
   Children's Hospital of Philadelphia
      2023   -   NCT05568134   United States
   Emory University
      2014   -   NCT02202876   United States
   Katie Larson Ode
      2019   -   NCT03650712   United States
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2013   -   NCT01975259   United Kingdom
   University of Texas Southwestern Medical Center
      2006   -   NCT00287456   United States
      2006   -   NCT00287443   United States
   Yale University
      2015   Early Phase 1   NCT02398383   United States
Oral glucose tolerance test (ogtt) assessment ARM
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2011   -   NCT03644199   United Kingdom
Oral glutathione
   University of Minnesota
      2017   Phase 2   NCT03020719   United States
Oral reduced L-glutathione
   Clark Bishop
      2011   -   NCT02029521   Italy
Oral roflumilast
   The University of Hong Kong
      2018   Phase 2   NCT03428334   Hong Kong
Orkambi
   ASSISTANC-PUBLIQUE-HOPITAUX DE PARIS (AP-HP)
      -   Phase 4   EUCTR2018-002624-16-FR   France
   Antwerp University Hospital
      2018   Phase 4   EUCTR2018-001573-24-BE   Belgium
   Assistance Publique - Hôpitaux de Paris
      2019   -   NCT03894657   France
   Children's Hospital of Philadelphia
      2019   -   NCT03795363   United States
   Parion Sciences
      2016   Phase 2   NCT02709109   France;Ireland;United Kingdom;United States
   University Hospital, Antwerp
      2018   Phase 4   NCT03956589   Belgium
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
      2016   Phase 4   EUCTR2016-000066-34-GB   Australia;United Kingdom
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
Orkambi 100 MG/125 MG FILM-coated tablets
   Vertex Pharmaceuticals Incorporated
      2018   Phase 2   EUCTR2017-003761-99-DE   Germany
Orkambi 200 MG/125 MG FILM-coated tablets
   Vertex Pharmaceuticals Incorporated
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
Orkambi: contains lumacaftor and ivacaftor
      2019   Phase 4   EUCTR2019-001314-41-NL   Netherlands
Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 MG/0.250 MG
   University of Pennsylvania
      2014   Phase 1   NCT02144246   United States
Oseltamivir
   Inserm
      2009   Phase 4   EUCTR2009-016662-90-FR   France
Other NON-sponsor pancreatic enzyme replacement therapy
   AbbVie
      2012   -   NCT01652157   United States
Other respiratory system products
   DEBIOPHARM S.A.
      2005   -   EUCTR2004-002341-12-IT   Belgium;Germany;Italy;United Kingdom
Oxygen
   Karolinska University Hospital
      2016   -   NCT02684552   Sweden
Oxygen - AIR
   Assistance Publique - Hôpitaux de Paris
      2012   -   NCT01586728   France
P-1037
   Parion Sciences
      2015   Phase 2   NCT02343445   United States
PAAG15
   Synspira Therapeutics, Inc.
      2019   Phase 2   EUCTR2019-003178-25-HU   Hungary
Pancreas powder
   Abbott Laboratories GmbH
      2015   -   EUCTR2014-004519-35-HU   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-GB   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-CZ   Czech Republic;Hungary;Spain;United Kingdom
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-DE   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
   Axcan Pharma Inc.
      -   -   EUCTR2010-019267-11-DE   Germany
Pancrease MT
   Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
      -   -   EUCTR2015-001219-11-Outside-EU/EEA   Canada;United States
Pancrease MT 10.5, or MT 21
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2008   Phase 3   NCT00662675   Canada;United States
Pancreaslipase
   Aptalis Pharma US Inc.
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
Pancreatin
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
   Abbott Laboratories GmbH
      2015   -   EUCTR2014-004519-35-HU   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-GB   Czech Republic;Hungary;Spain;United Kingdom
      2015   -   EUCTR2014-004519-35-CZ   Czech Republic;Hungary;Spain;United Kingdom
      2013   -   EUCTR2013-002819-10-HU   Hungary;Russian Federation;Spain
      2013   -   EUCTR2013-002819-10-ES   Hungary;Russian Federation;Spain
   Abbott Products
      2012   Phase 3   NCT01747330   Russian Federation
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-DE   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
   Axcan Pharma Inc.
      -   -   EUCTR2010-019267-11-DE   Germany
   McNeil Consumer and Specialty Pharmaceuticals
      2005   Phase 2   EUCTR2005-001438-34-BE   Belgium
   Terese Katzenstein
      2020   Phase 4   EUCTR2019-004940-31-DK   Denmark
Pancreatina
   Abbott Laboratories GmbH
      2013   -   EUCTR2013-002819-10-ES   Hungary;Russian Federation;Spain
Pancreatina (Páncreas polvo
   Abbott Laboratories GmbH
      2015   Phase 2   EUCTR2014-004519-35-ES   Czech Republic;Hungary;Spain;United Kingdom
Pancreaze
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
   AbbVie
      2012   -   NCT01652157   United States
Pancrelipase
   AbbVie
      2019   Phase 4   NCT03924947   Spain;United States
   Digestive Care, Inc.
      2008   Phase 4   NCT00744250   United States
      2007   Phase 3   NCT00432861   United States
   University of Colorado, Denver
      2014   -   NCT02372383   United States
Pancrelipase amylase
   Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
      -   -   EUCTR2015-001219-11-Outside-EU/EEA   Canada;United States
Pancrelipase delayed release
   Solvay Pharmaceuticals
      2009   Phase 3   NCT00775528   United States
      2008   Phase 3   NCT00690820   United States
      2007   Phase 3   NCT00510484   Hungary;Israel;South Africa;Spain;United States
Pancrelipase delayed release capsule
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Pancrelipase microtablets
   McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
      2005   Phase 2   NCT00217204   Belgium;Netherlands
   McNeil Consumer and Specialty Pharmaceuticals
      2005   Phase 2   EUCTR2005-001438-34-BE   Belgium
Pancrelipase with bicarbonate
   National Center for Research Resources (NCRR)
      1999   -   NCT00006063   -
Pancrelipase/pancreas powder
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Pankreatin
   Terese Katzenstein
      2020   Phase 4   EUCTR2019-004940-31-DK   Denmark
Panzytrat 25000
   Axcan Pharma Inc.
      -   -   EUCTR2010-019267-11-DE   Germany
Panzytrat® 25,000
   Forest Laboratories
      2011   Phase 4   NCT01327703   Germany;Poland
Panzytrat® OK
   McNeil Consumer and Specialty Pharmaceuticals
      2005   Phase 2   EUCTR2005-001438-34-BE   Belgium
Pari eflow nebulizer system
   Savara Inc.
      2019   Phase 2   NCT03597347   United States
PBI4050
   Liminal BioSciences Ltd.
      2017   Phase 2   NCT02955888   Canada
PC945
   Pulmocide Ltd
      2019   Phase 2   NCT03870841   United Kingdom
      2018   Phase 2   EUCTR2018-000243-87-GB   United Kingdom
Perfluorinated GAS/oxygen mixture
   Hal C Charles
      2009   Phase 1   NCT01710449   United States
Perfluoropropane
   The Hospital for Sick Children
      2015   Phase 2   NCT02740868   Canada
Pertzye
   AbbVie
      2012   -   NCT01652157   United States
PFP
   University of North Carolina, Chapel Hill
      2018   Early Phase 1   NCT03482960   United States
      2015   Early Phase 1   NCT03489590   United States
PFP and SF6 human lung coil
   Thunder Bay Regional Health Research Institute
      2020   Early Phase 1   NCT02748798   Canada
PGM169/GL67A
   Imperial College
      2012   Phase 2   EUCTR2011-004761-33-GB   United Kingdom
      2008   -   EUCTR2007-004050-85-GB   United Kingdom
   Imperial College London
      2012   Phase 2   NCT01621867   United Kingdom
      2008   Phase 1/Phase 2   NCT00789867   United Kingdom
PGT-1 gene lipid complex
   University of Alabama at Birmingham
      1995   Phase 1   NCT00004471   -
PHQ-8
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Physiologic serum nebulized nasally
   Virginie ESCABASSE
      2017   Phase 3   NCT02888730   France
Physiological solution
   Serafino A. Marsico
      2010   Phase 3   NCT01450267   Italy
Physiotherapy, exercise, percutaneous gastrostomy feeds
   Bayside Health
      2001   -   NCT00164021   Australia
Pilocarpine
   Richard Barry Moss
      2015   -   NCT02310789   United States
Pilocarpine iontophoresis
   Emory University
      2022   -   NCT04732195   United States
Pilocarpine microneedle patch
   Emory University
      2022   -   NCT04732195   United States
Pioglitazone
   Paul Beringer
      2008   Phase 1   NCT00719381   United States
   University Hospitals Cleveland Medical Center
      2007   -   NCT00531882   United States
      2006   -   NCT00322868   United States
Piperacillin
   Aarhus University Hospital, Department of Respiratory Medicine
      2015   Phase 2   EUCTR2015-003662-87-DK   Denmark
Piperacillin sodium
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Piperacillin sodium , tazobactam sodium
   COP:TRIN Region Hovedstaden (Gentofte hospital)
      2017   Phase 4   EUCTR2015-003399-58-DK   Denmark
Piperacillin-tazobactam combination product
   University Ghent
      2016   -   NCT02840136   Belgium
   West Virginia University
      2012   Phase 4   NCT01694069   United States
Piperacillin/tazobactam
   COP:TRIN Region Hovedstaden (Gentofte hospital)
      2017   Phase 4   EUCTR2015-003399-58-DK   Denmark
   Chronic Obstructive Pulmonary Disease Trial Network, Denmark
      2018   Phase 4   NCT03262142   Denmark
Piperacillin/tazobactam kabi - fresenius kabi austria
   Medical University of Vienna
      2020   Phase 4   EUCTR2019-000955-16-AT   Austria
Piperacilline/tazobactam fresenius kabi 2 G/0,25 G poeder voor oplossing voor infusie
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
Piperacilline/tazobactam fresenius kabi 4 G/0,5 G poeder voor oplossing voor infusie
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
PL 0010/0211
   Southampton University Hospital Trust
      2008   -   EUCTR2008-001769-27-GB   United Kingdom
Plerixafor mobilization OF autologous CD117 stem cells
   University of Colorado, Denver
      2013   Phase 1   NCT01916577   United States
PO azithromycin
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
PO ciprofloxacin
   Seattle Children's Hospital
      2004   -   NCT00153634   United States
POL6014
   Santhera Pharmaceuticals
      2018   Phase 1/Phase 2   NCT03748199   Germany
   Santhera Pharmaceuticals (Switzerland) Ltd
      2018   Phase 1;Phase 2   EUCTR2018-002550-71-DE   Germany
      2017   Phase 1;Phase 2   EUCTR2016-005110-22-DE   Germany
POL7080
   Polyphor Ltd.
      2014   Phase 2   EUCTR2013-002202-31-DE   Germany;Spain;United Kingdom
      2013   Phase 2   NCT02096315   Spain;United Kingdom
      2013   Phase 2   EUCTR2013-002202-31-GB   Germany;Spain;United Kingdom
      2013   -   EUCTR2013-002202-31-ES   Germany;Spain;United Kingdom
Polyethylene glycol
   University Hospital, Bordeaux
      2020   Phase 2   NCT04458129   -
Polyethylene glycol 3350
   St. Louis University
      2019   Phase 4   NCT04210427   United States
Porcine (PIG) pert
   Anthera Pharmaceuticals
      2015   Phase 3   NCT02279498   Canada;Czech Republic;Czechia;Hungary;Israel;Poland;Spain;United States
Porcine pert
   Anthera Pharmaceuticals
      2017   Phase 3   NCT03051490   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
   AzurRx BioPharma, Inc.
      2020   Phase 2   NCT04375878   Poland;United States
      2019   Phase 2   NCT03746483   Poland;United States
Portable cardiac monitor cardioqvark
   I.M. Sechenov First Moscow State Medical University
      2023   -   NCT05727852   Russian Federation
Posaconazole
   Bambino Gesù Children's Hospital
      2022   Phase 2;Phase 3   EUCTR2019-004511-31-DE   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 2;Phase 3   EUCTR2019-004511-31-IE   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
   Bayside Health
      2018   -   NCT03421366   Australia
   MSD
      2012   -   EUCTR2012-003140-68-GB   United Kingdom
Posaconazole 40 MG/ML
   Bambino Gesù Hospital and Research Institute
      2021   Phase 2/Phase 3   NCT04966234   Czechia;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom
Posaconazolo
   IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
      2020   Phase 2;Phase 3   EUCTR2019-004511-31-IT   Czech Republic;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;Switzerland;United Kingdom
Positive expiratory pressure
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2015   -   NCT02535130   Belgium
PPI treatment
   University of Colorado, Denver
      2017   -   NCT02769637   United States
Prednisolone
   Birmingham Children's Hospital NHS Foundation Trust
      2012   -   EUCTR2011-005790-23-GB   United Kingdom
Prednisone
   The Hospital for Sick Children
      2017   Phase 3   NCT03070522   Canada
Prefolic*30CPR gastror 15MG
   AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
      2010   -   EUCTR2010-020516-11-IT   Italy
Probiotic
   ResBiotic Nutrition, Inc.
      2022   -   NCT05523180   United States
Probiotic throat spray
   University Hospital, Antwerp
      2022   -   NCT06057558   Belgium
Procalcitonin
   Assiut University
      2024   -   NCT06352944   -
Progesterone
   Johns Hopkins University
      2023   Phase 4   NCT05704036   United States
Prograft capsules
   Hopital Erasme - Chest service
      2009   Phase 4   EUCTR2009-014050-15-BE   Belgium
Promixin
   Aarhus University Hospital, Department of Respiratory Medicine
      2015   Phase 2   EUCTR2015-003662-87-DK   Denmark
   ZAMBON SPA
      2020   Phase 3   EUCTR2016-004558-13-IT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
Promixin 1 million international units (IU) powder FOR nebuliser solution
   Profile Pharma Ltd
      2010   -   EUCTR2008-005045-34-IE   Ireland;United Kingdom
      2008   Phase 3   EUCTR2008-005045-34-GB   Ireland;Russian Federation;Ukraine;United Kingdom
Promixin*nebul 30monod 1MUI
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
Promixin, 1 million international units (IU) powder FOR nebuliser solution
   Zambon S.p.A.
      2020   Phase 3   EUCTR2016-004558-13-PT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2020   Phase 3   EUCTR2016-004558-13-GR   Argentina;Australia;Canada;France;Germany;Greece;Israel;Italy;New Zealand;Poland;Portugal;United States
      2020   Phase 3   EUCTR2016-004558-13-DE   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
      2017   Phase 3   EUCTR2016-004558-13-PL   Argentina;Australia;Canada;France;Germany;Greece;Israel;Italy;New Zealand;Poland;Portugal;United States
      2017   Phase 3   EUCTR2016-004558-13-FR   Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
Promixin,1 millóN DE unidades internacionales,polvo para solucióN para inhalacióN POR nebulizador
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
Promixin/tadim
   ZAMBON SPA
      2017   Phase 3   EUCTR2015-002743-33-IT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
   Zambon S.p.A.
      2018   Phase 3   EUCTR2015-002743-33-NL   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2015-002743-33-GR   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-PT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-GB   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-ES   Belgium;Germany;Italy;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2015-002743-33-DE   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
Proteasa
   ANTHERA Pharmaceuticals, Inc.
      2016   Phase 3   EUCTR2016-002851-92-ES   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
Protease
   ALTUS PHARMACEUTICALS INC
      2007   -   EUCTR2007-000178-21-IT   Italy
      2007   -   EUCTR2007-000171-41-IT   Italy
   ANTHERA Pharmaceuticals, Inc.
      2017   Phase 3   EUCTR2017-000571-85-LT   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-HU   Hungary;Israel;Lithuania;Poland;Spain;United States
      2017   Phase 3   EUCTR2017-000571-85-GB   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000571-85-ES   Hungary;Israel;Lithuania;Poland;Spain;United States
      2016   Phase 3   EUCTR2016-002851-92-HU   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 4   EUCTR2016-002851-92-CZ   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
      2016   Phase 3   EUCTR2015-002739-17-CZ   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-HU   Canada;Czech Republic;Hungary;Israel;Spain;United States
      2015   Phase 3   EUCTR2015-002739-17-ES   Canada;Czech Republic;Hungary;Israel;Spain;United States
      -   Phase 3   EUCTR2017-000571-85-PL   Hungary;Israel;Lithuania;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-002851-92-PL   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
   Altus Pharmaceuticals Inc
      2007   Phase 3   EUCTR2007-000171-41-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000171-41-PL   Italy;Poland;Slovakia
   Altus Pharmaceuticals Inc.
      2007   Phase 3   EUCTR2007-000178-21-SK   Italy;Slovakia
      -   Phase 3   EUCTR2007-000178-21-PL   Italy;Poland;Slovakia
   EURAND SPA
      2010   -   EUCTR2009-012842-21-IT   Bulgaria;Germany;Hungary;Italy;United Kingdom
Psaer IGY
   MUKOVISZIDOSE E.V.
      2012   Phase 3   EUCTR2011-000801-39-IT   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
   Mukoviszidose Institute gGmbH
      2014   Phase 3   EUCTR2011-000801-39-HU   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2014   Phase 3   EUCTR2011-000801-39-ES   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2014   Phase 3   EUCTR2011-000801-39-AT   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2013   Phase 3   EUCTR2011-000801-39-IE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2012   Phase 3   EUCTR2011-000801-39-SE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2012   Phase 3   EUCTR2011-000801-39-BE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
      2011   Phase 3   EUCTR2011-000801-39-DE   Austria;Belgium;Germany;Hungary;Ireland;Italy;Spain;Sweden
PTC-0161480
   PTC Therapeutics, Inc
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
PTC-124
   PTC Therapeutics, Inc
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
PTC-C124
   PTC Therapeutics, Inc
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
PTC124
   PTC THERAPEUTICS, INC.
      2010   -   EUCTR2010-019692-30-IT   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-IT   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
   PTC Therapeutics
      2014   Phase 3   NCT02139306   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2006   Phase 2   NCT00351078   Israel
      2005   Phase 2   NCT00234663   United States
   PTC Therapeutics, Inc
      2011   Phase 3   EUCTR2010-019692-30-GB   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019692-30-ES   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-019692-30-DE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   -   EUCTR2010-019692-30-SE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   -   EUCTR2010-019692-30-NL   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2010   -   EUCTR2010-019692-30-BE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-BE   Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   PTC Therapeutics, Inc.
      2016   Phase 3   EUCTR2014-005355-83-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-GR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2014-005355-83-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2014-005355-83-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-005449-35-FR   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2015   Phase 3   EUCTR2013-004581-34-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-GR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004581-34-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-005449-35-SE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-IT   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-ES   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-DE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-005449-35-BE   Belgium;France;Germany;Israel;Italy;Spain;Sweden;United States
      2014   Phase 3   EUCTR2013-004581-34-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Germany;Greece;Israel;Italy;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Germany;Greece;Israel;Italy;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004581-34-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2007   -   EUCTR2007-000724-40-BE   Belgium
PTI-428
   Proteostasis Therapeutics
      2017   Phase 1;Phase 2   EUCTR2016-001214-24-DK   Canada;Czech Republic;Denmark;France;Germany;Italy;United Kingdom;United States
      2017   Phase 1;Phase 2   EUCTR2016-001214-24-DE   Canada;Czech Republic;Denmark;France;Germany;Italy;United Kingdom;United States
   Proteostasis Therapeutics, Inc.
      2018   Phase 2   NCT03591094   United States
      2018   Phase 1/Phase 2   NCT03500263   United Kingdom
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2017   Phase 1   NCT03258424   United Kingdom
      2017   Phase 1/Phase 2   NCT03251092   Australia;Belgium;Canada;Denmark;France;Germany;New Zealand;United Kingdom;United States
      2016   Phase 1/Phase 2   NCT02718495   Canada;Czechia;Denmark;France;Germany;United Kingdom;United States
PTI-801
   Proteostasis Therapeutics, Inc.
      2018   Phase 1/Phase 2   NCT03500263   United Kingdom
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2017   Phase 1/Phase 2   NCT03251092   Australia;Belgium;Canada;Denmark;France;Germany;New Zealand;United Kingdom;United States
      2017   Phase 1   NCT03140527   Canada;Denmark;Germany;Portugal;Sweden;United States
PTI-808
   Proteostasis Therapeutics, Inc.
      2018   Phase 1/Phase 2   NCT03500263   United Kingdom
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2017   Phase 1/Phase 2   NCT03251092   Australia;Belgium;Canada;Denmark;France;Germany;New Zealand;United Kingdom;United States
      2017   Phase 1   NCT03140527   Canada;Denmark;Germany;Portugal;Sweden;United States
Pulmonary function testing
   The Hospital for Sick Children
      2010   -   NCT01155115   Canada
   University of Florida
      2007   -   NCT01851642   United States
Pulmozyme
   AO GENERIUM
      2017   Phase 3   NCT04468100   Russian Federation
   ErasmusMC - Sophia Children's Hospital
      -   -   EUCTR2007-000935-25-NL   Netherlands
   F. Hoffmann-La Roche AG
      -   Phase 4   EUCTR2015-003537-99-Outside-EU/EEA   United States
   Genentech, Inc.
      2012   Phase 4   NCT01712334   United States
   Nationwide Children's Hospital
      2005   Phase 2   NCT00179998   United States
   Pharmaxis Ltd
      2004   Phase 2   EUCTR2004-001888-21-GB   United Kingdom
   University Hospital, Tours
      2009   Phase 4   NCT00843817   France
   University of Jena
      2007   Phase 3   NCT00534079   Germany
      2005   Phase 3   NCT00265434   Germany
      -   Phase 3   EUCTR2007-001548-36-DE   Germany
   University of Vermont
      2006   Phase 2   NCT00416182   United States
Pulmozyme single USE ampule
   Milton S. Hershey Medical Center
      2013   Phase 3   NCT01155752   United States
PUR118
   Pulmatrix Inc.
      2012   Phase 1   NCT01543191   United Kingdom
QAU145
   Novartis Pharmaceuticals
      2007   Phase 2   NCT00506792   United States
QBW251
   Novartis Pharma AG
      2021   Phase 2   EUCTR2019-002840-26-DE   China;Germany;Spain;United Kingdom
      2020   Phase 2   EUCTR2019-002840-26-GB   China;Germany;Spain;United Kingdom
   Novartis Pharma Services AG
      2015   -   EUCTR2011-005085-37-FR   Belgium;France;Germany;Ireland;United Kingdom;United States
      2015   -   EUCTR2011-005085-37-BE   Belgium;France;Ireland;United Kingdom;United States
      2014   -   EUCTR2011-005085-37-IE   Belgium;France;Ireland;United Kingdom;United States
      2014   Phase 1;Phase 2   EUCTR2011-005085-37-DE   Belgium;France;Germany;Ireland;United Kingdom;United States
      2012   Phase 1;Phase 2   EUCTR2011-005085-37-GB   Belgium;France;Germany;Ireland;Netherlands;Romania;United Kingdom;United States
   Novartis Pharmaceuticals
      2012   Phase 1/Phase 2   NCT02190604   Belgium;France;Germany;Ireland;Netherlands;Romania;United Kingdom;United States
QBW276
   Novartis Pharmaceuticals
      2017   Phase 1/Phase 2   NCT02566044   Germany;United Kingdom;United States
QBW276 1500MCG
   Novartis Pharma AG
      2017   Phase 1;Phase 2   EUCTR2014-004915-35-DE   Germany;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2014-004915-35-GB   Germany;United Kingdom;United States
QBW276 300MCG
   Novartis Pharma AG
      2017   Phase 1;Phase 2   EUCTR2014-004915-35-DE   Germany;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2014-004915-35-GB   Germany;United Kingdom;United States
QBW276 succinate
   Novartis Pharma AG
      2017   Phase 1;Phase 2   EUCTR2014-004915-35-DE   Germany;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2014-004915-35-GB   Germany;United Kingdom;United States
QR-010
   ProQR Therapeutics
      2015   Phase 1   NCT02564354   Belgium;France;United States
      2015   Phase 1/Phase 2   NCT02532764   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
Quercetin
   University of Alabama at Birmingham
      2010   Phase 2   NCT01348204   United States
R03ac02
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000057-37-NL   Netherlands
R03cc02
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000057-37-NL   Netherlands
R05C B01
   Rigshospitalet
      2010   Phase 4   EUCTR2007-001401-15-DK   Denmark
Radiolabelled oligog CF-5/20 6% solution
   Bio-Images Research Ltd
      2014   Phase 2   NCT01991028   United Kingdom
Radiolabelled oligog CF-5/20 6% solution FOR nebulisation
   AlgiPharma AS
      2014   Phase 2   EUCTR2013-003774-27-GB   United Kingdom
Radiolabelled oligog CF-5/20 DPI
   Bio-Images Research Ltd
      2014   Phase 2   NCT01991028   United Kingdom
Rapeglinide
   Papworth Hospital NHS Foundation Trust
      2005   Phase 4   EUCTR2004-005019-28-GB   United Kingdom
Ravicti high dose
   National Jewish Health
      2018   Phase 1/Phase 2   NCT02323100   United States
Ravicti LOW dose
   National Jewish Health
      2018   Phase 1/Phase 2   NCT02323100   United States
RCT2100
   ReCode Therapeutics
      2024   Phase 1   NCT06237335   France;Netherlands;New Zealand;United Kingdom;United States
Reaction time and postural control
   Hacettepe University
      2019   -   NCT03902236   Turkey
Recombinant human IGF-1
   Stony Brook University
      2008   Phase 1   NCT00566241   United States
Recombinant humanized monoclonal antibody omalizumab TO IGE
   Novartis Pharma Services AG
      2009   -   EUCTR2007-006648-23-NL   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
Recombinant truncated spint2 protease inhibitor
   Aerovance Inc
      2005   Phase 1;Phase 2   EUCTR2005-000313-35-GB   United Kingdom
RED blood cell ZN
   Indiana University
      2019   -   NCT04302428   United States
Reduced glutathione
   Mukoviszidose Institut gGmbH i. G.
      2006   -   EUCTR2005-003870-88-DE   Germany
Reduced glutathione sodium salt
   Mukoviszidose Institut gGmbH
      2007   Phase 2   NCT00506688   Germany
Repaglinide
   Arbelaez, Ana Maria
      2006   -   NCT00763412   United States
   Mukoviszidose Institut gGmbH
      2001   Phase 3   NCT00662714   Austria;France;Germany;Italy
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2001   Phase 3   NCT00072904   Canada;United States
Repaglinide and insulin
   Children's Hospital of Philadelphia
      2005   -   NCT00231192   United States
Reparixin
   IST. DI RICERCHE FARMACOLOG. M. NEGRI
      2010   -   EUCTR2009-013340-36-IT   Italy
Resistance exercise
   University of Alabama at Birmingham
      2008   -   NCT01759342   United States
RESP301
   Papworth Hospital NHS Foundation Trust
      2021   Phase 2   NCT05101915   United Kingdom
RESP302
   Thirty Respiratory Limited
      2024   Phase 1/Phase 2   NCT06663176   Ukraine
RESP303
   Thirty Respiratory Limited
      2024   Phase 1/Phase 2   NCT06663176   Ukraine
Respiratory symptom questionnaire: criss
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Resunab, ajulemic acid, anabasum
   Corbus Pharmaceuticals, Inc.
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2020-001762-11-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-RO   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2019   Phase 2   EUCTR2017-003723-29-NL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SK   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-PT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      2018   Phase 2   EUCTR2017-003723-29-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-SE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2020-001762-11-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
      -   Phase 2   EUCTR2017-003723-29-FR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Russian Federation;Réunion;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
Resveratrol
   Virginia Commonwealth University
      2020   Early Phase 1   NCT04166396   United States
Rhbssl
   Biovitrum AB
      2008   -   EUCTR2007-004063-21-NL   Netherlands
   Swedish Orphan Biovitrum
      2008   Phase 2   NCT00743483   Netherlands;Poland
Rhdnase
   Hospices Civils de Lyon
      2023   -   NCT05663255   -
   Pharmaxis Ltd
      2004   Phase 2   EUCTR2004-001888-21-GB   United Kingdom
   The Hospital for Sick Children
      2008   Phase 4   NCT00557089   Canada
   University of Jena
      -   Phase 3   EUCTR2007-001548-36-DE   Germany
Rifampicin
   AOU Meyer
      2013   Phase 3   EUCTR2013-000219-25-IT   Italy
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Rifampin
   AOU Meyer
      2013   Phase 3   EUCTR2013-000219-25-IT   Italy
   Johns Hopkins University
      2020   Phase 4   NCT02547116   United States
      2012   Phase 2   NCT01594827   United States
   University of Colorado, Denver
      2014   -   NCT02372383   United States
   University of North Carolina, Chapel Hill
      2011   Phase 2   NCT01349192   United States
   Vertex Pharmaceuticals Incorporated
      2013   Phase 1   NCT01768663   United States
      2009   Phase 1   NCT01018368   United States
Rifaximin
   Wake Forest University Health Sciences
      2025   Phase 2/Phase 3   NCT05408910   United States
Rimactan
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Riociguat
   Bayer
      2014   Phase 2   NCT02170025   Belgium;Canada;France;Germany;Greece;Italy;Netherlands;United Kingdom;United States
   Bayer AG
      2015   Phase 2   EUCTR2013-004595-35-BE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-GB   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004595-35-DE   Belgium;Canada;France;Germany;Italy;Netherlands;United Kingdom;United States
   Bayer HealthCare AG
      2015   Phase 2   EUCTR2013-004595-35-NL   Belgium;Canada;France;Germany;Netherlands;United Kingdom;United States
Roflumilast
   Assiut University
      2019   Early Phase 1   NCT04090294   -
   Prince of Songkla University
      2015   Phase 3   NCT04122547   Thailand
   University of Sao Paulo General Hospital
      2019   Phase 2   NCT03988816   Brazil
Roflumilast oral tablet
   The University of Hong Kong
      2020   Phase 2   NCT04322929   Hong Kong
Roscovitine
   University Hospital, Brest
      2016   Phase 2   NCT02649751   France
Rosuvastatin calcium
   University of Liverpool
      2014   Phase 2   EUCTR2014-002387-32-GB   United Kingdom
Routine therapy
   Shanghai Pulmonary Hospital, Shanghai, China
      2011   Phase 4   NCT02782312   China
Roxithromycin
   First Affiliated Hospital of Guangxi Medical University
      2009   -   ChiCTR-TRC-13003979   China
RPL554
   Verona Pharma plc
      2017   Phase 2   NCT02919995   United Kingdom
      2017   Phase 2   EUCTR2015-004263-36-DE   Germany;United Kingdom
      2016   Phase 2   EUCTR2015-004263-36-GB   Germany;United Kingdom
RPS 2505
   PTC Therapeutics, Inc
      2010   Phase 3   EUCTR2010-019692-30-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-SE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-NL   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-GB   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-FR   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-003924-52-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-003924-52-DE   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
RSP-1502
   Respirion Pharmaceuticals Pty Ltd
      2024   Phase 1/Phase 2   NCT06016088   Australia;United States
RSS0343 tabella
   Jiangsu HengRui Medicine Co., Ltd.
      2025   Phase 2   NCT06775340   China
Répaglinide
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2006   -   EUCTR2006-001254-27-FR   France
S-1226
   SolAeroMed Inc.
      2019   Phase 2   NCT03903913   Canada
Salbutamol
   China-Japan Friendship Hospital
      2024   Phase 0   ChiCTR2400093811   China
   Rambam Health Care Campus
      2023   -   NCT05932316   Israel
   UMC Utrecht
      2015   Phase 2   EUCTR2015-001317-28-NL   Netherlands
   University Medical Centre Utrecht
      2014   Phase 2   EUCTR2014-000057-37-NL   Netherlands
   University of British Columbia
      2018   -   NCT03522831   Canada
   ZAMBON SPA
      2017   Phase 3   EUCTR2015-002743-33-IT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
Salbutamol-ratiopharm® N metered-dose aerosol inhaler
   ZAMBON SPA
      2020   Phase 3   EUCTR2016-004558-13-IT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
Salbutamol-ratiopharm® N metereddose aerosol inhaler
   ZAMBON SPA
      2020   Phase 3   EUCTR2016-004558-13-IT   Argentina;Canada;France;Germany;Greece;Italy;Poland;Portugal;United States
Salbutamolo
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2020-004068-24-IT   Argentina;Australia;Canada;China;Denmark;Germany;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation;Spain;United Kingdom;United States;Vietnam
Saline
   AlgiPharma AS
      2011   Phase 1/Phase 2   NCT01465529   Ireland;United Kingdom
   Joseph Zabner
      2013   Phase 1/Phase 2   NCT00928135   United States
   Lakshmi Durairaj
      2017   Phase 1   NCT03078088   United States
   Parion Sciences
      2016   Phase 2   NCT02709109   France;Ireland;United Kingdom;United States
   Universitaire Ziekenhuizen KU Leuven
      2022   -   NCT05531630   Belgium
   University of Arizona
      2009   -   NCT01880723   United States
Saline 0.9% inhalation solution
   Medical Center Alkmaar
      2016   Phase 2/Phase 3   NCT02657473   Netherlands
Salmeterol
   National Center for Research Resources (NCRR)
      2000   -   NCT00005110   United States
Saxagliptin
   Ram Weiss
      2015   -   NCT02239458   Israel
      2014   -   NCT02148978   Israel
SB-656933 tablets
   GlaxoSmithKline Research & Development Limited
      2010   -   EUCTR2010-018738-27-DE   Germany
SB-656933-AAA
   GlaxoSmithKline Research & Development Limited
      2010   -   EUCTR2010-018738-27-DE   Germany
SB656933
   GlaxoSmithKline
      2009   Phase 2   NCT00903201   Canada;France;Germany;Israel;United States
      2008   Phase 1   NCT00605761   United States
SE10599
   University of Nottingham
      2005   Phase 2   EUCTR2005-000311-98-GB   United Kingdom
Seliciclib
   CHRU de Brest
      2015   Phase 2   EUCTR2015-002911-13-FR   France
Semaglutide
   University of Minnesota
      2023   Phase 2/Phase 3   NCT05788965   United States
Serum ZN
   Indiana University
      2019   -   NCT04302428   United States
Sildenafil
   Augusta University
      2014   Phase 2   NCT02057458   United States
   Children's Hospital Medical Center, Cincinnati
      2012   Phase 1/Phase 2   NCT01194232   United States
   National Jewish Health
      2015   Phase 1/Phase 2   NCT02626182   United States
      2015   Phase 2   NCT01132482   United States
      2008   Phase 1/Phase 2   NCT00659529   United States
Sildenafil 40MG oral capsule
   National Jewish Health
      2019   Phase 2/Phase 3   NCT04039087   United States
Simvastatin
   University Hospitals Cleveland Medical Center
      2007   -   NCT00531882   United States
   University of British Columbia
      2010   Phase 1/Phase 2   NCT01092572   Canada
Simvastatin treatment FOR 28 days
   Akron Children's Hospital
      2004   Phase 1   NCT00255242   United States
SIN asignar
   ANTHERA Pharmaceuticals, Inc.
      2016   Phase 3   EUCTR2016-002851-92-ES   Canada;Czech Republic;Hungary;Israel;Poland;Spain;United States
SIT-TO-stand test
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Sitagliptin
   Emory University
      2010   Phase 3   NCT00967798   Canada;United States
   Nemours Children's Clinic
      2012   Phase 1   NCT01721382   United States
   University of British Columbia
      2010   Phase 2   NCT01257464   Canada
   University of Pennsylvania
      2013   -   NCT01879228   United States
SIX-minute walk test
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Slit amikacin
   Transave, Inc
      2005   Phase 2   EUCTR2005-004389-17-HU   Hungary
Slit(TM) amikacin
   Transave, Inc.
      2005   -   EUCTR2005-004899-21-BE   Belgium
Slit™ amikacin
   Insmed Incorporated
      2004   Phase 1   NCT06238856   -
Smartpill motility system & pillcam patency capsule
   St. Louis University
      2019   Phase 4   NCT04210427   United States
SMX
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
Snack beverage
   Institut de Recherches Cliniques de Montreal
      2019   -   NCT03710538   Canada
SNSP113
   Synspira Therapeutics, Inc.
      2019   Phase 2   EUCTR2019-003178-25-HU   Hungary
Sodio bicarbonato S.A.L.F. - 10 MEQ/10 ML concentrato PER soluzione PER infusione 5 fiale 10 ML
   IRCCS ISTITUTO GIANNINA GASLINI
      -   Phase 2   EUCTR2015-000513-48-IT   Italy
Sodio cloruro
   IRCCS ISTITUTO GIANNINA GASLINI
      -   Phase 2   EUCTR2015-000513-48-IT   Italy
Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-YL)-5-(1-(tetrahydro-2H-pyran-4-YL)ethoxy)quinoline-4-CA
   Proteostasis Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-GB   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-DE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-003319-21-BE   Belgium;Canada;Denmark;France;Germany;United Kingdom;United States
Sodium 4-phenylbutyrate
   Children's Hospital of Philadelphia
      2003   Phase 1/Phase 2   NCT00590538   United States
      2001   Phase 1/Phase 2   NCT00016744   United States
Sodium alginate
   AlgiPharma AS
      2011   -   EUCTR2010-023090-19-IE   Ireland;United Kingdom
Sodium bicarbonate
   University of Pittsburgh
      2002   Phase 1   NCT00177645   United States
Sodium bicarbonate BP
   Fundació Parc Taulí
      2017   Phase 2   EUCTR2016-004033-25-ES   Spain
   IRCCS ISTITUTO GIANNINA GASLINI
      -   Phase 2   EUCTR2015-000513-48-IT   Italy
Sodium chloride
   Erasmus MC
      2018   Phase 3   EUCTR2015-004143-39-IT   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2017   Phase 3   EUCTR2015-004143-39-DK   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-NL   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      2016   Phase 3   EUCTR2015-004143-39-BE   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
      -   Phase 3   EUCTR2015-004143-39-FR   Australia;Belgium;Denmark;France;Italy;Netherlands;Spain;United States
   Fundació Parc Taulí
      2017   Phase 2   EUCTR2016-004033-25-ES   Spain
   IRCCS ISTITUTO GIANNINA GASLINI
      -   Phase 2   EUCTR2015-000513-48-IT   Italy
   Joseph Pilewski
      2014   Phase 1   NCT03391414   United States
   University Hospital Ghent
      2007   -   EUCTR2007-002707-40-BE   Belgium
   University of Jena
      2010   -   NCT01086839   Germany
   University of North Carolina, Chapel Hill
      2009   Phase 1   NCT01094704   United States
Sodium fusidate
   Aceragen
      2023   Phase 2   NCT05641298   United States
Sodium nitrite
   Schmidhofer, Mark, MD
      2016   Phase 1/Phase 2   NCT02694393   United States
Sodium pyruvate IN 0.9% sodium chloride solution
   Emphycorp
      2006   Phase 1   NCT00308243   United States
Soluble fiber supplementation
   Institut de Recherches Cliniques de Montreal
      2016   -   NCT02810691   Canada
Somalgen
   Genaera Corporation
      2005   Phase 2   EUCTR2004-004334-13-IE   Ireland
Somatropin
   Genentech, Inc.
      2003   Phase 2   NCT00079742   United States
SP-101 and doxorubicin cohort 1
   Spirovant Sciences, Inc.
      2024   Phase 1/Phase 2   NCT06526923   United States
SP-101 and doxorubicin cohort 2
   Spirovant Sciences, Inc.
      2024   Phase 1/Phase 2   NCT06526923   United States
Sperti DEL SOL lamp
   Atlanta VA Medical Center
      2006   -   NCT00450073   United States
SPI-1005 ebselen 200MG capsule X1
   Sound Pharmaceuticals, Incorporated
      2017   Phase 2   NCT02819856   United States
SPI-1005 ebselen 200MG capsule X2
   Sound Pharmaceuticals, Incorporated
      2017   Phase 2   NCT02819856   United States
SPI-1005 ebselen 200MG capsule X3
   Sound Pharmaceuticals, Incorporated
      2017   Phase 2   NCT02819856   United States
Spiriva respimat 2.5 MCG
   Boehringer Ingelheim
      2010   Phase 3   EUCTR2010-019802-17-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-019802-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim España, S.A
      2010   -   EUCTR2010-019802-17-ES   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim France
      2010   -   EUCTR2010-019802-17-PT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim Limited
      2010   -   EUCTR2010-019802-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2010   -   EUCTR2010-019802-17-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2010   -   EUCTR2010-019802-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH&Co KG
      2010   Phase 3   EUCTR2010-019802-17-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2010   Phase 3   EUCTR2010-019802-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
Spiriva respimat 2.5 microgram, solution FOR inhalation
   BOEHRINGER ING.
      2010   -   EUCTR2010-019802-17-IT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-001156-43-IT   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim
      2010   Phase 3   EUCTR2010-019802-17-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-019802-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim España, S.A
      2010   -   EUCTR2010-019802-17-ES   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim France
      2010   -   EUCTR2010-019802-17-PT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001156-43-FR   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Limited
      2010   -   EUCTR2010-019802-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2010   -   EUCTR2010-019802-17-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2008   -   EUCTR2008-001156-43-GB   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2010   -   EUCTR2010-019802-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co.KG
      2008   -   EUCTR2008-001156-43-DE   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Pharmaceuticals, Inc.
      2009   -   EUCTR2008-001156-43-PT   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim RCV GmbH & Co KG
      2010   -   EUCTR2010-019802-17-HU   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim RCV GmbH&Co KG
      2010   Phase 3   EUCTR2010-019802-17-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
   Boehringer Ingelheim bv
      2009   -   EUCTR2008-001156-43-NL   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2010   Phase 3   EUCTR2010-019802-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2008   -   EUCTR2008-001156-43-BE   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
Spirometry
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
   Rambam Health Care Campus
      2023   -   NCT05932316   Israel
Spirulina platensis
   University of Miami
      2022   -   NCT05223881   United States
SPL84
   SpliSense Ltd.
      2024   Phase 2   NCT06429176   United States
Sporanox 10 MG/ML oral solution
   CHU de Rennes (Rennes University Hospital Centre)
      2012   -   EUCTR2011-005799-41-GB   United Kingdom
Sputum
   University of Miami
      2010   -   NCT02198079   United States
Sputum collection
   The Hospital for Sick Children
      2010   -   NCT01155115   Canada
Sputum sample
   Assistance Publique - Hôpitaux de Paris
      2019   -   NCT03894657   France
   Emory University
      2015   -   NCT02589444   United States
SPX-101
   SPYRYX BIOSCIENCES, INC.
      2017   Phase 2   EUCTR2016-005230-30-IT   Australia;Canada;France;Italy;Portugal;United Kingdom
   Spyryx Biosciences, Inc.
      2017   Phase 2   NCT03229252   Canada;France;Italy;Portugal;United Kingdom
      2017   Phase 1   NCT03056989   Canada
      2017   Phase 2   EUCTR2016-005230-30-PT   Australia;Canada;France;Italy;Portugal;United Kingdom
      2017   Phase 2   EUCTR2016-005230-30-GB   Australia;Canada;France;Italy;Portugal;United Kingdom
Standard care
   Liverpool Heart and Chest Hospital NHS Foundation Trust
      2017   Phase 4   NCT02894684   United Kingdom
   Postgraduate Institute of Medical Education and Research
      2023   Phase 3   NCT06160713   India
Standard dose YPT-01
   Yale University
      2021   Phase 1/Phase 2   NCT04684641   United States
Standard formula
   Laboratorios Ordesa
      2012   -   NCT02128984   Peru;Spain
   University of Massachusetts, Worcester
      2003   -   NCT00530244   United States
Standard nutritional supplement + pert
   GlycosBio, Inc.
      2018   -   NCT04966897   United States
Standard oxygen therapy/RA
   The Leeds Teaching Hospitals NHS Trust
      2019   -   NCT03965832   United Kingdom
Standardized turmeric root extract
   Ramsey, Bonnie, MD
      2005   Phase 1   NCT00219882   United States
Stool sample
   Emory University
      2015   -   NCT02589444   United States
Study medication, azithromycin
   Rigshospitalet, Denmark
      2008   Phase 4   NCT00411736   Denmark;Norway;Sweden
SUB185183
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
Sulfamethoxazole
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Sulfato DE amikacina
   Insmed Incorporated
      2011   Phase 3   EUCTR2011-000443-24-ES   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2011-000441-20-ES   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
Sunflower OIL
   Hospices Civils de Lyon
      2010   Phase 2   NCT02690857   -
Supplementation with vitamin D2/D3
   Karolinska Institutet
      2010   -   NCT01321905   Sweden
Sweat chloride test
   Sohag University
      2022   -   NCT05599958   Egypt
Symbiotic formula with DHA and antioxidants
   Laboratorios Ordesa
      2012   -   NCT02128984   Peru;Spain
Symdeko
   University of Alabama at Birmingham
      2019   Early Phase 1   NCT03587961   United States
   Vertex Pharmaceuticals Incorporated
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 1   EUCTR2020-000689-40-Outside-EU/EEA   United States
Symkevi
      2019   Phase 4   EUCTR2019-001314-41-NL   Netherlands
   Vertex Pharmaceuticals Incorporated
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
Symkevi 100MG/150MG FILM-coated tablets
   VERTEX PHARMACEUTICALS INCORPORATED
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
Synrinse
   University of Washington
      2017   Phase 1/Phase 2   NCT03154541   United States
T 100 pari
   PARI GmbH
      -   Phase 1   EUCTR2005-004103-10-PL   Germany;Poland
T-326
   CHIRON CORPORATION LIMITED
      2006   -   EUCTR2005-003772-37-IT   Germany;Greece;Hungary;Italy;Spain;United Kingdom
T100
   PARI Pharma GmbH
      -   Phase 1   EUCTR2010-023235-41-PL   Poland
T100 pari
   PARI GmbH
      2007   -   EUCTR2007-000959-33-DE   Germany
   PARI Pharma GmbH
      2006   -   EUCTR2005-004103-10-DE   Germany
Tacrolimus and MMF
   University Hospital, Limoges
      2009   Phase 4   NCT00975663   Belgium;France
Tacrolimus capsules
   Hopital Erasme - Chest service
      2009   Phase 4   EUCTR2009-014050-15-BE   Belgium
Tacrolimus prolonged-release hard capsules
   Hopital Erasme - Chest service
      2009   Phase 4   EUCTR2009-014050-15-BE   Belgium
TAD
   Aarhus University Hospital
      2014   Phase 2   EUCTR2013-005481-19-DK   Denmark
TAD 600
   AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI
      2009   -   EUCTR2008-005080-33-IT   Italy
   Mukoviszidose Institut gGmbH i. G.
      2006   -   EUCTR2005-003870-88-DE   Germany
Tafluprost
   Santen Oy
      2016   Phase 1   EUCTR2013-004302-26-SK   Hungary;Poland;Slovakia;United Kingdom;United States
      2016   Phase 1   EUCTR2013-004302-26-HU   Hungary;Poland;Slovakia;United Kingdom;United States
      2014   Phase 1   EUCTR2013-004302-26-GB   Hungary;Poland;Slovakia;United Kingdom;United States
Talniflumate
   Genaera Corporation
      2005   Phase 2   EUCTR2004-004334-13-IE   Ireland
Tauroursodeoxycholic acid
   Children's Hospital Medical Center, Cincinnati
      1997   -   NCT00004441   Italy;United States
Tazobactam
   Aarhus University Hospital, Department of Respiratory Medicine
      2015   Phase 2   EUCTR2015-003662-87-DK   Denmark
Tazobactam sodium
   Ghent University
      2016   Phase 4   EUCTR2016-000398-19-BE   Belgium
TBD
   AbbVie Deutschland
      2019   Phase 2   EUCTR2019-000750-63-NL   Belgium;Canada;Czech Republic;France;Hungary;Netherlands;Poland;Puerto Rico;Serbia;Slovakia;Spain;United Kingdom;United States
TBM100
   NOVARTIS PHARMA SERVICES AG
      2016   Phase 2   EUCTR2015-003040-39-IT   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-003532-23-ES   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharma GmbH
      2014   Phase 4   EUCTR2014-001204-21-DE   Germany
      2008   -   EUCTR2007-004507-36-DE   Germany
   Novartis Pharma Services AG
      2017   Phase 2   EUCTR2015-003040-39-NL   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-IE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-GB   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-FR   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-ES   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-DE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-BE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2012-001565-33-IE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-003532-23-DE   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   Phase 4   EUCTR2012-001565-33-GB   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-001565-33-DE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2009-016590-15-PL   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland;United States
      2012   -   EUCTR2012-003532-23-HU   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2010   -   EUCTR2009-016590-15-DE   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland
      2009   -   EUCTR2009-016590-15-HU   Canada;France;Germany;Greece;Hungary;Italy;Poland;Russian Federation;Switzerland
      -   Phase 4   EUCTR2011-002000-32-FR   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Pharmaceuticals
      2013   Phase 4   NCT01775137   Argentina;Australia;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
      2012   Phase 4   NCT01519661   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
TBM100C
   NOVARTIS FARMA
      2013   -   EUCTR2012-003532-23-IT   Argentina;Australia;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
      2012   -   EUCTR2011-002000-32-IT   Argentina;Australia;Brazil;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Farmaceutica S. A
      2011   Phase 4   EUCTR2011-002000-32-ES   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-003532-23-ES   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharma GmbH
      2014   Phase 4   EUCTR2014-001204-21-DE   Germany
   Novartis Pharma Services AG
      2015   -   EUCTR2012-001565-33-IE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-003532-23-DE   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   Phase 4   EUCTR2012-001565-33-GB   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-001565-33-DE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2012   -   EUCTR2012-003532-23-HU   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   -   EUCTR2011-002000-32-HU   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   -   EUCTR2011-002000-32-DE   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   Phase 3   EUCTR2005-003772-37-IE   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2010   -   EUCTR2009-016734-26-LV   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-LT   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-EE   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-BG   Bulgaria;Estonia;Latvia;Lithuania
      2008   Phase 3   EUCTR2005-003772-37-GR   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003772-37-HU   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003772-37-GB   Germany;Greece;Hungary;Italy;Spain;United Kingdom
Technetium [TC-99M] sulfur colloid and indium [IN-111] dtpa
   University of Pittsburgh
      2007   -   NCT00541190   United States
Technetium sulfur colloid
   Tim Corcoran
      2017   Phase 1   NCT02947126   United States
Tedizolid IV
   University of Southern California
      2015   Phase 4   NCT02444234   United States
Tedizolid PO
   University of Southern California
      2015   Phase 4   NCT02444234   United States
Tefibazumab
   Bristol-Myers Squibb
      2005   Phase 2   NCT00198289   United States
Teicoplanin
   Neupharma Srl
      2019   Phase 1   NCT04176328   Italy
Teicoplanina sandoz - 200 MG polvere E solvente PER soluzione iniettabile O infusione 1 flaconcino vetro DA 200 MG E 1 fiala vetro DA 3 ML
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2024   Phase 2   EUCTR2023-000005-12-IT   Italy
Teicoplanina sandoz 200 MG
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2024   Phase 2   EUCTR2023-000005-12-IT   Italy
Telavancin injection
   Joseph L. Kuti, PharmD
      2017   Phase 4   NCT03172793   United States
TEM
   Peking Union Medical College Hospital
      2024   -   ChiCTR2400082471   China
Tenapanor
   Massachusetts General Hospital
      2025   Phase 3   NCT06810167   -
Terlipressin acetate
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2021   Phase 3   EUCTR2020-005931-58-FR   France
Test soda
   Emory University
      2014   -   NCT02202876   United States
TEZ
   VERTEX PHARMACEUTICALS INCORPORATED
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2017   Phase 2   EUCTR2016-000454-36-IT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-005930-40-FR   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005320-38-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 3   NCT03691779   Australia;Ireland;United Kingdom;United States
      2018   Phase 3   NCT03525574   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   NCT03447262   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2016-000454-36-NL   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-GB   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-ES   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-DE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-BE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-AT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 1   NCT03486236   United Kingdom
      2016   Phase 2   NCT02951182   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000454-36-DK   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
TEZ/IVA
   Vertex Pharmaceuticals Incorporated
      2019   Phase 2   NCT03912233   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 1/Phase 2   NCT03768089   Netherlands;United Kingdom
      2018   Phase 3   NCT03559062   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   NCT03537651   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2017   Phase 1/Phase 2   NCT03227471   Australia;Belgium;Netherlands;United States
      2017   Phase 2   NCT03224351   Ireland;Israel;United Kingdom;United States
      2016   Phase 3   NCT02953314   Canada;United States
      2015   Phase 3   NCT02565914   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
Teza
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
Tezacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1   NCT06154447   United States
      2023   Phase 3   EUCTR2021-005930-40-FR   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-PL   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-FR   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2016   Phase 1   NCT03029455   United Kingdom
      2016   Phase 2   NCT02951195   United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-004479-35-IE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
Tezacaftor/ivacaftor
   Vertex Pharmaceuticals Incorporated
      2017   -   NCT03278314   -
      2017   Phase 3   NCT03150719   France;Germany;United States
      2016   Phase 2   NCT02730208   Australia
      2016   Phase 2   NCT02508207   United States
      2015   Phase 3   NCT02412111   Australia;Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      -   Phase 1   EUCTR2020-000689-40-Outside-EU/EEA   United States
Tezacaftor/ivacaftor + ivacaftor
   Nottingham University Hospitals NHS Trust
      2019   Phase 2   NCT04006873   United Kingdom
Tezacaftor/ivacaftor 100MG/150MG
   VERTEX PHARMACEUTICALS INCORPORATED
      2017   Phase 2   EUCTR2016-000454-36-IT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2018-000126-55-NL   Netherlands
      2017   Phase 2   EUCTR2017-000797-11-NL   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 3   EUCTR2017-000540-18-DE   France;Germany;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-NL   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-GB   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-ES   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-DE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-BE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-AT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000454-36-DK   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-000540-18-FR   France;Germany;United States
Tezacaftor/ivacaftor/100MG/150MG
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-004133-82-IE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-GB   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-ES   Australia;Germany;Ireland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2017-004133-82-DE   Australia;Germany;Ireland;Spain;United Kingdom;United States
Tgaavcf
   Targeted Genetics Corporation
      2003   Phase 2/Phase 3   NCT00073463   United States
Tham
   Lakshmi Durairaj
      2017   Phase 1   NCT03078088   United States
THE GUT mycobiota and microbiota profile
   University Hospital, Bordeaux
      2018   -   NCT03565692   France
THE lung mycobiota and microbiota profile
   University Hospital, Bordeaux
      2018   -   NCT03565692   France
Theophylline
   The First Affiliated Hospital of Guangzhou Medical University
      2012   Phase 4   NCT01684683   China
   The first affiliated hospital of Guangzhou Medical University
      2012   -   ChiCTR-TRC-12002470   China
Thymosin alpha 1
   SciClone Pharmaceuticals Limited Ltd
      2019   Phase 2   EUCTR2019-001441-40-IT   Italy
Tiotropium bromide
   BOEHRINGER ING.
      2010   -   EUCTR2010-019802-17-IT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-001156-43-IT   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2010   -   EUCTR2010-019802-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
Tiotropium bromide 5 MCG
   Boehringer Ingelheim
      2008   Phase 2   NCT00737100   Australia;Belgium;France;Germany;Italy;Netherlands;New Zealand;Portugal;Russian Federation;United Kingdom;United States
Tiotropium bromide high
   Boehringer Ingelheim
      2006   Phase 1   NCT02172534   -
Tiotropium bromide LOW
   Boehringer Ingelheim
      2006   Phase 1   NCT02172534   -
Tiotropium bromide medium
   Boehringer Ingelheim
      2006   Phase 1   NCT02172534   -
Tiotropium bromide monohydrate
   Boehringer Ingelheim
      2010   Phase 3   EUCTR2010-019802-17-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-019802-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim España, S.A
      2010   -   EUCTR2010-019802-17-ES   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim France
      2010   -   EUCTR2010-019802-17-PT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim Limited
      2010   -   EUCTR2010-019802-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2010   -   EUCTR2010-019802-17-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co.KG
      2008   -   EUCTR2008-001156-43-DE   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim RCV GmbH & Co KG
      2010   -   EUCTR2010-019802-17-HU   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim RCV GmbH&Co KG
      2010   Phase 3   EUCTR2010-019802-17-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2010   Phase 3   EUCTR2010-019802-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
Tiotropium bromide-LOW DOSE-2.5MCG
   Boehringer Ingelheim
      2008   Phase 2   NCT00737100   Australia;Belgium;France;Germany;Italy;Netherlands;New Zealand;Portugal;Russian Federation;United Kingdom;United States
Tiotropium respimat
   Boehringer Ingelheim
      2010   Phase 3   EUCTR2010-019802-17-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-019802-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim España, S.A
      2010   -   EUCTR2010-019802-17-ES   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim France
      2010   -   EUCTR2010-019802-17-PT   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim Limited
      2010   -   EUCTR2010-019802-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
      2010   -   EUCTR2010-019802-17-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2010   -   EUCTR2010-019802-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH & Co KG
      2010   -   EUCTR2010-019802-17-HU   Austria;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Spain;United Kingdom
   Boehringer Ingelheim RCV GmbH&Co KG
      2010   Phase 3   EUCTR2010-019802-17-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Ireland;Italy;Portugal;Slovakia;Spain;United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2010   Phase 3   EUCTR2010-019802-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
Tiotropium respimat 1.25 microgram solution FOR inhalation
   Boehringer Ingelheim France
      2008   Phase 2   EUCTR2008-001156-43-FR   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Limited
      2008   -   EUCTR2008-001156-43-GB   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim Pharmaceuticals, Inc.
      2009   -   EUCTR2008-001156-43-PT   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   Boehringer Ingelheim bv
      2009   -   EUCTR2008-001156-43-NL   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2008   -   EUCTR2008-001156-43-BE   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
Tiotropium respimat 1.25 microgram, solution FOR inhalation
   Boehringer Ingelheim Pharma GmbH & Co.KG
      2008   -   EUCTR2008-001156-43-DE   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
Tiotropium respimat 1.25 micrograms solution FOR inhalation
   BOEHRINGER ING.
      2009   -   EUCTR2008-001156-43-IT   Belgium;France;Germany;Italy;Netherlands;Portugal;United Kingdom
Tiotropium respimat® inhaler
   Boehringer Ingelheim
      2010   Phase 3   NCT01179347   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;United Kingdom;United States
TIP
   CHIRON CORPORATION LIMITED
      2006   -   EUCTR2005-003772-37-IT   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Chiron Corporation Ltd
      2006   -   EUCTR2005-003772-37-ES   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Novartis Farmaceutica S. A
      2011   Phase 4   EUCTR2011-002000-32-ES   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Pharma Services AG
      2011   -   EUCTR2011-002000-32-HU   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   Phase 3   EUCTR2005-003772-37-IE   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2010   -   EUCTR2009-016734-26-LV   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-LT   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-EE   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-BG   Bulgaria;Estonia;Latvia;Lithuania
      2008   Phase 3   EUCTR2005-003772-37-GR   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003772-37-HU   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003772-37-GB   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-002035-28-LT   Lithuania
      -   Phase 4   EUCTR2011-002000-32-FR   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      -   -   EUCTR2005-003772-37-DE   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Novartis Pharmaceuticals
      2017   Phase 2   NCT02712983   Belgium;France;Germany;Italy;Netherlands;Spain;United Kingdom
TIS or TIP
   Novartis Pharmaceuticals
      2015   Phase 4   NCT02248922   Germany
TMP
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
Tnse
   ECUPHARMA S.R.L.
      2007   -   EUCTR2007-003628-39-IT   Italy
Tobacco questionnaire
   University Hospital, Toulouse
      2019   -   NCT04437641   France
Tobacco treatment specialist (TTS) intervention
   University of Alabama at Birmingham
      2021   -   NCT04777344   United States
Tobi
   CHRU de Lille
      -   Phase 2   EUCTR2014-003882-10-FR   France
   Chiesi Farmaceutici S.p.A
      2008   Phase 3   EUCTR2006-006215-68-ES   Czech Republic;France;Germany;Hungary;Spain
   EREMPHARMA SAS
      -   Phase 1   EUCTR2010-023533-34-FR   France
   Erempharma SAS
      2009   -   EUCTR2009-013660-39-FR   France
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-DK   Belgium;Denmark
   Gilead Sciences Inc
      2010   -   EUCTR2007-004277-26-AT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2007-004277-26-GB   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-PT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-NL   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-FR   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-ES   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DK   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-BE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      -   -   EUCTR2007-004277-26-Outside-EU/EEA   United States
   Gilead Sciences, Inc.
      -   -   EUCTR2015-000398-11-Outside-EU/EEA   United States
   INSMED INCORPORATED
      2011   -   EUCTR2011-000441-20-IT   Austria;Bulgaria;Canada;Denmark;Greece;Hungary;Ireland;Italy;Netherlands;Spain;United Kingdom
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-IE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
   Novartis Pharma GmbH
      2008   -   EUCTR2007-004507-36-DE   Germany
   Novartis Pharma Services AG
      2011   Phase 3   EUCTR2005-003772-37-IE   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2005-003772-37-GR   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003772-37-HU   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003772-37-GB   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      -   -   EUCTR2005-003772-37-DE   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Novartis Pharmaceuticals
      2010   Phase 3   NCT01082367   Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland;United States
   PARI GmbH
      2007   -   EUCTR2007-000959-33-DE   Germany
      -   Phase 1   EUCTR2005-004103-10-PL   Germany;Poland
   PARI Pharma GmbH
      2006   -   EUCTR2005-004103-10-DE   Germany
      -   Phase 1   EUCTR2010-023235-41-PL   Poland
   Pari Pharma GmbH
      2013   Phase 1   NCT01953367   Germany
   Seattle Children's Hospital
      2004   Phase 2   NCT00097773   United States
   St. Michael's Hospital, Toronto
      2014   Phase 1   NCT02212587   Canada
   Universitaire Ziekenhuizen Leuven
      2001   Phase 4   NCT01400750   Belgium
Tobi 300 MG / 5 ML nebuliser solution
   Novartis Pharma Services AG
      2013   -   EUCTR2009-016590-15-PL   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland;United States
      2009   -   EUCTR2009-016590-15-HU   Canada;France;Germany;Greece;Hungary;Italy;Poland;Russian Federation;Switzerland
Tobi 300 MG/5 ML Lösung FüR einen
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-DE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
Tobi 300 MG/5 ML Lösung FüR einen vernebler
   Novartis Pharma Services AG
      2010   -   EUCTR2009-016590-15-DE   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland
Tobi 300 MG/5 ML nebuliser solution
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-BE   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-AT   Austria;Belgium;Denmark
   Leeds Teaching Hospitals NHS Trust
      2007   -   EUCTR2007-005346-20-GB   United Kingdom
   Mpex Pharmaceuticals, Inc.
      2011   Phase 3   EUCTR2010-019634-26-GB   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
Tobi 300 MG/5 ML solucióN para inhalacióN POR nebulizador
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
Tobi 300 MG/5 ML, solution pour inhalation PAR Nébuliseur
   Mpex Pharmaceuticals, Inc.
      -   Phase 3   EUCTR2010-019634-26-FR   France;Germany;Ireland;United Kingdom
Tobi 300MG/ 5ML solucióN para inhalacióN CON nebulizador
   Insmed Incorporated
      2011   Phase 3   EUCTR2011-000441-20-ES   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
Tobi 300MG/5ML nebuliser solution
   Chiesi Farmaceutici S.p.A
      2009   Phase 3   EUCTR2006-006215-68-FR   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-HU   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-DE   Czech Republic;France;Germany;Hungary;Spain
      2008   Phase 3   EUCTR2006-006215-68-CZ   Czech Republic;France;Germany;Hungary;Spain
   Chiron Corporation Ltd
      2006   -   EUCTR2005-003772-37-ES   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Insmed Incorporated
      2012   -   EUCTR2011-000441-20-NL   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-IE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-DK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-BG   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2012   Phase 3   EUCTR2011-000441-20-BE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-SK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-HU   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-GR   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000441-20-GB   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-DE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-AT   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
   Novartis Pharma Services AG
      2010   -   EUCTR2009-016590-15-GR   France;Germany;Greece;Hungary;Italy;Poland
      2010   Phase 3   EUCTR2009-016590-15-FR   France;Germany;Greece;Hungary;Italy;Poland
Tobi inhalant product
   University Hospital, Lille
      2017   Phase 3   NCT03066453   France
Tobi nebcinal
   Erempharma
      2010   -   NCT01288170   France
Tobi podhaler
   Mylan Inc.
      2018   Phase 4   NCT03502070   United States
      2015   -   NCT02449031   United States
   NOVARTIS PHARMA SERVICES AG
      2016   Phase 2   EUCTR2015-003040-39-IT   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
   Novartis Farmaceutica S. A
      2011   Phase 4   EUCTR2011-002000-32-ES   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-003532-23-ES   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharma GmbH
      2014   Phase 4   EUCTR2014-001204-21-DE   Germany
   Novartis Pharma Services AG
      2017   Phase 2   EUCTR2015-003040-39-NL   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-IE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-GB   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-FR   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-ES   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-DE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-BE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2012-001565-33-IE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-003532-23-DE   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   Phase 4   EUCTR2012-001565-33-GB   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-001565-33-DE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2012   -   EUCTR2012-003532-23-HU   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      -   Phase 4   EUCTR2011-002000-32-FR   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Pharmaceuticals
      2014   Phase 4   NCT02178540   United States
   Novartis Pharmaceuticals Corporation
      -   Phase 4   EUCTR2016-004318-82-Outside-EU/EEA   United States
      -   Phase 4   EUCTR2016-001840-20-Outside-EU/EEA   United States
Tobi podhaler 28 MG hartkapseln MIT pulver ZUR inhalation
   Novartis Pharma Services AG
      2011   -   EUCTR2011-002000-32-DE   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
Tobi podhaler 28 MG inhaláCIóS POR, KEMéNY kapszula
   Novartis Pharma Services AG
      2011   -   EUCTR2011-002000-32-HU   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
Tobi podhaler*448CPS 28MG+10IN
   NOVARTIS FARMA
      2013   -   EUCTR2012-003532-23-IT   Argentina;Australia;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
Tobi*nebul 56F 1D 300MG/5ML
   AZIENDA OSPEDALIERA MEYER
      2008   -   EUCTR2008-006502-42-IT   Italy
   Gilead Sciences Inc
      2008   -   EUCTR2007-004277-26-IT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
   NOVARTIS FARMA
      2011   -   EUCTR2009-016590-15-IT   Canada;France;Germany;Greece;Hungary;Italy;Poland;Russian Federation;Switzerland
Tobi™ podhaler™ 112 MG inhaled twice daily
   Dartmouth-Hitchcock Medical Center
      2014   -   NCT02113397   United States
Tobramcyin
   The Univeristy of Nottingham
      2010   Phase 4   EUCTR2010-023030-23-GB   United Kingdom
Tobramicina
   Chiesi Farmaceutici S.p.A
      2008   Phase 3   EUCTR2006-006215-68-ES   Czech Republic;France;Germany;Hungary;Spain
   ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
      -   Phase 4   EUCTR2014-001401-41-IT   Italy;Netherlands
   Insmed Incorporated
      2011   Phase 3   EUCTR2011-000441-20-ES   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
Tobramicina polvere inalatoria
   NOVARTIS PHARMA SERVICES AG
      2016   Phase 2   EUCTR2015-003040-39-IT   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
Tobramicina solfato
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
Tobramicyn
   UNIVERSITY OF LIVERPOOL
      -   Phase 4   EUCTR2009-012575-10-IT   Italy;Sweden;United Kingdom
Tobramycin
   AZIENDA OSPEDALIERA MEYER
      2011   -   EUCTR2011-006171-19-IT   Italy
      2008   -   EUCTR2008-006502-42-IT   Italy
   CHRU de Lille
      -   Phase 2   EUCTR2014-003882-10-FR   France
   Chiesi Farmaceutici S.p.A
      2009   Phase 3   EUCTR2006-006215-68-FR   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-HU   Czech Republic;France;Germany;Hungary;Spain
      2008   Phase 3   EUCTR2006-006215-68-ES   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-DE   Czech Republic;France;Germany;Hungary;Spain
      2008   Phase 3   EUCTR2006-006215-68-CZ   Czech Republic;France;Germany;Hungary;Spain
   Chiesi Farmaceutici S.p.A.
      2009   Phase 3   NCT01111383   France;Poland;Ukraine
   ECUPHARMA S.R.L.
      2007   -   EUCTR2007-003628-39-IT   Italy
   Erasmus University Medical Centre
      2012   -   EUCTR2012-002503-17-NL   Netherlands
   Erempharma
      2011   Phase 1/Phase 2   NCT01337219   France
   FDA Office of Orphan Products Development
      1995   Phase 3   NCT00004829   -
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
      2011   -   EUCTR2011-001821-26-IT   Italy
   Forest Laboratories UK Ltd
      2005   -   EUCTR2004-003675-36-DK   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-BE   Belgium;Denmark
      2005   -   EUCTR2004-003675-36-AT   Austria;Belgium;Denmark
   Gilead Sciences Inc
      2010   -   EUCTR2007-004277-26-AT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2007-004277-26-GB   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-PT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-NL   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IT   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-IE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-FR   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-ES   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DK   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   -   EUCTR2007-004277-26-DE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-004277-26-BE   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;United Kingdom
      -   -   EUCTR2007-004277-26-Outside-EU/EEA   United States
   Gilead Sciences, Inc.
      -   -   EUCTR2015-000398-11-Outside-EU/EEA   United States
   Haga Hospital
      2014   -   EUCTR2013-004488-30-NL   Netherlands
   INSMED INCORPORATED
      2011   -   EUCTR2011-000441-20-IT   Austria;Bulgaria;Canada;Denmark;Greece;Hungary;Ireland;Italy;Netherlands;Spain;United Kingdom
   Imperial College London
      2010   Phase 4   NCT01044719   United Kingdom
   Imperial College, London
      2009   -   EUCTR2009-014042-28-GB   United Kingdom
   Insmed Incorporated
      2012   -   EUCTR2011-000441-20-NL   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2012   -   EUCTR2011-000441-20-IE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-DK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-000441-20-BG   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2012   Phase 3   EUCTR2011-000441-20-BE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-SK   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Serbia;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-HU   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-GR   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom;United States
      2011   -   EUCTR2011-000441-20-GB   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-DE   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
      2011   -   EUCTR2011-000441-20-AT   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Slovakia;Spain;United Kingdom
   Leeds Teaching Hospitals NHS Trust
      2007   -   EUCTR2007-005346-20-GB   United Kingdom
   Mpex Pharmaceuticals, Inc.
      2011   -   EUCTR2010-019634-26-IE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019634-26-GB   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      2011   -   EUCTR2010-019634-26-DE   Canada;France;Germany;Ireland;Israel;United Kingdom;United States
      -   Phase 3   EUCTR2010-019634-26-FR   France;Germany;Ireland;United Kingdom
   NOVARTIS FARMA
      2013   -   EUCTR2012-003532-23-IT   Argentina;Australia;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   -   EUCTR2009-016590-15-IT   Canada;France;Germany;Greece;Hungary;Italy;Poland;Russian Federation;Switzerland
   National Jewish Health
      2016   Phase 4   NCT02918409   United States
   Novartis
      2008   Phase 3   NCT00634192   Germany
      2006   Phase 1   NCT00420836   -
      2006   Phase 1   NCT00399945   United Kingdom
   Novartis Farmaceutica, S.A.
      2013   -   EUCTR2012-003532-23-ES   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   -   EUCTR2012-001565-33-ES   Germany;Ireland;Spain;Switzerland;United Kingdom
   Novartis Pharma GmbH
      2014   Phase 4   EUCTR2014-001204-21-DE   Germany
      2008   -   EUCTR2007-004507-36-DE   Germany
   Novartis Pharma Services AG
      2015   -   EUCTR2012-001565-33-IE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-003532-23-DE   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2013   Phase 4   EUCTR2012-001565-33-GB   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2012-001565-33-DE   Germany;Ireland;Spain;Switzerland;United Kingdom
      2013   -   EUCTR2009-016590-15-PL   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland;United States
      2012   -   EUCTR2012-003532-23-HU   Argentina;Australia;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   -   EUCTR2011-002000-32-DE   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2010   -   EUCTR2009-016590-15-GR   France;Germany;Greece;Hungary;Italy;Poland
      2010   Phase 3   EUCTR2009-016590-15-FR   France;Germany;Greece;Hungary;Italy;Poland
      2010   -   EUCTR2009-016590-15-DE   Argentina;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Switzerland
      2009   -   EUCTR2009-016590-15-HU   Canada;France;Germany;Greece;Hungary;Italy;Poland;Russian Federation;Switzerland
   Novartis Pharmaceuticals Corporation
      -   Phase 4   EUCTR2016-004318-82-Outside-EU/EEA   United States
   PARI Pharma GmbH
      -   Phase 1   EUCTR2010-023235-41-PL   Poland
   Pari Pharma GmbH
      2013   Phase 1   NCT01953367   Germany
   The Leeds Teaching Hospitals NHS Trust
      2015   -   NCT02489955   United Kingdom
   University College Cork
      2013   -   NCT02526004   Ireland
   University Hospitals Bristol NHS Foundation Trust
      2016   Phase 4   EUCTR2009-012575-10-SE   Sweden;United Kingdom
      2009   Phase 4   EUCTR2009-012575-10-GB   Sweden;United Kingdom
   University Medical Center Groningen
      2019   Phase 1/Phase 2   NCT03485456   Netherlands
   University Medical Centre Groningen
      2013   Phase 1/Phase 2   NCT02035488   Netherlands
   University of Jena
      2008   Phase 2   NCT00774072   Germany
      2008   -   EUCTR2008-000164-17-DE   Germany
   University of Milan
      2012   Phase 4   NCT01608555   Italy
Tobramycin / bramitob
   Chiesi Farmaceutici S.p.A.
      2009   Phase 3   NCT00885365   Czech Republic;Czechia;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
Tobramycin / tobi
   Chiesi Farmaceutici S.p.A.
      2009   Phase 3   NCT00885365   Czech Republic;Czechia;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
Tobramycin 100 pari
   PARI GmbH
      2007   -   EUCTR2007-000959-33-DE   Germany
      -   Phase 1   EUCTR2005-004103-10-PL   Germany;Poland
   PARI Pharma GmbH
      2006   -   EUCTR2005-004103-10-DE   Germany
Tobramycin DRY powder
   University Medical Center Groningen
      2013   -   EUCTR2012-004437-16-NL   Netherlands
Tobramycin FOR inhalation
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2000   Phase 2   NCT00006280   United States
Tobramycin inhalation powder
   CHIRON CORPORATION LIMITED
      2006   -   EUCTR2005-003772-37-IT   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Chiron Corporation Ltd
      2006   -   EUCTR2005-003772-37-ES   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   NOVARTIS FARMA
      2012   -   EUCTR2011-002000-32-IT   Argentina;Australia;Brazil;Canada;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis
      2005   Phase 3   NCT00125346   Argentina;Brazil;Bulgaria;Canada;Chile;Former Serbia and Montenegro;Lithuania;Mexico;United States
   Novartis Farmaceutica S. A
      2011   Phase 4   EUCTR2011-002000-32-ES   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
   Novartis Pharma Services AG
      2017   Phase 2   EUCTR2015-003040-39-NL   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-IE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-GB   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-FR   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-ES   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-DE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2016   Phase 2   EUCTR2015-003040-39-BE   Belgium;France;Germany;Ireland;Italy;Netherlands;Spain;Switzerland;United Kingdom
      2011   -   EUCTR2011-002000-32-HU   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      2011   Phase 3   EUCTR2005-003772-37-IE   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2010   -   EUCTR2009-016734-26-LV   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-LT   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-EE   Bulgaria;Estonia;Latvia;Lithuania
      2010   -   EUCTR2009-016734-26-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-004764-39-BG   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LV   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-LT   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-EE   Bulgaria;Estonia;Latvia;Lithuania
      2009   -   EUCTR2008-002318-22-BG   Bulgaria;Estonia;Latvia;Lithuania
      2008   Phase 3   EUCTR2005-003772-37-GR   Germany;Greece;Hungary;Ireland;Italy;Spain;United Kingdom
      2007   -   EUCTR2005-003772-37-HU   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-003772-37-GB   Germany;Greece;Hungary;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-002035-28-LT   Lithuania
      -   Phase 4   EUCTR2011-002000-32-FR   Argentina;Australia;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Spain;United States
      -   -   EUCTR2005-003772-37-DE   Germany;Greece;Hungary;Italy;Spain;United Kingdom
   Novartis Pharmaceuticals
      2014   Phase 4   NCT02015663   United States
      2013   Phase 4   NCT01844778   Germany;Ireland;Spain;Switzerland;United Kingdom
      2010   Phase 3   NCT01069705   Bulgaria;Estonia;Latvia;Lithuania;Romania;Russian Federation;South Africa
      2009   Phase 3   NCT00982930   Estonia;Russian Federation
      2009   Phase 3   NCT00918957   Bulgaria;Egypt;Estonia;India;Latvia;Lithuania;Romania;Russian Federation;South Africa
      2006   Phase 3   NCT00388505   Australia;Canada;Chile;Colombia;France;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Spain;United Kingdom;United States
Tobramycin inhalation solution
   Gilead Sciences
      2012   Phase 3   NCT01641822   United States
      2008   Phase 3   NCT00757237   Austria;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
   Horizon Pharma USA, Inc.
      2011   Phase 3   NCT01270347   France;Germany;Ireland;Israel;United Kingdom;United States
   Insmed Incorporated
      2012   Phase 3   NCT01315678   Austria;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom
   Medical Center Alkmaar
      2016   Phase 2/Phase 3   NCT02657473   Netherlands
   Novartis Pharmaceuticals
      2013   Phase 4   NCT01844778   Germany;Ireland;Spain;Switzerland;United Kingdom
   Qianfoshan Hospital
      2023   -   NCT06106789   China
   Respirion Pharmaceuticals Pty Ltd
      2024   Phase 1/Phase 2   NCT06016088   Australia;United States
Tobramycin injection 40MG/1ML
   The Univeristy of Nottingham
      2010   Phase 4   EUCTR2010-023030-23-GB   United Kingdom
Tobramycin nebulized nasally
   Virginie ESCABASSE
      2017   Phase 3   NCT02888730   France
Tobramycin powder
   University Hospital Tuebingen
      2014   Phase 3   NCT03341741   -
Tobramycin solution FOR inhalation
   Bonnie Ramsey
      2014   Phase 3   NCT02054156   United States
   Novartis Pharmaceuticals
      2010   -   NCT01460836   -
      2006   Phase 3   NCT00388505   Australia;Canada;Chile;Colombia;France;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Spain;United Kingdom;United States
   Seattle Children's Hospital
      2004   Phase 2   NCT00097773   United States
Tobramycin solution FOR inhalation 300 MG
   Novartis
      2003   Phase 3   NCT00391976   -
Tobramycin steri-NEB 300 MG/5 ML, inhalation solution
   Noordwest Ziekenhuisgroep
      2016   Phase 2;Phase 3   EUCTR2016-000166-35-NL   Netherlands
Tobramycin sulfate
   Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)
      2014   Phase 4   EUCTR2013-004295-35-AT   Austria
   St. Vincent's University Hospital
      2016   Phase 4   EUCTR2016-001785-29-IE   Ireland
Tobramycin time OF administration
   University of Nottingham
      2011   Phase 4   NCT01207245   United Kingdom
Tobramycine
   Erempharma SAS
      2009   -   EUCTR2009-013660-39-FR   France
   Novartis Pharma Services AG
      2005   -   EUCTR2005-002035-28-LT   Lithuania
Tobramycinum
   PARI GmbH
      -   Phase 1   EUCTR2005-004103-10-PL   Germany;Poland
   PARI Pharma GmbH
      -   Phase 1   EUCTR2010-023235-41-PL   Poland
Tobrineb/bramitob
   Chiesi Farmaceutici S.p.A
      2009   Phase 3   EUCTR2006-006215-68-FR   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-HU   Czech Republic;France;Germany;Hungary;Spain
      2008   Phase 3   EUCTR2006-006215-68-ES   Czech Republic;France;Germany;Hungary;Spain
      2008   -   EUCTR2006-006215-68-DE   Czech Republic;France;Germany;Hungary;Spain
      2008   Phase 3   EUCTR2006-006215-68-CZ   Czech Republic;France;Germany;Hungary;Spain
Tozinameran
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
TR02
   Transave, Inc
      2005   Phase 2   EUCTR2005-004389-17-HU   Hungary
   Transave, Inc.
      2005   -   EUCTR2005-004899-21-BE   Belgium
Tranexamic acid
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2021   Phase 3   EUCTR2020-005931-58-FR   France
Transdermal estrogen
   Johns Hopkins University
      2023   Phase 4   NCT05704036   United States
Treatment
   China-Japan Friendship Hospital
      2024   Phase 0   ChiCTR2400093811   China
   Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine
      2015   -   ChiCTR-IPC-15005915   -
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
   Johns Hopkins All Children's Hospital
      2016   Phase 2   NCT02613884   United States
   University Hospital, Bordeaux
      2020   Phase 2   NCT04458129   -
Treatment with cystic fibrosis transmembrane regulator (cftr) modualtors ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, elexacaftor-tezacaftor-ivacaftor
   Charite University, Berlin, Germany
      2018   -   NCT04732910   Germany
Trifakta
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
Trikafta
   Emory University
      2023   Phase 4   NCT05743946   United States
      2019   Phase 2   NCT03506061   United States
   University of British Columbia
      2021   -   NCT05279040   Canada
   VERTEX PHARMACEUTICALS INCORPORATED
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
Trimethoprim
   University of North Carolina, Chapel Hill
      2018   Phase 2   NCT03489629   United States
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Trimethoprim and sulfamethoxazole
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
Trimethoprim-sulfamethoxazole
   AOU Meyer
      2013   Phase 3   EUCTR2013-000219-25-IT   Italy
Trimethoprim/sulfamethoxazole
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
   University of North Carolina, Chapel Hill
      2011   Phase 2   NCT01349192   United States
Trimetoprim
   Vãstre Gõtalandsregionen, Sweden
      2021   Phase 4   EUCTR2019-003501-10-NO   Denmark;Norway;Sweden
   Västra Götalandsregionen
      2021   Phase 4   EUCTR2019-003501-10-DK   Denmark;Norway;Sweden
      2020   Phase 4   EUCTR2019-003501-10-SE   Denmark;Norway;Sweden
Triple combination therapy
   National Jewish Health
      2019   -   NCT04038710   United States
Ultrase® MT12
   Forest Laboratories
      2009   Phase 3   NCT00880100   United States
Ultrase® MT20
   Forest Laboratories
      2007   Phase 3   NCT00513682   United States
      2006   Phase 3   NCT00408317   United States
Ultrasound SUB-study OF assessment OF appendage muscles using ultrasound
   Jaeb Center for Health Research
      2023   -   NCT05639556   United States
Ultresa
   AbbVie
      2012   -   NCT01652157   United States
Unsupervised exercise
   Universidad Europea de Madrid
      2020   -   NCT04415268   Spain
Uridine
   FDA Office of Orphan Products Development
      1996   -   NCT00004705   -
Urinary collect
   University Hospital, Strasbourg, France
      2008   -   NCT00476281   France
Urinary levels OF piiinp AS A marker OF changes IN renal function
   Nantes University Hospital
      2012   -   NCT01572194   France
Ursodiol
   Children's Hospital Medical Center, Cincinnati
      1997   -   NCT00004441   Italy;United States
   National Center for Research Resources (NCRR)
      1995   Phase 2   NCT00004315   United States
V-fend
   CHU de Rennes (Rennes University Hospital Centre)
      2012   -   EUCTR2011-005799-41-GB   United Kingdom
Vaccin grippal pandémique H1n1
   Inserm
      2009   Phase 4   EUCTR2009-016662-90-FR   France
Vaccination with vaccine against hepatitis A and B
   Karolinska University Hospital
      2015   -   NCT02605538   Sweden
Valganciclovir
   Hoffmann-La Roche
      2004   Phase 1   NCT00377741   United States
Vancomycin
   Case Western Reserve University
      2012   Phase 1   NCT01509339   United States
Vancomycin hydrochloride inhalation powder
   Savara Inc.
      2013   Phase 2   NCT01746095   United States
Vancomycin inhalation powder
   Savara Inc.
      2017   Phase 3   NCT03181932   Canada;United States
Vanzacaftor
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1   NCT05867147   United States
Vardenafil
   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
      2011   Phase 2   NCT01002534   Belgium
Vaxzevria suspension FOR injection covid-19 vaccine (chadox1-S
   Medical University of Innsbruck, University Clinic for Pediatrics III
      2021   Phase 4   EUCTR2021-003277-55-AT   Austria;Canada;European Union;Ireland;United Kingdom;United States
Vedrop
   ORPHAN
      2007   -   EUCTR2007-001007-38-FR   France
Ventolin® evohaler
   ZAMBON SPA
      2017   Phase 3   EUCTR2015-002743-33-IT   Australia;Belgium;France;Germany;Greece;Israel;Italy;Netherlands;New Zealand;Portugal;Spain;Switzerland;United Kingdom
Vfend
   Leeds Teaching Hospital NHS Trust
      2007   Phase 4   EUCTR2006-006362-41-GB   United Kingdom
Vfend 40 MG/ML powder FOR oral suspension
   CHU de Rennes (Rennes University Hospital Centre)
      2012   -   EUCTR2011-005799-41-GB   United Kingdom
Vitamin D
   Hadassah Medical Organization
      2014   -   NCT02043717   Israel
Vitamin D OIL
   Emory University
      2013   Phase 4   NCT01880346   United States
Vitamin D powder
   Emory University
      2013   Phase 4   NCT01880346   United States
Vitamin D2
   Atlanta VA Medical Center
      2006   -   NCT00450073   United States
Vitamin D3
   Atlanta VA Medical Center
      2006   -   NCT00450073   United States
   Emory University
      2020   Phase 4   NCT04118010   United States
      2008   -   NCT00788138   United States
   University of Pittsburgh
      2010   -   NCT01222273   United States
   University of Southern California
      2019   -   NCT03734744   United States
Vitamin E - tgps
   ORPHAN
      2007   -   EUCTR2007-001007-38-FR   France
Vitamin K supplementation, dose #1
   Institut de Recherches Cliniques de Montreal
      2020   -   NCT04496921   Canada
Vitamin K supplementation, dose #2
   Institut de Recherches Cliniques de Montreal
      2020   -   NCT04496921   Canada
Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1
   University of British Columbia
      2007   -   NCT01070446   Canada
VNZ/TEZ/D-IVA
   Vertex Pharmaceuticals Incorporated
      2024   Phase 1   NCT06299709   United States
      2024   Phase 1   NCT06299696   United States
      2023   Phase 3   NCT05844449   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
Voriconazole
   CHU de Rennes (Rennes University Hospital Centre)
      2012   -   EUCTR2011-005799-41-GB   United Kingdom
   Leeds Teaching Hospital NHS Trust
      2007   Phase 4   EUCTR2006-006362-41-GB   United Kingdom
VR496
   VECTURA LIMITED
      2010   -   EUCTR2007-006276-11-IT   Ireland;Italy
VRT-813077
   Vertex Pharmaceuticals Incorporated
      2010   Phase 3   EUCTR2009-012997-11-FR   Czech Republic;France;Germany;Ireland;United Kingdom
      -   -   EUCTR2009-010261-23-Outside-EU/EEA   United States
VRT-826809
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2009   -   EUCTR2008-006446-25-NL   Belgium;Germany;Netherlands
      2009   -   EUCTR2008-006446-25-DE   Belgium;Germany;Netherlands
      2009   -   EUCTR2008-006446-25-BE   Belgium;Germany;Netherlands
VRT-893661
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-PL   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-FR   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2016   Phase 3   EUCTR2014-004827-29-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   -   EUCTR2014-004827-29-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-004479-35-IE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
VRT-893661 VRT-0893661
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2014-004838-25-DE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-AT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004788-18-BE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-BE   Austria;Belgium;Canada;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-SE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-NL   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IT   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-GB   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-ES   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DK   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-IT   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004787-37-ES   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-DE   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-AT   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
VX-118
   Vertex Pharmaceuticals Incorporated
      2024   Phase 1   NCT06312787   United States
      2023   Phase 1   NCT06154447   United States
VX-121
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-005930-40-FR   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 2   NCT03912233   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 1/Phase 2   NCT03768089   Netherlands;United Kingdom
      2018   Phase 1;Phase 2   EUCTR2018-000126-55-NL   Netherlands
VX-121/TEZ/D-IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-000713-17-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-000713-17-PT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-HU   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 1   NCT05535959   United States
      2022   Phase 3   NCT05444257   Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 1   NCT05437120   United States
      2022   Phase 3   NCT05422222   Australia;Canada;France;Germany;Netherlands;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-NO   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-FR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-DK   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   NCT05076149   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   NCT05033080   Australia;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-PL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
VX-121/tezacaftor/deutivacaftor
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-000713-17-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-000713-17-PT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-HU   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-NO   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-FR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-DK   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-PL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
VX-152
   Vertex Pharmaceuticals Incorporated
      2016   Phase 2   NCT02951195   United States
VX-371
   Parion Sciences
      2016   Phase 2   NCT02709109   France;Ireland;United Kingdom;United States
VX-371 IN hypertonic saline
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
VX-371 IN saline
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
VX-440
   VERTEX PHARMACEUTICALS INCORPORATED
      2017   Phase 2   EUCTR2016-000454-36-IT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2016-000454-36-NL   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-GB   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-ES   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-DE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-BE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-AT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 1   NCT03486236   United Kingdom
      2016   Phase 2   NCT02951182   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000454-36-DK   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
VX-445
   VERTEX PHARMACEUTICALS INCORPORATED
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005320-38-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   NCT03691779   Australia;Ireland;United Kingdom;United States
      2018   Phase 3   NCT03525574   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2017   Phase 1/Phase 2   NCT03227471   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2017-000797-11-NL   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
VX-445 / TEZ / IVA
   Vertex Pharmaceuticals Incorporated
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
VX-445 / TEZ / IVA FDC
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
VX-445 /TEZ/IVA
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
VX-445/TEZ/IVA
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2018   Phase 3   NCT03525548   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   NCT03525444   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
VX-522 mrna therapy
   Vertex Pharmaceuticals Incorporated
      2023   Phase 1/Phase 2   NCT05668741   Australia;Belgium;Canada;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
VX-561
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-000713-17-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-000713-17-PT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-HU   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-NO   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-FR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-DK   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 2   NCT03912233   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   NCT03911713   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-NL   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-GB   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-DE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-BE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      2017   Phase 1/Phase 2   NCT03227471   Australia;Belgium;Netherlands;United States
      2017   Phase 2   NCT03224351   Ireland;Israel;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
      2016   Phase 2   NCT02971839   United States
      -   Phase 3   EUCTR2021-000713-17-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-PL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
VX-659
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   NCT03447262   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 2   NCT03224351   Ireland;Israel;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
      2016   Phase 1   NCT03029455   United Kingdom
VX-659/ TEZ/IVA
   Vertex Pharmaceuticals Incorporated
      2019   Phase 3   EUCTR2017-004134-29-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
VX-659/TEZ/IVA
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   NCT03633526   United States
      2018   Phase 3   NCT03460990   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   NCT03447249   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-IE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-GB   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-ES   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-004133-82-DE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2017-004132-11-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
VX-659/tezacaftor/ivacaftor
   Vertex Pharmaceuticals Incorporated
      2019   Phase 3   EUCTR2017-004134-29-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-IE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-GB   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-ES   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-004133-82-DE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2017-004132-11-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
VX-661
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000713-17-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2023   Phase 3   EUCTR2021-000713-17-PT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-HU   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000713-17-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005930-40-SE   Australia;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000713-17-NO   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-IE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-FR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-DK   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000713-17-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004134-29-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2014   Phase 2   NCT02070744   United States
      2014   Phase 1   NCT02015507   -
      2012   Phase 2   NCT01531673   Canada;Germany;United Kingdom;United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2021-000713-17-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000713-17-PL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-004132-11-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
VX-661 / VX-770
   VERTEX PHARMACEUTICALS INCORPORATED
      2019   Phase 3   EUCTR2018-002835-76-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2020   Phase 3   EUCTR2018-002835-76-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-001735-31-GB   Australia;Belgium;Germany;United Kingdom
      2019   Phase 3   EUCTR2018-002835-76-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002835-76-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2019-001735-31-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2018-002835-76-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
VX-661 plus ivacaftor combination
   Vertex Pharmaceuticals Incorporated
      2015   Phase 3   NCT02516410   Australia;Austria;Canada;France;Israel;Spain;United States
      2015   Phase 3   NCT02347657   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
VX-661, VRT-893661
   Vertex Pharmaceuticals Incorporated
      2013   Phase 2   EUCTR2011-003821-93-DE   Canada;Germany;United Kingdom;United States
      2012   Phase 2   EUCTR2011-003821-93-GB   Canada;Germany;United Kingdom;United States
VX-661/ivacaftor
   Vertex Pharmaceuticals Incorporated
      2015   Phase 3   NCT02392234   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
VX-661/ivacaftor (VX-770) 100MG/150 MG
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2014-004827-29-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   -   EUCTR2014-004827-29-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
VX-661/ivacaftor 100 MG/ 150 MG
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-PL   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-FR   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-004479-35-IE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
VX-661/ivacaftor 100MG/150 MG
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2014-004788-18-BE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-IT   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
VX-661/ivacaftor 100MG/150MG
   Vertex Pharmaceuticals Incorporated
      2016   Phase 3   EUCTR2014-004838-25-DE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-AT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-BE   Austria;Belgium;Canada;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-SE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-NL   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IT   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-GB   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-ES   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DK   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004787-37-ES   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-DE   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-AT   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
VX-661/ivacaftor 50 MG/ 75 MG
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-PL   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-FR   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-004479-35-IE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
VX-661/VX-770
   VERTEX PHARMACEUTICALS INCORPORATED
      2017   Phase 2   EUCTR2016-000454-36-IT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2019   Phase 2   EUCTR2018-002496-18-PT   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-NL   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-GB   Germany;Netherlands;Portugal;United Kingdom;United States
      2019   Phase 2   EUCTR2018-002496-18-DE   Germany;Netherlands;Portugal;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2018-000126-55-NL   Netherlands
      2018   Phase 3   EUCTR2017-004133-82-IE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-GB   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004133-82-ES   Australia;Germany;Ireland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2017-000797-11-NL   Australia;Belgium;Netherlands;United States
      2017   Phase 2   EUCTR2017-000797-11-BE   Australia;Belgium;Netherlands;United States
      2017   Phase 3   EUCTR2017-000540-18-DE   France;Germany;United States
      2017   Phase 2   EUCTR2016-003585-11-GB   Ireland;Israel;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-NL   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-GB   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-ES   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-DE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-BE   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000454-36-AT   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000454-36-DK   Australia;Austria;Belgium;Canada;Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-DE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-AT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004788-18-BE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-BE   Austria;Belgium;Canada;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-SE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-NL   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IT   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-GB   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-ES   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DK   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   -   EUCTR2014-004827-29-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-IT   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004787-37-ES   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-DE   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-AT   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      -   Phase 1   EUCTR2020-000689-40-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2017-004133-82-DE   Australia;Germany;Ireland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2017-000540-18-FR   France;Germany;United States
VX-77
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
VX-770
   VERTEX PHARMACEUTICALS INCORPORATED
      2022   Phase 3   EUCTR2021-005914-33-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2021   Phase 3   EUCTR2021-000694-85-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2020   Phase 3   EUCTR2020-003170-44-IT   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2019   Phase 3   EUCTR2019-000833-37-IT   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2022   Phase 3   EUCTR2021-005914-33-PT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-FR   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005914-33-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NO   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-HU   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Portugal;Spain;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-CZ   Austria;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-005320-38-AT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      2022   Phase 3   EUCTR2021-000712-31-SE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-PT   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-HU   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-ES   Australia;Czech Republic;Czechia;Germany;Ireland;Israel;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000712-31-DE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-PL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000694-85-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-002239-31-DE   Australia;Canada;Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001628-16-ES   Australia;Belgium;Canada;Spain
      2021   Phase 3   EUCTR2021-000712-31-CZ   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2021-000694-85-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004885-21-ES   Belgium;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-004885-21-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      2021   Phase 3   EUCTR2020-002251-38-DE   Germany;United Kingdom;United States
      2021   Phase 3   EUCTR2020-001404-42-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2021   Phase 3   EUCTR2020-001404-42-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2020-003170-44-CZ   Australia;Belgium;Czech Republic;Czechia;France;Italy;Netherlands;Spain
      2020   Phase 3   EUCTR2020-001404-42-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-NL   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-GB   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DK   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003554-86-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-GB   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-003455-11-DE   Australia;Belgium;Germany;United Kingdom
      2020   Phase 3   EUCTR2019-001827-11-IE   Australia;Canada;Ireland;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-NL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000833-37-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004652-38-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-ES   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000833-37-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004652-38-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-NL   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-GB   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-DE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003970-28-BE   Australia;Belgium;Germany;Ireland;Netherlands;United Kingdom;United States
      2019   Phase 3   EUCTR2018-001695-38-GB   Australia;Canada;Ireland;United Kingdom;United States
      2019   Phase 3   EUCTR2018-000185-11-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004134-29-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-NL   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GR   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000185-11-BE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-NL   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-GB   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000184-89-BE   Belgium;Netherlands;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-000183-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004134-29-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-IE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-GB   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-ES   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DK   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004132-11-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2017-001379-21-GB   Canada;Germany;Ireland;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001997-16-IE   Canada;Germany;Ireland;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
      2016   Phase 3   EUCTR2015-001267-39-GB   Australia;Canada;France;United Kingdom
      2015   Phase 3   NCT02514473   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-000386-20-GB   Canada;United Kingdom;United States
      2013   Phase 3   EUCTR2012-000204-15-GB   Canada;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-GB   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000389-39-BE   Belgium;France;United Kingdom;United States
      2012   Phase 3   EUCTR2012-000388-26-BE   Belgium;France;United States
      2012   -   EUCTR2012-000387-19-GB   United Kingdom;United States
      2011   -   NCT01381289   -
      2010   Phase 1   NCT01216046   United States
      2010   Phase 1   NCT01208285   Czech Republic;Slovakia
      2010   Phase 2   NCT01161537   United States
      2010   Phase 1   NCT01153542   United States
      2010   Phase 1   NCT01060566   United States
      2009   Phase 1   NCT01018368   United States
      -   Phase 3   EUCTR2021-005914-33-SE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-PL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005914-33-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-005320-38-DE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;Switzerland
      -   Phase 3   EUCTR2021-001628-16-BE   Australia;Belgium;Canada;Spain
      -   Phase 3   EUCTR2021-000712-31-IE   Australia;Czech Republic;Czechia;Germany;Hungary;Ireland;Israel;New Zealand;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2021-000694-85-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2020-004885-21-NL   Belgium;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-004885-21-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-NL   Australia;Belgium;Czechia;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-FR   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-003170-44-BE   Australia;Belgium;Czech Republic;France;Italy;Netherlands;Spain
      -   Phase 3   EUCTR2020-001404-42-FR   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2020-001404-42-DE   Australia;Canada;Denmark;France;Germany;Israel;Netherlands;Spain;Switzerland;United Kingdom
      -   Phase 3   EUCTR2019-003455-11-BE   Australia;Belgium;Germany;United Kingdom
      -   Phase 3   EUCTR2019-001827-11-GB   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2019-000833-37-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-004652-38-DE   Australia;Canada;Denmark;Germany;Ireland;Israel;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2018-001695-38-IE   Australia;Canada;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-SE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000185-11-DE   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2018-000183-28-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2017-004132-11-PL   Australia;Canada;Denmark;Germany;Ireland;Israel;Norway;Poland;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-IE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2017-001379-21-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2017-000673-37-Outside-EU/EEA   United States
      -   Phase 2   EUCTR2017-000672-28-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2015-001997-16-GB   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001997-16-DE   Canada;Germany;Ireland;United Kingdom;United States
      -   Phase 3   EUCTR2015-001267-39-FR   Australia;Canada;France;United Kingdom
      -   -   EUCTR2009-010261-23-Outside-EU/EEA   United States
VX-770, VRT-8130077
   Vertex Pharmaceuticals Incorporated
      2010   Phase 3   EUCTR2009-012997-11-FR   Czech Republic;France;Germany;Ireland;United Kingdom
VX-770, VRT-813077
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2018   Phase 3   EUCTR2017-002968-40-PL   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-IE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-GB   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-FR   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-DK   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002968-40-BE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2016-004479-35-PL   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-FR   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-DE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2018   Phase 3   EUCTR2016-004479-35-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      2016   Phase 3   EUCTR2014-004838-25-DE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004838-25-AT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004827-29-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004788-18-BE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IT   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-IE   Austria;Belgium;Canada;France;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004838-25-BE   Austria;Belgium;Canada;Germany;Ireland;Italy;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-SE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-NL   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IT   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-IE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-GB   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-ES   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DK   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004837-13-DE   Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-SE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   -   EUCTR2014-004827-29-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-IE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004827-29-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-IT   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004788-18-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Switzerland;United Kingdom;United States
      2015   Phase 3   EUCTR2014-004787-37-ES   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-DE   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2015   Phase 3   EUCTR2014-004787-37-AT   Australia;Austria;Canada;France;Germany;Israel;Spain;United States
      2014   -   EUCTR2010-020413-90-IE   Australia;Belgium;France;Germany;Ireland;United Kingdom;United States
      2014   Phase 2   EUCTR2010-020413-90-GB   Australia;Belgium;Germany;Ireland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-003821-93-DE   Canada;Germany;United Kingdom;United States
      2012   Phase 2   EUCTR2011-003821-93-GB   Canada;Germany;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-DE   Australia;Belgium;Germany;New Zealand;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-BE   Australia;Belgium;Germany;Ireland;New Zealand;United Kingdom;United States
      2010   -   EUCTR2010-020546-96-GB   Canada;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   Phase 3   EUCTR2009-012997-11-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2010   -   EUCTR2009-012997-11-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   -   EUCTR2008-007479-26-IE   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007479-26-GB   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007479-26-FR   France;Germany;Ireland;United Kingdom
      2009   -   EUCTR2008-007479-26-DE   Australia;Canada;France;Germany;Ireland;United Kingdom;United States
      2009   -   EUCTR2008-007416-15-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007416-15-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
      2009   Phase 3   EUCTR2008-007416-15-FR   Czech Republic;France;Germany;Ireland;United Kingdom
      2009   -   EUCTR2008-007416-15-CZ   Czech Republic;France;Germany;Ireland;United Kingdom
      2007   -   EUCTR2007-002657-23-DE   Germany
      -   Phase 3   EUCTR2017-002968-40-DE   Australia;Belgium;Canada;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-004479-35-IE   Australia;Belgium;Denmark;France;Germany;Ireland;Poland;Switzerland;United Kingdom
      -   -   EUCTR2008-007416-15-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;United Kingdom;United States
VX-809
   Vertex Pharmaceuticals Incoporated
      2017   Phase 4   EUCTR2016-004996-33-ES   Australia;Canada;Spain;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2016   Phase 2   EUCTR2016-001585-29-NL   Netherlands
      2015   Phase 3   NCT02514473   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2010   Phase 1   NCT01216046   United States
      2009   Phase 2   NCT00865904   Belgium;Canada;Germany;Netherlands;United States
      2009   -   EUCTR2008-006446-25-NL   Belgium;Germany;Netherlands
      2009   -   EUCTR2008-006446-25-DE   Belgium;Germany;Netherlands
      2009   -   EUCTR2008-006446-25-BE   Belgium;Germany;Netherlands
VX-809 & VX-770
   Vertex Pharmaceuticals Incorporated
      2009   Phase 1   NCT00966602   Netherlands
VX-809 / VX-770
   Vertex Pharmaceuticals Incorporated
      2018   Phase 2   EUCTR2017-003761-99-DE   Germany
      2016   Phase 3   EUCTR2015-001644-11-GB   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-FR   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DK   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-DE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001644-11-BE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-SE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-GB   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-DK   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-DE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-000543-16-BE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000604-41-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   -   EUCTR2013-000604-41-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2013-000604-41-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2013-000604-41-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-ES   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003990-24-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   -   EUCTR2012-003990-24-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Spain;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-SE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-NL   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IT   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-IE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-GB   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003989-40-DE   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003989-40-CZ   Australia;Canada;Czech Republic;France;Germany;Ireland;Italy;Netherlands;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-001644-11-SE   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2015-000543-16-FR   Australia;Belgium;Canada;Denmark;France;Germany;Sweden;United Kingdom;United States
VX-809, VRT-826809
   Vertex Pharmaceuticals Incorporated
      2014   -   EUCTR2010-020413-90-IE   Australia;Belgium;France;Germany;Ireland;United Kingdom;United States
      2014   Phase 2   EUCTR2010-020413-90-GB   Australia;Belgium;Germany;Ireland;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-DE   Australia;Belgium;Germany;New Zealand;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-BE   Australia;Belgium;Germany;Ireland;New Zealand;United Kingdom;United States
VX-809/VX-770
   Vertex Pharmaceuticals Inc.
      2016   Phase 2   EUCTR2015-004841-13-IE   Czech Republic;France;Ireland;United Kingdom;United States
      -   Phase 2   EUCTR2015-004841-13-FR   Czech Republic;France;Ireland;United Kingdom;United States
   Vertex Pharmaceuticals Incorporated
      2017   Phase 2   EUCTR2015-004841-13-CZ   Czech Republic;France;Ireland;United Kingdom;United States
      2016   Phase 4   EUCTR2016-000066-34-GB   Australia;United Kingdom
      2014   -   EUCTR2010-020413-90-IE   Australia;Belgium;France;Germany;Ireland;United Kingdom;United States
      2014   Phase 2   EUCTR2010-020413-90-GB   Australia;Belgium;Germany;Ireland;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-DE   Australia;Belgium;Germany;New Zealand;United Kingdom;United States
      2011   -   EUCTR2010-020413-90-BE   Australia;Belgium;Germany;Ireland;New Zealand;United Kingdom;United States
      -   Phase 3   EUCTR2023-000946-41-Outside-EU/EEA   Canada;United States
      -   Phase 3   EUCTR2017-001309-34-Outside-EU/EEA   United States
      -   Phase 3   EUCTR2017-001078-41-Outside-EU/EEA   Canada;United States
   Vertex Pharmaceuticals, Inc.
      2016   Phase 2   EUCTR2015-004841-13-GB   Czech Republic;France;Ireland;United Kingdom;United States
VX-828
   Vertex Pharmaceuticals Incorporated
      2025   Phase 1   NCT06861413   United States
      2023   Phase 1   NCT06154447   United States
Water
   Johns Hopkins University
      2012   Phase 2   NCT01594827   United States
   Nordmark Arzneimittel GmbH & Co. KG
      2013   Phase 1/Phase 2   NCT01710644   United States
Water FOR injections, EP
   Fundació Parc Taulí
      2017   Phase 2   EUCTR2016-004033-25-ES   Spain
Whole body protein turnover
   University of Texas Southwestern Medical Center
      2006   -   NCT00287456   United States
      2006   -   NCT00287443   United States
Whole body protein turnover study
   University of Texas Southwestern Medical Center
      2006   -   NCT00287430   -
Wrair-PAM-CF1
   National Institute of Allergy and Infectious Diseases (NIAID)
      2022   Phase 1/Phase 2   NCT05453578   United States
Xenon
   Children's Hospital Medical Center, Cincinnati
      2021   -   NCT04793867   United States
   The Hospital for Sick Children
      2015   Phase 2   NCT02740868   Canada
Xolair
   NOVARTIS FARMA
      2009   -   EUCTR2007-006648-23-IT   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
   Novartis Pharma Services AG
      2009   -   EUCTR2007-006648-23-NL   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2009   Phase 4   EUCTR2007-006648-23-IE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2009   -   EUCTR2007-006648-23-GB   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-006648-23-BE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
Xolair 150 MG pulver UND injektionslösung ZUR herstellung einer injektionslösung
   Novartis Pharma Services AG
      2008   -   EUCTR2007-006648-23-DE   Belgium;Germany;Ireland;Italy;Netherlands;United Kingdom
Xylitol
   Joseph Zabner
      2013   Phase 1/Phase 2   NCT00928135   United States
      2011   Phase 1/Phase 2   NCT01355796   United States
Zadaxin
   SciClone Pharmaceuticals Limited Ltd
      2019   Phase 2   EUCTR2019-001441-40-IT   Italy
Zavesca
   Actelion Pharmaceuticals Ltd
      2008   -   EUCTR2008-002352-20-BE   Belgium
      2007   Phase 2   EUCTR2006-002049-35-ES   Spain
Zenpep
   AbbVie
      2012   -   NCT01652157   United States
   Aptalis Pharma US Inc.
      2013   -   EUCTR2009-012842-21-HU   Bulgaria;Germany;Hungary;Italy;United Kingdom
      2012   Phase 3   EUCTR2009-012842-21-BE   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
      2011   -   EUCTR2009-012842-21-BG   Belgium;Bulgaria;France;Germany;Hungary;Ireland;Italy;Poland;Romania;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-012842-21-GB   Belgium;Bulgaria;Germany;Hungary;Italy;United Kingdom
   EURAND SPA
      2010   -   EUCTR2009-012842-21-IT   Bulgaria;Germany;Hungary;Italy;United Kingdom
Zinc acetate
   Cystic Fibrosis Foundation Therapeutics
      2004   -   NCT00104494   United States
Zithomax 40 MG/ML enfants
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      -   Phase 3   EUCTR2014-003023-22-FR   France
Zithromax
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      -   Phase 3   EUCTR2014-003023-22-FR   France
Zitromax
   Copenhagen CF-centre
      2009   Phase 4   EUCTR2006-003275-12-NO   Denmark;Norway;Sweden
      2007   Phase 4   EUCTR2006-003275-12-DK   Denmark
      -   Phase 4   EUCTR2006-003275-12-SE   Denmark;Norway;Sweden
Zoledronic acid
   Papworth Hospital NHS Foundation Trust
      2013   Phase 4   NCT01702415   United Kingdom